Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.134183713522416,0.00280084226351923,0.128694062685918,0.139673364358914,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,39980,-0.469501608386963,0.0111905228001539,-0.491435033075265,-0.447568183698661,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.196615722559334,0.00471110569877209,-0.205849489728927,-0.187381955389741,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,40332,-0.17450535959899,0.00374482831031877,-0.181845223087215,-0.167165496110765,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.126845288311355,0.0027969823410369,0.121363202922923,0.132327373699788,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.102141004426931,0.00246548956984358,0.0973086448700376,0.106973363983824,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.155635935672206,0.0037867730940752,-0.163058010936594,-0.148213860407819,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,40293,-0.134588637110483,0.00366746363356558,-0.141776865832271,-0.127400408388694,4.80333804899931e-283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,40516,-0.177638619836734,0.00485632779609032,-0.187157022317071,-0.168120217356397,1.8988545564397e-281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.0965748045895808,0.00266749324041278,-0.10180309134079,-0.0913465178383718,8.73255400428195e-276
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,37990,-0.255929665490842,0.00722455961935381,-0.270089802344775,-0.241769528636908,5.8571288554904e-263
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,40489,-0.209032771254321,0.00608246319869935,-0.220954399123772,-0.19711114338487,8.36434632392058e-250
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,40372,0.0836168125811125,0.00245113336602663,0.0788125911837003,0.0884210339785247,3.10353464133383e-246
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYY,Peptide YY,37562,-0.293687136881213,0.00864295052074752,-0.310627319901878,-0.276746953860548,1.24475724405441e-242
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,40305,-0.276542515488876,0.00843241019650362,-0.293070039474024,-0.260014991503729,2.71694826962577e-228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,37987,0.0723238272139746,0.00221354589214454,0.0679852772653713,0.0766623771625779,1.89488575692404e-225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.194662024138275,0.0061661417903569,-0.206747662047375,-0.182576386229176,4.32134734191909e-212
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,38013,0.191628602935341,0.00610135986230503,0.179669937605224,0.203587268265459,4.47537649433134e-209
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.0900667705142556,0.00294496373862663,-0.0958388994419638,-0.0842946415865474,1.30371675218005e-199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,40280,-0.20831282280372,0.00719060059807483,-0.222406399975946,-0.194219245631493,7.46391673429442e-180
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.353014887326415,0.0121906981143303,-0.376908655630502,-0.329121119022327,9.28560383001137e-180
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,40359,0.119123720735501,0.00424112657515632,0.110811112648195,0.127436328822807,1.83616788152811e-169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.140432694406063,0.00503773062546423,-0.150306646431973,-0.130558742380153,2.64537973115472e-166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0841776728592239,0.00313244090215467,-0.0903172570274471,-0.0780380886910008,1.24913014881044e-155
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,40352,-0.18893925294331,0.00705444994445665,-0.202765974834445,-0.175112531052175,1.3446610001788e-154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.165397587804198,0.00625436091330756,-0.177656135194281,-0.153139040414116,7.61084333293269e-151
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.134482200491147,0.00510139695672033,-0.144480938526319,-0.124483462455975,6.2572204739421e-150
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.0527698962977147,0.00202256476189505,0.0488056693644004,0.056734123231029,5.39683800150885e-147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FURIN,Furin,40411,-0.0809346297713175,0.00311900870898766,-0.0870478868409333,-0.0748213727017017,1.91538739347151e-145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.282602892625208,0.0108934118003048,0.261251805496611,0.303953979753806,2.15789885860262e-145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,40461,0.0806024934640673,0.0031784814937263,0.0743726697363637,0.0868323171917708,3.95127207005013e-139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.0711561703110725,0.00283058789534551,-0.0767041225859497,-0.0656082180361953,8.92073559067204e-137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.0791926262604116,0.00317055673937218,-0.0854069174695811,-0.0729783350512421,4.1849959510315e-135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.0973968534597013,0.00393931414012708,-0.10511790917435,-0.0896757977450522,2.0374770541791e-132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,40470,-0.0458309310631603,0.00185714520395606,-0.0494709356629142,-0.0421909264634064,5.29486693803837e-132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.0987012511863049,0.00400629713552779,-0.106553593571939,-0.0908489088006704,1.39417503677593e-131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,40309,-0.122232033058586,0.00497666802870231,-0.131986302394843,-0.11247776372233,9.04918898840538e-131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0730837969365129,0.00297588396984239,-0.078916529517404,-0.0672510643556218,3.3002529633784e-130
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.104848310779569,0.00429312666844128,-0.113262839049714,-0.0964337825094243,2.30806252976442e-129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,40359,-0.135004183687429,0.00553156348193557,-0.145846048112022,-0.124162319262835,3.45672119097575e-129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.121072844568425,0.00496857931082603,-0.130811260017644,-0.111334429119205,8.60040152186657e-129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.094612459192765,0.00389640353407958,-0.102249410119561,-0.086975508265969,6.20805089451986e-128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,40489,0.0777111112840744,0.00320874507511378,0.0714219709368514,0.0840002516312974,2.71449757174462e-127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.0765715562971004,0.00317043469570426,0.0703575042935201,0.0827856083006808,1.32892518130971e-126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,40357,-0.118445607069424,0.00491910539112268,-0.128087053636024,-0.108804160502823,7.4027418440846e-126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,37572,-0.17497964642016,0.00733752123314536,-0.189361188037125,-0.160598104803196,4.41282811972501e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.0763789404484194,0.00320944114548497,-0.08266944509357,-0.0700884358032689,4.80588966457178e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,40338,0.100806641562931,0.00423940868412742,0.0924974005420415,0.109115882583821,7.73800606026479e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,40536,-0.116065492464005,0.00493017524623441,-0.125728635946625,-0.106402348981386,1.64636692309284e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.106932304318233,0.00455188023238563,-0.115853989573709,-0.0980106190627573,5.93178689616095e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.119438503048139,0.00509361337369153,-0.129421985260575,-0.109455020835704,1.6217684430615e-119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.056100385462665,0.00241885061348986,-0.0608413326651051,-0.0513594382602248,1.07528121805193e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.09890154329584,0.00427783380428479,-0.107286097552238,-0.0905169890394418,2.55549876289379e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,40516,-0.0562716225876228,0.00244579762181114,-0.0610653859263726,-0.051477859248873,2.84439926583481e-115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,40044,-0.163103337126315,0.00713120262011556,-0.177080494261742,-0.149126179990889,6.59479063535667e-114
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0785683274081009,0.00344526465539355,-0.0853210461326723,-0.0718156086835296,2.5927377361069e-113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.0810465758814821,0.00355488987507702,-0.0880141600366331,-0.0740789917263312,2.9480224417766e-113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.0735537007346083,0.0032294139785934,-0.0798833521326514,-0.0672240493365653,4.87563772200355e-113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.15799387750469,0.00695027801835401,-0.171616422420664,-0.144371332588716,1.44542108803736e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,40332,-0.0901243304241637,0.00396658888996831,-0.0978988446485016,-0.0823498161998258,1.72019827449766e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9,Complement component C9,37987,0.103467963175451,0.00454822925502779,0.0945534338355963,0.112382492515305,1.85966523255134e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.0627478593834077,0.00277176751820989,0.0573151950477163,0.0681805237190991,1.05032706496642e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,40415,-0.0721109121228054,0.00318667715550226,-0.0783567993475898,-0.0658650248980209,1.27583737028744e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.0793615215730891,0.00351431147151722,-0.0862495720572629,-0.0724734710889154,7.95965008350197e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.157313483135439,0.00702420558382069,-0.171080926079727,-0.14354604019115,4.15716544515794e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.110962783842673,0.00497419822939284,0.101213355313063,0.120712212372283,1.51303636742195e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0557702930856896,0.00250949086335026,0.0508516909935231,0.0606888951778562,8.7949361530846e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.0679889660283555,0.00307169743926609,-0.0740094930093171,-0.061968439047394,5.9103886495494e-107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,40419,-0.120152956506053,0.00545490527980172,-0.130844570854464,-0.109461342157641,6.02638875240969e-106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,39243,-0.0819330838604294,0.00372044659249957,-0.0892251591817285,-0.0746410085391302,8.74427462598401e-106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0626883020662427,0.00285069585015078,0.0571009381999471,0.0682756659325382,2.71007012630419e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.238298437383699,0.0109063637215919,-0.259674910278019,-0.216921964489378,2.61973759126084e-104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,39961,-0.102168085027371,0.00468551249874778,-0.111351689524917,-0.0929844805298256,7.49259986736599e-104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,37981,0.0738528290126332,0.00338893961527341,0.0672105073666973,0.080495150658569,1.63919841446447e-103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,40337,-0.203737547479554,0.00940544432491643,-0.222172218356391,-0.185302876602718,1.43240511353172e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,37990,-0.184720580791682,0.00852073508319791,-0.20142122155475,-0.168019940028614,1.77696994770767e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,40372,-0.0682708453598967,0.00316071663651298,-0.0744658499674621,-0.0620758407523312,5.23135661945994e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.112089045530943,0.00519282966054579,-0.122266991665613,-0.101911099396273,7.59672792762684e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0619591718836677,0.00287113502970016,-0.06758659654188,-0.0563317472254554,8.03818929551915e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.062817182317871,0.00291134496707155,0.0571109461824108,0.0685234184533313,8.6150924285662e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,40516,-0.0685771611893285,0.00319573476459029,-0.0748408013279255,-0.0623135210507316,9.73608196288328e-101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.103810845919964,0.00483699409223134,-0.113291354340738,-0.094330337499191,1.84051635021873e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0876515508023165,0.00409159126598683,-0.0956710696836507,-0.0796320319209823,2.30201729553329e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.29553255250956,0.0138195650030576,-0.322618899915553,-0.268446205103567,4.90650838450633e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,40502,0.107894809543136,0.00506577986585524,0.0979658810060601,0.117823738080213,2.74823666037978e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.0594280294414193,0.00279119759287436,-0.0648987767234531,-0.0539572821593856,3.30359787197015e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,40372,-0.0357878677551749,0.00168137079975584,-0.0390833545226963,-0.0324923809876534,3.7548483013741e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,37345,0.0888683465151825,0.00417280733613824,0.0806896441363516,0.0970470488940135,6.06787182079435e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,40424,0.055969713192678,0.00263494597769689,0.0508052190763921,0.0611342073089639,9.17859864338713e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0811067783183211,0.00382675346055066,-0.0886072151010004,-0.0736063415356418,2.40930745714919e-98
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,40330,-0.0572162862380272,0.00270301107677159,-0.0625141879484995,-0.0519183845275548,4.28747006462811e-98
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,40332,-0.0466539858070765,0.00220965890611498,-0.0509849172630619,-0.0423230543510912,1.30282951504892e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,40345,-0.0613367233992845,0.00290675389370038,-0.0670339610309372,-0.0556394857676317,1.67079004907811e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,40332,0.0530686860936397,0.00251500945971472,0.0481392675525988,0.0579981046346806,1.69784332539203e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,37671,-0.0825160315386922,0.00390752217809857,-0.0901747750077654,-0.074857288069619,2.22322976193158e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.165525294759441,0.00785601970608997,-0.180923093383377,-0.150127496135504,3.39020967215942e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.141700472650738,0.00678362310267245,-0.154996373931976,-0.1284045713695,2.15787856679548e-95
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.106396990003649,0.00511616146938307,-0.11642466648364,-0.0963693135236582,8.59477441243523e-95
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,40516,-0.0584217445706618,0.00280955162874722,-0.0639284657630063,-0.0529150233783172,8.6698404091036e-95
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.0669906673750582,0.00324578696889909,-0.0733524098341004,-0.060628924916016,1.99612450155285e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.159561209361526,0.00773162865408031,-0.174715201523523,-0.144407217199528,2.12000723652661e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,40465,-0.0507906836304676,0.00247216261120218,-0.0556361223484239,-0.0459452449125114,1.32890987411748e-92
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,40305,-0.105955920307969,0.00516983423367116,-0.116088795405964,-0.0958230452099734,3.71953996281319e-92
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.0518095819976597,0.00253237338354047,-0.056773033829399,-0.0468461301659204,7.51136781611395e-92
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.11783945875801,0.00576178538463275,-0.12913255811189,-0.10654635940413,9.3183686135015e-92
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,40536,-0.0849152981333892,0.00416666199478374,-0.0930819556431654,-0.0767486406236131,3.57957300234712e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,37642,-0.0691787006164065,0.00339082165826562,-0.0758247110666071,-0.0625326901662059,4.08553587288896e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.0717046401967083,0.00352200760764737,0.0648015052857194,0.0786077751076972,5.58441682846314e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.119395540775908,0.00592001869310118,-0.130998777414387,-0.10779230413743,2.3946734346283e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,40375,0.0378646190412455,0.00188305201806149,0.034173837085845,0.041555400996646,7.91978910660944e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0649954173433771,0.00324783015062704,-0.0713611644386061,-0.0586296702481481,5.19313212238124e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.0697830712271292,0.00349098364635599,-0.0766253991739869,-0.0629407432802714,7.92704286867521e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.077266061172124,0.00388207436704883,-0.0848749269315397,-0.0696571954127082,4.40078454698103e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,37671,-0.0538191319497962,0.00270415529792748,-0.059119276333734,-0.0485189875658583,7.22413016269245e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0528850567775166,0.00266515978716884,-0.0581087699603675,-0.0476613435946657,1.39329422038176e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MENT,Protein MENT,37671,0.0401077370090055,0.00203488072902461,0.0361193707801173,0.0440961032378937,2.94448691037046e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,40376,-0.0552146580640429,0.00280528867303423,-0.06071302386319,-0.0497162922648958,3.14210942598266e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.152448564256833,0.00778886365683837,-0.167714737024236,-0.13718239148943,3.8894046575825e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.144655685576776,0.00739884860620086,-0.15915742884493,-0.130153942308623,3.94521525707306e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,37959,-0.0844438024751153,0.00431837486620923,-0.0929078172128854,-0.0759797877373452,5.45138598288801e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.112664751199608,0.00576892496085227,0.101357658276337,0.123971844122878,5.99139804077849e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,39963,-0.108488868636781,0.00556983007305239,-0.119405735579963,-0.097572001693598,1.67606877722888e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0710182277046903,0.00365169831650111,-0.0781755564050324,-0.0638608990043481,2.8234680017709e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.139856896359835,0.00720697723296473,-0.153982571736446,-0.125731220983224,6.30957773853612e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,40359,-0.107812121966766,0.00556892297552403,-0.118727210998793,-0.0968970329347387,1.50459979813421e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.106092999425705,0.00548592580446738,-0.116845414002461,-0.0953405848489493,2.33712766949722e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.0988408139216183,0.00514310596956643,-0.108921301621968,-0.0887603262212681,2.21908659327771e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0622958626590242,0.00324291394954848,0.0559397513179092,0.0686519740001393,2.49077433136972e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,40305,-0.0890530371107099,0.00464070846910552,-0.0981488257101567,-0.0799572485112631,3.76112936833811e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,40392,-0.0577912162329682,0.00301512225410661,-0.0637008558510172,-0.0518815766149192,5.66677280469387e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,40305,-0.0642114423722385,0.00338317585308494,-0.070842467044285,-0.0575804177001921,1.90813479193745e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0288125271309637,0.00153617213409035,0.0258016297481466,0.0318234245137808,1.16292551297646e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,40398,-0.112383633058306,0.00600205370585262,-0.124147658321777,-0.100619607794835,2.12336079310193e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.052138612272166,0.00278841573258319,-0.0576039071080291,-0.0466733174363029,3.42420139707166e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,40536,0.0483209926762321,0.00259202507546479,0.0432406235283211,0.053401361824143,9.40211921847639e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.0505017824075046,0.00271046358973224,-0.0558142910433798,-0.0451892737716294,1.1562845730645e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0473975162852427,0.00254792585184169,-0.0523914509548524,-0.042403581615633,2.81374022875155e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0401942219931656,0.00217121421397723,-0.044449801852561,-0.0359386421337703,1.02066420501587e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.130752071134554,0.00709167864235407,-0.144651761273568,-0.11685238099554,4.16457106326985e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.180762987896402,0.00981832990336207,-0.200006914506991,-0.161519061285812,6.49489547802642e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0583995834922004,0.0031762594589144,-0.0646250520316726,-0.0521741149527282,1.00493757441402e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.0546490357475011,0.00297628938617319,0.0488155085506016,0.0604825629444005,1.56899243678666e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,40350,-0.0548109237123418,0.00301407536294338,-0.0607185114237108,-0.0489033360009728,3.7393676020143e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MME,Neprilysin,40305,-0.138570623969079,0.00762262768344832,-0.153510974228638,-0.123630273709521,4.19249769214371e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OCLN,Occludin,37959,-0.0744205681704395,0.00409397112853339,-0.0824447515823649,-0.0663963847585141,5.69158106262106e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.0926341731620174,0.00510499818757338,-0.102639969609661,-0.0826283767143735,7.78133816777149e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0898978926081061,0.0049715207602576,-0.099642073298211,-0.0801537119180012,2.32164421287314e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.0344901871179684,0.00190747476631137,-0.0382288376599387,-0.0307515365759981,2.3694986822142e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.0637574479414196,0.00353261694284178,-0.0706813771493895,-0.0568335187334497,4.27274472923286e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.15511247151748,0.00860394328916422,-0.171976200364242,-0.138248742670718,6.30140297385144e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.13573813946553,0.00753640669921172,-0.150509496595985,-0.120966782335075,8.58277560787693e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,40359,-0.0435830913888014,0.00242571974328608,-0.0483375020856421,-0.0388286806919607,1.7936051388959e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.041404440918584,0.002305142761694,0.0368863611056638,0.0459225207315043,1.97784195180674e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,40434,-0.080101019763075,0.00445978692628476,-0.0888422021385931,-0.0713598373875569,1.99137177945155e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.0451505229695776,0.00253303584746485,0.0401857727085465,0.0501152732306087,2.20396524532179e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.0428691512226663,0.00241117977626431,-0.0475950635841444,-0.0381432388611883,4.83794861890787e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.14612196026837,0.0082287286047702,-0.16225026833372,-0.129993652203021,7.15295262817864e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0644079615918117,0.00363558977163838,-0.0715337175442229,-0.0572822056394004,2.02116303233331e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.051206644400651,0.00289533149223888,-0.0568814941254393,-0.0455317946758628,2.45984543204464e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,40203,-0.0488264085095252,0.00276266478513089,-0.0542412314883817,-0.0434115855306687,3.11540259332397e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,40422,0.0734314365515513,0.00416051739021329,0.0652768224667333,0.0815860506363694,4.63601671534654e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.0458302349223191,0.00259897327121187,0.0407362473107438,0.0509242225338944,6.09035081857631e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.061977363691166,0.00351721934210381,-0.0688711136016895,-0.0550836137806425,7.73740734184388e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0537565987665544,0.00305169902590033,-0.0597379288573191,-0.0477752686757898,8.33267322085604e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,40332,-0.0932556431864917,0.00529676060951114,-0.103637293981134,-0.0828739923918499,9.92975485175819e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.0550462018910712,0.00312977845167967,-0.0611805676563634,-0.0489118361257791,1.34535329351737e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,40516,-0.044749165310238,0.00255400454760105,-0.0497550142235361,-0.0397433163969399,4.24293722953482e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.0636250211838569,0.00363375844612026,-0.0707471877382526,-0.0565028546294612,6.82898024211413e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0579038790304735,0.00331497149951914,-0.064401223169531,-0.051406534891416,1.08673919339263e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.0971367157408152,0.00556585343507832,-0.108045788473569,-0.0862276430080616,1.40242587651527e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0446761782671923,0.0025646895517713,-0.0497029697886641,-0.0396493867457206,2.46958257154518e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,40372,-0.0454851143539494,0.00263891861974342,-0.0506573948486465,-0.0403128338592523,5.63057421845147e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,37901,-0.179362668038621,0.0104005294212682,-0.199747705704306,-0.158977630372935,6.17816989665434e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.0499928134252012,0.00291681264424908,-0.0557097662079294,-0.044275860642473,3.73480369399801e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.0695211168590209,0.00407003110288226,-0.0774983778206701,-0.0615438558973717,7.76650948377425e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.109605375696179,0.00643397924970147,-0.122215975025594,-0.0969947763667642,2.12256183925379e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0493666865496762,0.00290331116732156,-0.0550571764376264,-0.0436761966617259,3.57364340174754e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.0340045653836445,0.00200436073521234,-0.0379331124246607,-0.0300760183426283,5.39630867302569e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,40192,-0.0875793899801805,0.00516241388808945,-0.0976977212008358,-0.0774610587595252,5.53705821245203e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0573092553968184,0.00338950331858617,-0.0639526819012473,-0.0506658288923895,1.42836580999278e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0489520765658414,0.00289847262890302,-0.0546330829184913,-0.0432710702131915,1.9930800246343e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0632221941804093,0.00374451402343399,-0.0705614416663399,-0.0558829466944787,2.10794826728395e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,40489,0.0258865719086096,0.00153616465002526,0.02287568919456,0.0288974546226591,3.57865110474522e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,40042,-0.0848859951669526,0.00503688051957697,-0.0947582809853234,-0.0750137093485817,3.61896038236493e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,40536,-0.0891230421631299,0.00529495209392222,-0.0995011482672175,-0.0787449360590424,4.94837629353617e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,40145,-0.0566981856289877,0.00337141544336823,-0.0633061598979895,-0.050090211359986,6.47560733512852e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0754177938039419,0.0044940666730677,-0.0842261644831545,-0.0666094231247292,1.15158044374473e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.081652959013129,0.00489084167707914,-0.0912390087002041,-0.0720669093260539,4.75997818577701e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,40411,-0.0637228623010012,0.00381944440517341,-0.0712089733351411,-0.0562367512668613,5.75595046555098e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.157150558325582,0.00952284212108214,-0.175815328882903,-0.138485787768261,1.1686798371235e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.0908994741890057,0.00551162857085551,-0.101702266187883,-0.0800966821901289,1.3176252697171e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0583759397222293,0.00355630652299523,-0.0653463005073,-0.0514055789371587,4.62667896525031e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0538817921351527,0.00330436528055961,-0.0603583480850496,-0.0474052361852559,2.73493132432488e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.112009808235678,0.00688232275959897,-0.125499160844492,-0.098520455626864,4.50803061222013e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.0430541710637096,0.00265883813062649,-0.0482654937997376,-0.0378428483276817,2.00295809709213e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.0503000560523273,0.0031131272330883,-0.0564017854291803,-0.0441983266754742,2.92545893652926e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,40341,-0.0797777688186112,0.00497757298117129,-0.0895338118617069,-0.0700217257755155,2.31434069500639e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,40447,-0.0558133614034197,0.00348317729943661,-0.0626403889103154,-0.0489863338965239,2.43933911929049e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,37628,-0.0821553861459476,0.00512937147244891,-0.0922089542319474,-0.0721018180599477,3.38623189034175e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.0955471833749461,0.00597364741792381,0.0838388344358154,0.107255532314077,3.8416079024965e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,40330,-0.0445891165708885,0.00279157874738681,-0.0500606109157666,-0.0391176222260103,5.50026952005191e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELE,E-selectin,40536,-0.0748444593546116,0.00470120028149794,-0.0840588119063476,-0.0656301068028756,1.2406512357984e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.0420855611559613,0.0026454146289723,-0.047270573828747,-0.0369005484831756,1.51933506530669e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.0918821666293845,0.00579174814878535,-0.103233993001004,-0.0805303402577653,3.00051928572113e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.101112489114195,0.00638439073314981,-0.113625894951169,-0.0885990832772214,4.61588206069018e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.0445813978676046,0.00281558088888225,0.0390628593253954,0.0500999364098138,4.96065567815019e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,40516,-0.0662426979076017,0.00418707787943696,-0.0744493705512982,-0.0580360252639053,5.92017697839156e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.193531665064048,0.0122342597040708,-0.217510814084027,-0.16955251604407,6.11027016586971e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,40341,-0.0639781802343931,0.00404444145524104,-0.0719052854866655,-0.0560510749821206,6.16890975014155e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0539402379904266,0.00341258255225317,-0.0606288997928428,-0.0472515761880103,7.5053922550018e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.0971957125425199,0.00615300361094202,-0.109255599619966,-0.0851358254650736,8.67561114758489e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,40341,0.0505280697775241,0.00319874245600381,0.0442585345637567,0.0567976049912916,8.77634417673356e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.0669796793238202,0.00424287696676694,-0.0752957181786834,-0.0586636404689569,1.01437266567046e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0945706176685154,0.00599597151244128,0.0828185135041305,0.1063227218329,1.55185669051781e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.0904548786721418,0.00574741789396207,-0.101719817744307,-0.0791899395999761,2.16320642075793e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.072040582310254,0.00457854021216846,-0.0810145211261042,-0.0630666434944038,2.78713630585948e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,37917,-0.0437335994156867,0.00278545938329026,-0.0491930998069356,-0.0382740990244378,4.60321873833371e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.0843890472524628,0.00539327591971523,-0.0949598680551047,-0.073818226449821,1.07947064006379e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,40516,-0.0592364156343356,0.00379098590195732,-0.0666667480021719,-0.0518060832664992,1.23022080501695e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.0503894346208967,0.00324632834866607,-0.0567522381842822,-0.0440266310575112,6.14303302430535e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0394165124573291,0.0025380745436754,-0.0443911385629329,-0.0344418863517253,6.37616688186455e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.0900255347364469,0.00581900524281008,-0.101430785012355,-0.0786202844605391,1.34028260902552e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.0858383999544798,0.0055779668152801,-0.0967712149124288,-0.0749055849965308,4.7039387802263e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,40359,0.0526258727296995,0.00342513955215037,0.0459125992074847,0.0593391462519142,6.78188844517888e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.0978925969142651,0.0063986039327493,-0.110433860622454,-0.0853513332060765,2.19752974671666e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.082576403392483,0.00540067612119076,-0.0931617285900169,-0.0719910781949492,2.44394329150319e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POSTN,Periostin,37998,0.0544514390318091,0.00356573940279382,0.0474625898023332,0.061440288261285,3.25970524180282e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0828085037044732,0.00544067224101148,-0.0934722212968557,-0.0721447861120907,7.01596872222248e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0651603984999722,0.00429156255233749,-0.0735718611025537,-0.0567489358973907,1.24226813986305e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.0535559058914285,0.00353747009321496,0.0466224645087272,0.0604893472741299,2.02038150411702e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0626890929645824,0.00415321393176566,-0.0708293922708431,-0.0545487936583217,3.96904435287895e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFM,Afamin,38013,-0.0265463591438259,0.0017582700008171,-0.0299925683454274,-0.0231001499422244,4.34047726946185e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,40228,-0.057842417571128,0.00383566689676093,-0.0653603246887794,-0.0503245104534765,4.96192982633881e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.0296627096581191,0.00197318923813729,-0.0335301605648682,-0.02579525875137,9.90867860235059e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,37628,-0.091440626213654,0.00607925521145812,-0.103355966428112,-0.0795252859991961,1.03547661824852e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REN,Renin,40359,-0.100913024092876,0.00671564081534685,-0.114075680090956,-0.0877503680947961,1.0955230682303e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.0441734042823683,0.00294407363659088,-0.0499437886100864,-0.0384030199546501,1.53334764472085e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,37987,0.0763302171139932,0.00509067685942228,0.0663524904695255,0.0863079437584608,2.03646226437849e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,40367,0.052084798646023,0.0034827301545283,0.0452586475431475,0.0589109497488984,3.16128937710868e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.110281005625529,0.00737563285052541,-0.124737246012559,-0.0958247652384993,3.31940639605437e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRN,Agrin,40422,-0.0466410281392035,0.00312083860933886,-0.0527578718135076,-0.0405241844648993,3.66328412052718e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0682089602221997,0.00456546394373005,0.0592606508924888,0.0771572695519106,4.52567760494841e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXN,Paxillin,39961,-0.0726011503693499,0.00486740077804469,-0.0821412558943175,-0.0630610448443823,5.77522376658142e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,40403,-0.0705008994811614,0.00472909094405838,-0.0797699177315159,-0.061231881230807,6.34737152128518e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,40489,-0.0376884669332581,0.00253064695417246,-0.0426485349634361,-0.0327283989030801,7.89971273272868e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.0479031385148423,0.00323224227498188,-0.0542383333738068,-0.0415679436558778,2.28885878435182e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.0535655541420009,0.00361621365999134,-0.0606533329155839,-0.0464777753684178,2.58799181477343e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0500411434458547,0.00338668011545182,-0.0566790364721403,-0.0434032504195692,4.51528100633845e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0800171639132211,0.00542507610278976,-0.090650313074689,-0.0693840147517531,7.46096345709261e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.107281641882474,0.00730437032942415,-0.121598207728145,-0.0929650760368025,1.60390109496912e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.0378544504200535,0.00258013474419394,-0.0429115145186736,-0.0327973863214334,2.02763486401753e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0846243609698748,0.00578113315143371,-0.0959553819466849,-0.0732933399930648,3.30964596358823e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.0418887521354572,0.00286257915930883,-0.0474994072877025,-0.0362780969832118,4.11045558512247e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSN,Gelsolin,37928,0.0262980832590983,0.0018005201487964,0.0227690637674573,0.0298271027507392,5.9922799539886e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,40353,0.0742716463870249,0.00508937484484025,0.064296471691138,0.0842468210829118,6.30791713038366e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,40305,-0.0695682117939483,0.00479964755792178,-0.0789755210074749,-0.0601609025804216,2.63619578042543e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0739882276901437,0.0051051421471927,-0.0839943062986414,-0.0639821490816461,2.67158611160888e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.0374274169640509,0.00258196099805392,-0.0424880605202366,-0.0323667734078653,2.9131872700914e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,40224,0.0387601488576739,0.00267563505745768,0.0335159041450569,0.044004393570291,2.97230930113984e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0748513994305616,0.00516702641087619,-0.0849787711958789,-0.0647240276652443,3.01672521762267e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,40471,0.0507365377035531,0.00350581245158203,0.0438651452984523,0.0576079301086539,3.60674072077348e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.0442153171281282,0.00306852418334471,-0.0502296245274838,-0.0382010097287726,1.02391993981395e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0514689400321948,0.00358219075442194,-0.0584900339108618,-0.0444478461535278,1.66580401641835e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAST,Gastrin,37942,-0.176166043751619,0.0122753701895181,-0.200225769323074,-0.152106318180163,2.29805243687219e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0631012719350805,0.00440024978970372,-0.0717257615228998,-0.0544767823472612,2.3790379425988e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.060413326297351,0.00421649040663213,-0.06867764749435,-0.0521490051003521,2.85647634462396e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,40516,-0.04741822829213,0.00331112209323021,-0.0539080275948612,-0.0409284289893988,3.12045750601914e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0711749682839358,0.00497417678467327,-0.0809243547818954,-0.0614255817859762,3.78394138763302e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.110850399429799,0.00775148197803369,-0.126043304106745,-0.0956574947528527,4.259897404433e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.0327291095622552,0.0022905558121778,0.0282396201703867,0.0372185989541237,4.94747085638913e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0344159307533149,0.00240865281425523,-0.0391368902692551,-0.0296949712373746,4.99267339026278e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,40341,-0.105002316571794,0.00736346459253355,-0.11943470717316,-0.0905699259704285,7.46171291681384e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,40292,-0.0634516397654361,0.00445660844659673,-0.0721865923207657,-0.0547166872101065,1.02409862290002e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0421837632260761,0.00296939754877115,-0.0480037824216676,-0.0363637440304846,1.58934166247122e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,40228,0.0447312990609328,0.0031572277490093,0.0385431326728746,0.050919465448991,2.74378006974899e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.0581916132124262,0.00412628054934064,-0.0662791230891338,-0.0501041033357185,6.82951534361563e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0460726114135584,0.00327087167053654,-0.05248351988781,-0.0396617029393068,8.68322515043977e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0454498950848334,0.00324097180525174,-0.0518021998231268,-0.03909759034654,2.0593492057538e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.0375997618992382,0.00268534661109637,-0.0428630412569871,-0.0323364825414894,2.76912294468463e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,37998,0.0795255737747751,0.00570562748044452,0.0683425439131038,0.0907086036364464,7.46373341299346e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.0284000243362028,0.00204004594057818,-0.0323985143797361,-0.0244015342926696,8.44626141829478e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.0361402421512865,0.00259947353876579,-0.0412352102872674,-0.0310452740153055,1.09624191530066e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_E,,40341,-0.0376643942507465,0.00271073799526666,-0.0429774407214692,-0.0323513477800239,1.23085593788006e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0587820918065452,0.00423371690050544,-0.0670801769315359,-0.0504840066815545,1.41791550067073e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.0386413746033284,0.00278912886185288,-0.0441080671725601,-0.0331746820340968,2.1511848350458e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,40536,-0.0743628859236904,0.00539294255978969,-0.0849330533408782,-0.0637927185065026,5.21976534306182e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,40471,-0.0536213683796532,0.00389214302156766,-0.0612499687019258,-0.0459927680573806,6.17450361777581e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0689579846642614,0.00500714505767969,-0.0787719889773136,-0.0591439803512092,6.63359087635941e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0334820504431717,0.00243786993151597,0.0287038253774004,0.038260275508943,1.10472031238353e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPN,Asporin,37990,0.0352841747362408,0.00257511923990473,0.0302369410260276,0.0403314084464541,1.89644352823869e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.0704083803900886,0.00515260409826871,-0.0805074844226952,-0.0603092763574819,2.86307550963187e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.0344110410611455,0.00251841428952525,-0.039347133068615,-0.029474949053676,2.93519824048544e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.0867464412565397,0.00635604994072379,-0.0992042991403583,-0.0742885833727211,3.58463101818672e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.0441344461037717,0.00323555080435738,0.0377927665272313,0.0504761256803122,3.96765727521023e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,40489,-0.0722748582123161,0.00530309654085142,-0.0826689274323849,-0.0618807889922473,4.63023248713389e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.074560513088199,0.00547549221726501,-0.0852924778340384,-0.0638285483423596,5.43628208132037e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.0467166701670453,0.00343152774796634,-0.0534424645530593,-0.0399908757810313,5.66092733493368e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0767611610324638,0.00564983150994499,-0.087834830791956,-0.0656874912729717,8.26075284716024e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.0338312261699718,0.00249316662240076,-0.0387178327498773,-0.0289446195900663,1.03631894133934e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.0253969489957144,0.00187490541979906,0.0217221343729082,0.0290717636185205,1.43054268560764e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,40268,-0.092356352823539,0.00682172263957894,-0.105726929197114,-0.0789857764499643,1.57710831589622e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,37998,-0.031773404758562,0.0023464651499251,-0.0363724764524152,-0.0271743330647088,1.66838860561056e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.0479880598659883,0.00354818740456997,-0.0549425071789455,-0.0410336125530312,1.90456387322565e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.11978683921723,0.00887086629891783,-0.137173737163109,-0.102399941271351,2.77374532793708e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.0855467644000767,0.00634523826684828,-0.0979834314030994,-0.0731100973970541,3.40178961297696e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,38013,-0.0403952916321553,0.00300061429985703,-0.046276495659875,-0.0345140876044355,4.77957945384898e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,37671,-0.0576384233416702,0.00428378961932242,-0.0660346509955421,-0.0492421956877982,5.35373939769011e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.0546734806065554,0.00406654529188256,-0.0626439093786452,-0.0467030518344656,6.05481483706114e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLN,Promotilin,40341,-0.111968400749288,0.0083421772050478,-0.128319068071182,-0.0956177334273944,7.50597177502578e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,40422,-0.0537106670380539,0.00400617408642556,-0.061562768247448,-0.0458585658286598,9.14372804217645e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,40332,-0.0562366210755344,0.00419574263175348,-0.0644602766337712,-0.0480129655172976,9.63531032246333e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.053049747580716,0.00396424125165744,-0.0608196604339646,-0.0452798347274675,1.27654726576471e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0644066208800081,0.00481710326043407,-0.0738481432704589,-0.0549650984895573,1.63339577601322e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0469070571183366,0.00351254530870944,-0.0537916459234071,-0.0400224683132661,1.85782320850822e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RETN,Resistin,40283,-0.0521911587917617,0.00390828016251319,-0.0598513879102875,-0.0445309296732358,1.85837595980608e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFI,Complement factor I,38013,-0.0253610839121584,0.00189829892557119,-0.0290817498062779,-0.0216404180180388,1.86840032652364e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.0383234012032078,0.00287970745379988,-0.0439676278126556,-0.03267917459376,3.402683196501e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.105649224477712,0.00795051363105782,-0.121232231194585,-0.0900662177608383,4.9005741787886e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0350889456838329,0.00264477030945084,-0.0402726954903565,-0.0299051958773092,5.84211432849421e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.0848362310641472,0.00639828925051174,-0.0973768779951503,-0.0722955841331442,7.10037311647971e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,40382,0.0484915323494119,0.00366412203153195,0.0413098531676093,0.0556732115312145,9.03587779338969e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0612034888329648,0.00462674714692169,-0.0702719132409314,-0.0521350644249983,9.72823306179667e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.063586652883505,0.0048101068481929,-0.0730144623059631,-0.0541588434610469,1.09654798608714e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,40359,-0.0796048258774846,0.00602352162087303,-0.0914109282543957,-0.0677987235005734,1.1531441234993e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0527007543047858,0.00400090699457997,0.0448589765954091,0.0605425320141626,2.03680123410794e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.064230989265386,0.00487874548218531,-0.0737933304104692,-0.0546686481203028,2.22551153975181e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0698077359559254,0.00530215330156894,-0.0801999564270006,-0.0594155154848503,2.44853702406931e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.047766469393105,0.00364623269129004,0.0406198533181766,0.0549130854680335,5.22864610734269e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.134150811936904,0.0102399759480705,-0.154221164795123,-0.114080459078686,5.25278874310559e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0531202373090086,0.00406037628864221,0.0451618997832699,0.0610785748347474,6.58068745675376e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.109371838202268,0.00836454207483438,-0.125766340668943,-0.0929773357355922,7.30608614500402e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0595866628806087,0.00456100162546125,-0.0685262260665128,-0.0506470996947047,8.34661226998019e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.0832626946938994,0.00639821158682163,-0.0958031894040698,-0.070722199983729,1.61655553233713e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.032452202765141,0.00249685818722672,-0.0373460448121054,-0.0275583607181766,1.98818492801929e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0514295835421744,0.00396746467877678,-0.0592058143125768,-0.0436533527717719,3.10688626083567e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.0798234396728362,0.00615571264640542,-0.0918886364597908,-0.0677582428858816,3.16370874344864e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.0402896141821153,0.00311381629541829,-0.0463926941211351,-0.0341865342430954,4.5865842068272e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,39960,-0.0480438386272995,0.00371912619111252,-0.0553333259618801,-0.040754351292719,5.59031409540409e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0546759843356332,0.00423849054927282,-0.062983425812208,-0.0463685428590585,7.64793552245745e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,40489,-0.0467570290195964,0.00364739528494261,-0.053905923778084,-0.0396081342611089,1.95227110193925e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.104317253665859,0.00814338775324938,-0.120278293662228,-0.0883562136694904,2.37716454597697e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,40360,0.0460267306928932,0.00360011542097228,0.0389705044677875,0.0530829569179989,3.04105252821189e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0321904766285497,0.00251881089160457,-0.0371273459760947,-0.0272536072810047,3.23938963085466e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,37628,-0.0735105030687569,0.00576614266976386,-0.0848121427014941,-0.0622088634360198,5.24687366418185e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,40359,-0.0423343814166814,0.00332293861353866,-0.0488473410992172,-0.0358214217341456,5.37085582141062e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.088743775836722,0.00696578697783819,-0.102396718313285,-0.0750908333601592,5.39572204291523e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,40471,-0.0440185620447012,0.0034597805250963,-0.0507997318738899,-0.0372373922155125,6.65283785765812e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,40341,-0.0727768509263684,0.0057230909327264,-0.0839941091545121,-0.0615595926982246,7.25544032758096e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.0375483665383423,0.00295385762085542,-0.043337927475219,-0.0317588056014657,7.66378167043703e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0434379290041652,0.00341837719590353,-0.0501379483081361,-0.0367379097001942,8.14922006604917e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.0453280483775506,0.00356761699216646,-0.0523205776821968,-0.0383355190729043,8.4393558663878e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0512632709732377,0.00403615149102822,-0.059174127895653,-0.0433524140508224,8.78407510144241e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.04776321696105,0.00376159549152145,-0.055135944124432,-0.0403904897976679,9.17734290112245e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,40097,-0.0501041270964064,0.0039462558099977,-0.0578387884840019,-0.0423694657088109,9.37282876711759e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,37990,-0.0300595389556268,0.00236735489026103,-0.0346995545405384,-0.0254195233707152,9.88447393273003e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.101091497358837,0.00798224064557502,-0.116736689024164,-0.0854463056935099,1.51756485956672e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0516800478226783,0.00408338714018718,-0.0596834866174452,-0.0436766090279115,1.68822596347872e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.0483597099368615,0.00382872531006359,0.0408554083291369,0.0558640115445861,2.13811658605685e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,37598,-0.0994152317229254,0.00787033316616047,-0.1148410847286,-0.0839893787172509,2.29789195283364e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.125053460631149,0.00992078970497111,-0.144498208452892,-0.105608712809405,3.16774206890998e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.077408586610291,0.00615295652881452,-0.0894683814067675,-0.0653487918138146,4.00762356353599e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.0449705339143135,0.00357716148822003,-0.0519817704312248,-0.0379592973974022,4.47649420461508e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0578490998071289,0.00460881141409015,-0.0668823701787456,-0.0488158294355122,5.79560966146513e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.055214494521722,0.0044000303671094,-0.0638385540412564,-0.0465904350021876,6.4155101759723e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.109937414612661,0.00877044514244242,-0.127127487091849,-0.0927473421334743,7.09904601470921e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,40228,0.0297049316176019,0.00237221638145394,0.0250553875099521,0.0343544757252516,8.37330012349514e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.0637145266974056,0.00509431184909978,-0.0736993779216412,-0.0537296754731701,1.00705315646423e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.0306273655798759,0.00245316912554758,0.0258191540938027,0.0354355770659492,1.41848346827176e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,40332,-0.0420903657485606,0.00337585752644028,-0.0487070465003835,-0.0354736849967376,1.63535342837207e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.0929874534987994,0.00746037410237072,-0.107609786739446,-0.0783651202581528,1.85678535552878e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,37575,-0.032256121147972,0.00258929879086495,-0.0373311467780673,-0.0271810955178767,2.01935457781657e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTR,Transthyretin,37871,-0.0300726772292229,0.00241541318409126,-0.0348068870700417,-0.025338467388404,2.18423298720583e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,40359,0.0609885107785555,0.00490798814600532,0.051368854012385,0.0706081675447259,2.7407086455117e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.122002499886447,0.00982150638079156,-0.141252652392799,-0.102752347380096,2.89989802860464e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,40305,-0.0352378899486224,0.00283770086454779,-0.0407997836431361,-0.0296759962541087,3.05314589186063e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.0780383358667849,0.00628667735753747,-0.0903602234875583,-0.0657164482460114,3.21843125343884e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,37671,0.0631921453158475,0.00509436400407438,0.0532071918678617,0.0731770987638332,3.88328462295259e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.0305447931949316,0.00246387552406342,-0.0353739892220959,-0.0257155971677673,3.93037309192004e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,39806,-0.0468763870734595,0.00378343928636589,-0.0542919280747366,-0.0394608460721823,4.36167306317505e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0615388409154748,0.00496950302701099,0.0517986149825333,0.0712790668484164,4.67158370748464e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,40044,-0.0555140282870699,0.00448573555686094,-0.0643060699785174,-0.0467219865956225,5.16722384021237e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0604374402277359,0.00488664484859035,-0.070015264130973,-0.0508596163244988,5.69364758530096e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.106006686983495,0.00858046527835996,-0.12282439892908,-0.0891889750379092,6.65742527277949e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,40228,-0.0777275946048206,0.00630692676722855,-0.0900891710685885,-0.0653660181410526,9.70038225821052e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0358835160244155,0.00291221699403105,-0.0415914613327164,-0.0301755707161147,1.01087298694698e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,40305,-0.062043217735356,0.00504508650806417,-0.0719315872911618,-0.0521548481795503,1.33907812248392e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,37671,-0.0726189904649111,0.00590408476271269,-0.084190996599828,-0.0610469843299942,1.40335528289188e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.0572033574094587,0.00465598445186607,-0.0663290869351161,-0.0480776278838012,1.5452020861686e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EZR,Ezrin,40471,-0.0273407226498375,0.00222736259304123,-0.0317063533321983,-0.0229750919674767,1.76440260913916e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.0274456144714708,0.00224138098835344,0.0230525077342981,0.0318387212086436,2.55471926052097e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.0885524404259117,0.0072419878816025,-0.102746736673853,-0.0743581441779708,3.15569811315476e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.0279054604211996,0.00228668387907523,0.0234235600182121,0.032387360824187,4.21538291239037e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.0371861252675336,0.00304717004629824,-0.0431585785582782,-0.0312136719767891,4.23492921713617e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.0391311872187115,0.00321251859543495,-0.045427723665764,-0.032834650771659,5.55771400859389e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.0968404015558745,0.00797834674896994,-0.112477961183856,-0.0812028419278934,9.44307099094202e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,40228,-0.101837031754627,0.0083961520360982,-0.118293489745379,-0.0853805737638745,1.04731541702359e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.139517941639692,0.0115208369808409,-0.162098782122141,-0.116937101157244,1.31490696024623e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.031617041736911,0.00261106795200685,-0.0367347349228444,-0.0264993485509775,1.33407564093983e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0656496096631034,0.00542343620342648,-0.0762795446218193,-0.0550196747043875,1.40334579578178e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0200535272800906,0.00165766688403794,-0.0233025543728049,-0.0168045001873762,1.62115101542482e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.0875721934876921,0.00724900150627198,-0.101780236439985,-0.073364150535399,1.87412575458056e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.055207768315136,0.00457719955104041,-0.0641790794351752,-0.0462364571950968,2.36573622257929e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,40332,0.0289418554377859,0.0024032806325303,0.0242314253980265,0.0336522854775453,2.96025460474715e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,40305,-0.0777254456364031,0.00646843843966262,-0.0904035849781419,-0.0650473062946644,4.07287682044531e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.0502687140325503,0.00419686516563339,-0.0584945697571918,-0.0420428583079089,6.83738885222749e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0372544472084805,0.00311481105775312,-0.0433594768816766,-0.0311494175352844,7.92865001919143e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,37628,-0.0642566990011534,0.00537281874720737,-0.0747874237456799,-0.053725974256627,8.55058879788072e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0298979558808524,0.00250080077623069,-0.0347995254022646,-0.0249963863594403,8.98164827598216e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,37598,-0.0524335853539077,0.00439274559776978,-0.0610433667255365,-0.0438238039822789,1.12774862315998e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.079028150971522,0.00663196083925755,-0.0920267942164668,-0.0660295077265772,1.43147065679036e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.0556945057845038,0.00467775771452344,-0.0648629109049697,-0.0465261006640379,1.5216106146378e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.043250307871097,0.00363454351858457,0.0361266025746713,0.0503740131675228,1.64056441335494e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,40411,-0.0448518035310893,0.0037710574405555,-0.0522430761145781,-0.0374605309476005,1.75071960067296e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.0476807049865992,0.00401234207262679,-0.0555448954489477,-0.0398165145242507,2.10793152440425e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.0813374054069858,0.00684555794208662,-0.0947546989734756,-0.0679201118404961,2.15421511568513e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,37998,-0.125729288050179,0.0105969895079397,-0.146499387485741,-0.104959188614617,2.61195897489971e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.0992578601520506,0.0083745172568776,-0.115671913975531,-0.0828438063285705,2.86879253654041e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,40489,-0.0733363321244656,0.00618884458040912,-0.0854664675020675,-0.0612061967468637,2.94211432618302e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.0324867507301084,0.00274150842557698,-0.0378601072442393,-0.0271133942159776,2.94672505572091e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,40311,-0.101890559204056,0.00860703960209558,-0.118760356824163,-0.0850207615839485,3.39076304648583e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.0460871432534369,0.00390106837432756,-0.0537332372671189,-0.0384410492397549,4.48739624970466e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,37671,-0.0577192337667946,0.004883956232597,-0.0672917879826847,-0.0481466795509045,4.56188216547276e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0481001606045451,0.0040876313577368,-0.0561119180657092,-0.040088403143381,7.79288331482465e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0528705062702868,0.00450046131702953,0.044049602088909,0.0616914104516647,9.80656388833261e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.0268979096735733,0.00229011469726125,-0.0313865344802053,-0.0224092848669412,1.0648356091815e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,40472,-0.0258280814995183,0.00220052493017282,-0.030141110362657,-0.0215150526363795,1.10720384524703e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.0774302272691161,0.00660076421705694,-0.0903677251345477,-0.0644927294036845,1.20952272059953e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,39757,-0.103000564355314,0.00878860219786713,-0.120226224663134,-0.0857749040474944,1.37709190512348e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.0744917751224459,0.00637311796687317,-0.0869830863375173,-0.0620004639073745,1.95716652291279e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0673829943180837,0.00577265726602997,-0.0786974025595025,-0.056068586076665,2.3578670730994e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.083024672172244,0.00711834989335756,-0.0969766379632248,-0.0690727063812632,2.61945971483523e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.0538604759616005,0.00462429919576774,-0.0629241023853053,-0.0447968495378957,3.16454227697902e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0612865936506787,0.00526335154992172,-0.0716027626885253,-0.0509704246128321,3.46544260791892e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.119187018834373,0.0102427319764256,-0.139262773508168,-0.0991112641605792,3.80510737658952e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,40333,0.0240636402588263,0.00207006845993588,0.020006306077352,0.0281209744403006,4.13210345595765e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,37942,-0.0405759510719009,0.00349292481280245,-0.0474220837049937,-0.0337298184388081,4.76836406838927e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.040554982146472,0.00349323747117059,-0.0474017275899663,-0.0337082367029776,4.93358952623754e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,37990,-0.0755725916034931,0.00653981674754724,-0.0883906324286857,-0.0627545507783005,9.62128394819528e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,40042,0.0257519085336082,0.00222980928608135,0.0213814823328887,0.0301223347343276,9.96835087992228e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.0447092318070556,0.00387304201982178,-0.0523003941659062,-0.0371180694482049,1.04955345861153e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDK,Midkine,40352,-0.0548041186854028,0.00477551897099525,-0.0641641358685535,-0.0454441015022522,2.29207031575266e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,37057,-0.0267615376766646,0.00233150823049536,-0.0313312938084355,-0.0221917815448937,2.40197143149659e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0507256259238107,0.00442407128339709,-0.059396805639269,-0.0420544462083524,2.59413055809532e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.035799678399145,0.00312191126355624,0.0296807323225748,0.0419186244757152,2.65962387039742e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELN,Elastin,37990,-0.0380742066352944,0.00332073119660126,-0.0445828397806329,-0.0315655734899559,2.70943817975977e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.0570442748064839,0.00497886913189099,-0.0668028583049903,-0.0472856913079776,2.84332031716942e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,40516,-0.0588923241556907,0.00514311568171737,-0.0689728308918568,-0.0488118174195247,3.0556966694282e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.122419056633234,0.0106994942305402,-0.143390065325093,-0.101448047941375,3.40441202720157e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.150817315741777,0.0131871004707826,-0.176664032664511,-0.124970598819043,3.77658529455374e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0556031574279119,0.00486924739981878,-0.0651468823315567,-0.0460594325242671,4.3989848295342e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.0526523025162712,0.00461129088439258,-0.0616904326496807,-0.0436141723828617,4.47658224557509e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,39980,-0.0792298810319487,0.00694522951563645,-0.0928425308825962,-0.0656172311813013,5.03358158602477e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,40295,0.0686046219135804,0.00601740777596445,0.0568105026726901,0.0803987411544707,5.40889096371046e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0676799041537618,0.00594252981625848,-0.0793272625936284,-0.0560325457138952,6.23125617180682e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.0322113462430609,0.00282958676056641,-0.0377573362937711,-0.0266653561923508,6.90277458026542e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,39961,-0.0642242546195422,0.00565489551902472,-0.0753078498368307,-0.0531406594022537,8.94584633233598e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0531331705552353,0.00467962154723931,-0.0623052287878243,-0.0439611123226462,9.73577571945542e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.0912680840791189,0.00804437750101467,-0.107035063981108,-0.0755011041771301,1.01573752335467e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0793802071610239,0.00699717118942727,-0.0930946626923013,-0.0656657516297464,1.07394385293882e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,40341,-0.0350374340004978,0.00309100650504748,-0.0410958067503908,-0.0289790612506047,1.14074057637387e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD248,Endosialin,37998,0.0429165623221429,0.00378697928291256,0.0354940829276342,0.0503390417166515,1.22926139069405e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.0847532478628298,0.0074892831763898,-0.0994322428885538,-0.0700742528371058,1.40643155905222e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.116139816819967,0.010263834940779,-0.136256933303894,-0.0960227003360405,1.49572120367788e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,40341,-0.03582191969393,0.00316873746042172,-0.0420326451163565,-0.0296111942715034,1.61075416271211e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.0978115345902992,0.00865319703147469,-0.11477180077199,-0.0808512684086088,1.70903843592834e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,37967,-0.0604006780831059,0.00534809370939483,-0.0708829417535197,-0.049918414412692,1.90640232906321e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,40305,-0.0777040814171377,0.00689034644360778,-0.091209160446609,-0.0641990023876665,2.19965898909782e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.0720737141239361,0.00639331365399338,-0.0846046088857631,-0.0595428193621091,2.2953266947088e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,40177,-0.035881025846031,0.00318351375653411,-0.0421207128088379,-0.0296413388832241,2.36781324552342e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.0846170297008904,0.00751091972701458,-0.099338432365839,-0.0698956270359418,2.6118318170119e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,40346,0.0293855069257815,0.00261064550998575,0.0242686417262094,0.0345023721253536,2.79135022507603e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.0243342325380313,0.00216202699977677,-0.0285718054575937,-0.0200966596184688,2.81547744011299e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,37878,-0.0443759131757774,0.00394236777439687,-0.0521029540135952,-0.0366488723379595,2.920359531763e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,40396,-0.0605122679545374,0.00538394746204026,-0.0710648049801363,-0.0499597309289385,3.36326197924628e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.0655957870029466,0.0058353426153793,-0.0770330585290901,-0.0541585154768032,3.45145172601789e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0516039455791905,0.0045946210117233,-0.0606094027621682,-0.0425984883962129,3.68069235144353e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,40332,0.025726745266835,0.00229435799054329,0.0212298036053702,0.0302236869282999,4.52482332982432e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,40228,-0.0554819329320864,0.00495479442783274,-0.0651933300106386,-0.0457705358535342,5.38714656100143e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.0430436324076468,0.00384873789442015,-0.0505871586807103,-0.0355001061345833,6.30507120410214e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.0292987688242912,0.00262214506091654,-0.0344381731436876,-0.0241593645048948,7.02433876223992e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.102206194762547,0.00916564675078179,-0.120170862394079,-0.0842415271310144,9.05873843024367e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0528638377078915,0.00474146138420951,-0.0621571020209421,-0.0435705733948408,9.28617884656479e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,40214,-0.0242222847271553,0.00217340699686877,-0.0284821624410181,-0.0199624070132925,9.71666653257075e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,37598,-0.0963654449840642,0.00864580441081134,-0.113311221629254,-0.079419668338874,1.00824098189071e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,39980,-0.0651871061679738,0.00585339633664668,-0.0766597629878012,-0.0537144493481463,1.06874979097712e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0440651973270171,0.00395913831613759,0.0363052862273874,0.0518251084266468,1.1448066341892e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.0271348631746694,0.00243984928029735,-0.0319169677640522,-0.0223527585852866,1.25563874234114e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.0463880344671114,0.00417177169027742,-0.0545647069800551,-0.0382113619541676,1.28656704085288e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.0835243852100183,0.00752578833637422,-0.0982749303493117,-0.0687738400707248,1.69758930417001e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.039379844834429,0.00354861303913122,-0.0463351263911262,-0.0324245632777318,1.71769535220733e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.063716817368993,0.00574524352029661,-0.0749774946687744,-0.0524561400692117,1.78731765568782e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.0310789871925982,0.00280510376255218,-0.0365769905672005,-0.025580983817996,2.10500053790998e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0385314057292191,0.00347906157562702,0.0317124450409901,0.045350366417448,2.19282683867597e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.0877355020886146,0.00792388145411235,-0.103266309738675,-0.0722046944385544,2.2662819262909e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.0447115470782929,0.00404331534211845,-0.0526364451488451,-0.0367866490077407,2.53975751839232e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.0557595671781212,0.00504773257454865,-0.0656531230242366,-0.0458660113320059,2.88438875354919e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.0573147224906709,0.00519216050912958,-0.0674913570885649,-0.0471380878927769,3.1656276447314e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.032393289855043,0.00294089662317027,-0.0381574472364567,-0.0266291324736293,4.09105488805166e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.0851169166056229,0.00773374770046598,-0.100275062098536,-0.0699587711127096,4.51159256353471e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,37681,0.0220193797802429,0.0020008608479957,0.0180976925181713,0.0259410670423144,4.78601209749281e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.033532538774781,0.00305302157387083,0.0275486164899942,0.0395164610595679,6.07530355529763e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0528669107016575,0.00481761191975975,-0.0623094300643866,-0.0434243913389284,6.71657157478502e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0324383470516521,0.00296069815497589,0.0266353786678994,0.0382413154354048,8.03326392847967e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.123038081203075,0.0112480669106488,-0.145084292347947,-0.100991870058203,9.9276238928193e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,40332,0.0299742981819901,0.0027425206616161,0.0245989576852226,0.0353496386787577,1.04595563333115e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.0319829119431801,0.00292733588702769,-0.0377204902817543,-0.0262453336046058,1.09071119197833e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,37987,-0.0268570849873013,0.00245833617323552,-0.0316754238868429,-0.0220387460877597,1.14333572264326e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.0990636710740714,0.00907102139453497,-0.11684287300736,-0.0812844691407829,1.14651927214183e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0615779279295211,0.00563814702678435,-0.0726286961020185,-0.0505271597570238,1.1844672528572e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.0599871990036567,0.0054947804695678,-0.0707569687240096,-0.0492174292833038,1.19475289801681e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,37714,-0.133024434616996,0.0121860556581164,-0.156909103706904,-0.109139765527088,1.26522493269339e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.0569571440403963,0.00521955251009808,-0.0671874669601885,-0.046726821120604,1.26913130093168e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,37671,-0.0318882149993968,0.00292371000652278,-0.0376186866121814,-0.0261577433866121,1.40231850759568e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,40489,-0.0419997501554381,0.00385807043560574,-0.0495615682092254,-0.0344379321016509,1.67369410626688e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.0714653910358883,0.00656769057636679,-0.0843380645655672,-0.0585927175062094,1.77558465119939e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.0785410075380329,0.00721597120460043,-0.0926843110990497,-0.064397703977016,1.78075456428834e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.0231798376240349,0.0021303825703599,-0.0273553874619403,-0.0190042877861295,1.86445681729583e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.061028924640938,0.00561880620141899,-0.0720417847957192,-0.0500160644861568,2.18950833661985e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.124899607615628,0.011498619988226,-0.147436902792551,-0.102362312438705,2.28187636426287e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,-0.0623838921952339,0.00576111896380633,-0.0736756853642943,-0.0510920990261735,3.1366855687834e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0388645942503496,0.00359036637392598,-0.0459017123432445,-0.0318274761574546,3.28596011946513e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.042779841261578,0.00395960972215562,-0.0505406763170031,-0.035019006206153,4.08687344287785e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.0738756004810814,0.00683858412402472,-0.0872792253641698,-0.0604719755979929,4.14894225190299e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0363202763539797,0.00337448210745914,0.0297062914233598,0.0429342612845996,6.35687074395398e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.0583067826137667,0.00542972841876146,-0.0689490503145391,-0.0476645149129942,8.30016860136619e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0515398652992774,0.00480034358734024,-0.0609485387304643,-0.0421311918680906,8.44024736326478e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,40536,-0.056699272831594,0.00528431300449706,-0.0670565263204082,-0.0463420193427798,9.09274507692639e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,38013,0.0280246561309645,0.00261448791068014,0.0229002598260314,0.0331490524358975,1.06052959222829e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.0581120341385525,0.0054297463095151,-0.0687543369052021,-0.0474697313719029,1.26750850156683e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,40192,-0.0809719782723836,0.00756947452631593,-0.0958081483439628,-0.0661358082008043,1.29525887814459e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.0709819948285639,0.00663335197425253,-0.0839833646980989,-0.057980624959029,1.29889033025077e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,40422,0.0630694750364466,0.00589734852756206,0.051510671922425,0.0746282781504683,1.32818278099744e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.034679198239015,0.0032432583965822,0.0283224117817139,0.0410359846963161,1.35610868411904e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBN,Nibrin,40044,-0.0512989456652128,0.00480394257070444,-0.0607146731037935,-0.0418832182266321,1.58475047242055e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.0185765422261785,0.00174169118924162,-0.0219902569570921,-0.0151628274952649,1.81901089118133e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.0336311200791792,0.00315687539991534,-0.0398185958630132,-0.0274436442953451,2.06547027263195e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0452518573498229,0.00424821324819969,-0.0535783553162943,-0.0369253593833515,2.09883854234954e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.0745505693878681,0.00700514099548288,-0.0882806457390145,-0.0608204930367216,2.42669987505368e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,37628,0.0705226965780796,0.00662721169374725,0.057533361658335,0.0835120314978243,2.44658301563649e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.0724799148658188,0.00681634635012712,-0.0858399537120679,-0.0591198760195696,2.55568751102438e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.069161905999838,0.00651331051212046,-0.0819279946035941,-0.0563958173960819,2.98862548495696e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFH,Complement factor H,37301,-0.023258403188884,0.00219749063899311,-0.0275654848413105,-0.0189513215364575,4.52266673794069e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.0288469207313523,0.00272752144926044,-0.0341928627719027,-0.0235009786908018,4.8799569439064e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.0736016949255652,0.00696635766163209,0.0599476339087663,0.0872557559423641,5.44917041342244e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.0287786081441743,0.00272397883368429,0.0234396096301531,0.0341176066581955,5.50068800324185e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.0296269505384612,0.00280693226503247,-0.0351285377779248,-0.0241253632989975,6.07689161476915e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASN,Vasorin,40116,0.0274124687220482,0.00259905368379412,0.0223183235018118,0.0325066139422847,6.39970384461787e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NADK,NAD kinase,40359,-0.0533063378575603,0.00505717972422708,-0.0632184101170453,-0.0433942655980752,6.82446437222716e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0738310150475107,0.00700293213544827,-0.0875567620329893,-0.0601052680620321,6.94220871979244e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00856843899010096,0.000816447322072266,0.00696820223883932,0.0101686757413626,1.10534237861714e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,40261,-0.0769129831337415,0.00734194827203056,-0.0913032017469214,-0.0625227645205616,1.35309254003551e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.051563608542391,0.00492441065492989,-0.0612154534260536,-0.0419117636587284,1.47033774207097e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,40489,0.0452998693689457,0.00433523406255954,0.036802810606329,0.0537969281315624,1.7833674061693e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0389815755246184,0.00373933865950847,-0.046310679297255,-0.0316524717519818,2.38670035116098e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,37959,-0.0531211882726521,0.0050963858283058,-0.0631101044961314,-0.0431322720491727,2.4216213430518e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAYN,Layilin,40192,-0.0337676656563673,0.00324489314007834,-0.0401276562109209,-0.0274076751018138,2.79995782736966e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,38013,-0.06432811781365,0.00618148907788255,-0.0764438364062998,-0.0522123992210002,2.88064520195655e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0535078729353508,0.00514515554929899,-0.0635923778119768,-0.0434233680587248,2.99984115526163e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,40305,-0.0537730787542578,0.00518388258455666,-0.0639334886199889,-0.0436126688885268,3.95415709295428e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0313480462720554,0.00302684077949633,-0.0372806541998682,-0.0254154383442426,4.68072937672762e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0279997968057086,0.00270424711127811,0.0226994724676035,0.0333001211438137,4.82144711615155e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0342091466829977,0.00330351236570477,-0.0406840309197791,-0.0277342624462164,4.90490109359204e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,40357,-0.025001713238947,0.00241514134599452,-0.0297353902770963,-0.0202680362007978,4.9179784843264e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,-0.041182415076563,0.00397979053778532,-0.0489828045306223,-0.0333820256225038,5.13354066944812e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.062595721618815,0.00605820012845091,-0.0744697938705788,-0.0507216493670512,6.05729958428635e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0275988094770861,0.0026712955054969,0.0223630702863121,0.03283454866786,6.07571124820978e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.0809700468454433,0.00784106780998817,-0.0963385397530201,-0.0656015539378665,6.4190912586364e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.0271559077567609,0.00263227104295311,-0.032315159000949,-0.0219966565125728,7.10676351202488e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.0252763053396944,0.00245039160281906,0.0204735377981691,0.0300790728812198,7.43353613533817e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,40422,-0.0460557471289039,0.00446685149832276,-0.0548107760656165,-0.0373007181921913,7.55393974812763e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.0349597869348363,0.00339776693205243,-0.041619410121659,-0.0283001637480135,9.44538249260045e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.0825281958161313,0.00802982779905117,-0.0982666583022716,-0.066789733329991,1.06592956707835e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0440862516829647,0.00429014123872736,-0.0524949285108703,-0.0356775748550591,1.07857524310834e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.0748082218843431,0.00728531067837286,-0.0890874308139539,-0.0605290129547323,1.20486478667749e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0460038557275796,0.00448231696339183,-0.0547891969758275,-0.0372185144793316,1.26842803935181e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,40203,-0.0504150295349703,0.00491871318903636,-0.0600557073854816,-0.040774351684459,1.41888786103078e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.0560687318642926,0.00547267518311592,-0.0667951752231998,-0.0453422885053854,1.48753907728184e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.086467354248433,0.00846141567973602,0.0698829795161504,0.103051728980716,1.93998697221239e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COCH,Cochlin,37990,-0.0450271292444149,0.00441038879705896,-0.0536714912866505,-0.0363827672021794,2.2072452786381e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,39991,-0.0478883504089813,0.00469345965833092,-0.0570875313393099,-0.0386891694786527,2.28951700580832e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.0794686194903459,0.00779118977323349,-0.0947393514458836,-0.0641978875348083,2.36146744368458e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,40341,0.0410764925434704,0.00402748738044996,0.0331826172777884,0.0489703678091523,2.38010256721695e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.0319586718231366,0.00313627018797769,-0.0381057613915729,-0.0258115822547003,2.60785615321168e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.0802219862512415,0.00787356974325789,-0.0956541829480269,-0.064789789554456,2.73652027006815e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0287549957222757,0.0028274762178832,-0.0342968491093268,-0.0232131423352246,3.20874540678549e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.0322143872496395,0.00316910076493679,-0.0384258247489156,-0.0260029497503634,3.36417765500158e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.0402637443177485,0.00396855108307531,-0.0480421044405761,-0.0324853841949209,4.24300103812172e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.0436553225127143,0.00430461459657473,-0.0520923671220008,-0.0352182779034279,4.27179795637168e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,40359,-0.0231881967100334,0.00229006174159484,-0.0276767177235593,-0.0186996756965076,5.03142579727425e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0289142447473795,0.00285602749352313,-0.0345120586346848,-0.0233164308600742,5.27420618419372e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,40341,-0.0371060752095635,0.00367669475858427,-0.0443123969363886,-0.0298997534827383,7.05675426726269e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.0373031065627857,0.00369630153646748,-0.0445478575742619,-0.0300583555513094,7.05896850770961e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0526043242732631,0.00521431654265701,-0.0628243846968709,-0.0423842638496554,7.36134848775884e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.0483743371276435,0.00480192706055596,-0.0577861141663331,-0.0389625600889538,8.77679068363905e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0545569769785444,0.0054206485902843,-0.0651814482155017,-0.0439325057415872,9.3555244490234e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.0495460893289572,0.00492329354206421,-0.0591957446714031,-0.0398964339865114,9.42674152267744e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0500180252454715,0.0049792536337241,0.0402586881233723,0.0597773623675707,1.13393190337156e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.0946434299515458,0.00943084184812345,-0.113127879973868,-0.0761589799292238,1.24892656152775e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.0401046118458177,0.00400005679619558,-0.047944723166361,-0.0322645005252744,1.42130587401587e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.0254778680559277,0.00254302088339985,-0.0304621889873914,-0.020493547124464,1.48077675161129e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.0897909476842898,0.00897492217714781,-0.1073817951515,-0.0722001002170801,1.70652905203058e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0459655306289539,0.00460193637104887,-0.0549853259162097,-0.0369457353416981,2.07813754048714e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,40341,-0.0883819319102387,0.00885551162358115,-0.105738734692458,-0.0710251291280197,2.1753508059679e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,39980,-0.0576006515926217,0.00577259185426503,-0.0689149316269811,-0.0462863715582622,2.23072350150969e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.027329125923545,0.00273991769315579,0.0219588872449597,0.0326993646021304,2.30587338538079e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,37959,-0.0973568909273225,0.00975888916602995,-0.116484313692741,-0.0782294681619038,2.33309873199092e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.0375013151536127,0.00376238786156349,-0.0448755953622772,-0.0301270349449483,2.47725908064598e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.0739142684697689,0.00744837300617089,-0.0885130795618638,-0.0593154573776739,3.85466246770222e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.0813354907605679,0.00820909374928617,-0.0974253145091688,-0.065245667011967,4.48306578126222e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.0711909810325846,0.00718528187337001,-0.0852741335043898,-0.0571078285607794,4.48918235425765e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.0298582192339192,0.00301365856396337,-0.0357649900192874,-0.023951448448551,4.62350509224354e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0625018086609997,0.00631938683776495,-0.074887806863019,-0.0501158104589804,5.32825417211778e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.0353387506027839,0.00357306616145065,-0.0423419602792272,-0.0283355409263406,5.35955281030666e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0358281039268977,0.00362755678486779,-0.0429381152252386,-0.0287180926285568,6.13854939373854e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0673920302351475,0.00683541476787766,-0.0807894431801877,-0.0539946172901073,7.47271458751505e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0519907963067732,0.00527718171796514,-0.0623340724739849,-0.0416475201395615,7.79912983685411e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,40403,-0.093304815417566,0.00947350387950063,-0.111872883021387,-0.0747367478137448,8.04016193003372e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.0698760699507358,0.00709431774381394,-0.0837809327286111,-0.0559712071728605,8.25152488150178e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,37900,-0.0915368866413259,0.00929434660323288,-0.109753805983662,-0.0733199672989894,8.29649697609112e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0225010039671101,0.00228803349733133,0.0180164583123407,0.0269855496218795,9.30753788533329e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,40411,-0.0484484852789963,0.0049285477895345,-0.0581084389464839,-0.0387885316115087,9.6856312079918e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,40516,-0.0869725943096852,0.00885406854396443,-0.104326568655855,-0.0696186199635149,1.03967505822833e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.0876303910966165,0.00893314724532667,-0.105139359697457,-0.0701214224957763,1.18870179837567e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0589472432135469,0.0060104433803395,-0.0707277122390123,-0.0471667741880815,1.25078263405032e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.0343110391247928,0.00350301520961178,-0.0411769489356319,-0.0274451293139537,1.41783275596323e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.0577157042588844,0.00589821157363804,-0.0692761989432149,-0.0461552095745538,1.54760424761575e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,40471,0.0214940890349024,0.00219741758190322,0.017187150574372,0.0258010274954327,1.5629390588699e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,40516,-0.0422076538449469,0.00431555663345576,-0.0506661448465202,-0.0337491628433736,1.58040112080516e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,40358,-0.0531855766171729,0.00544173171478283,-0.0638513707781473,-0.0425197824561986,1.69029064695192e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,40516,-0.0450792419909676,0.00461373342373304,-0.0541221595014844,-0.0360363244804509,1.73804737041989e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.0427602702305438,0.00438024621981501,-0.0513455528213812,-0.0341749876397064,1.89729256057051e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.0801055332771959,0.00824268559372652,-0.0962611970408998,-0.0639498695134919,2.90247255722044e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0589393439499431,0.00606819218709209,-0.0708330006366436,-0.0470456872632426,3.14358481979218e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.0559845740784635,0.00577733095646692,-0.0673081427531386,-0.0446610054037883,3.82798356899933e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,37900,-0.0188179064988306,0.00194267603304693,-0.0226255515236026,-0.0150102614740586,4.06050508766172e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.0312870505882966,0.0032310723126087,0.0249541488555836,0.0376199523210096,4.08671975133771e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,39934,-0.0629890305615848,0.0065135049536334,-0.0757555002707063,-0.0502225608524634,4.64447678890446e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.0378465858391929,0.00391425927499046,-0.0455185340181742,-0.0301746376602116,4.69863848369677e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.0738071715350283,0.00763139401698477,-0.0887647038083185,-0.0588496392617382,4.71779218099987e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.0367443441495826,0.0038029695334563,-0.0441981644351569,-0.0292905238640082,5.15199319775598e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,40014,-0.0363210769320232,0.00376082055252356,-0.0436922852149694,-0.0289498686490771,5.25378347316688e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.0943161731699833,0.00976582763096473,-0.113457195326674,-0.0751751510132924,5.37074126647646e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0366242842601684,0.0038123830385001,-0.0440965550156286,-0.0291520135047082,8.59849491958084e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,37987,-0.0220748547429379,0.00230010082443326,-0.0265830523588271,-0.0175666571270487,9.62055313989553e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.0252248050877867,0.00263011142903255,-0.0303798234886905,-0.0200697866868829,1.00025956544651e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0401199437220236,0.00418302587645073,-0.048318674439867,-0.0319212130041801,1.02470579485204e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.023556836366792,0.00245813780515356,0.018738886268691,0.0283747864648929,1.07509305828039e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.0242132404429983,0.00252849021704339,0.0192573996175933,0.0291690812684034,1.17991117191579e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0223076035953777,0.00233034598362154,-0.026875081723276,-0.0177401254674795,1.18996373789841e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.0462697780693514,0.00483423929441223,-0.0557448870863994,-0.0367946690523035,1.20798568835148e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,37970,-0.0415050935568485,0.00434197362746318,-0.0500153618666763,-0.0329948252470207,1.39070613499135e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.0942482858621043,0.00986300415447637,-0.113579774004878,-0.0749167977193307,1.40141995433888e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0448330313362486,0.00469031551649665,-0.0540260497485821,-0.0356400129239152,1.40681548097415e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.0312945303037262,0.00327558008882267,-0.0377146672778186,-0.0248743933296338,1.4279131829852e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0300504870381813,0.00314560723830809,0.0238850968510975,0.0362158772252652,1.43583395803905e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.0621328935569046,0.00650852829847258,-0.0748896090219109,-0.0493761780918984,1.53802007042342e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.086983469324388,0.00911227895297518,-0.104843536072219,-0.0691234025765567,1.54750062093682e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.023821257007362,0.00249713953742423,0.0189268635140105,0.0287156505007135,1.64059321039638e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.0340582005239917,0.00357218713437358,0.0270567137406195,0.0410596873073639,1.72566701233633e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.036805982519466,0.00386410850099664,-0.0443796351814194,-0.0292323298575126,1.88317085984609e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.0272913058964746,0.00286600731116038,-0.0329086802263489,-0.0216739315666003,1.92850898981086e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0601051902019085,0.00631362110542587,-0.0724798875685432,-0.0477304928352738,1.97677324588338e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,40376,-0.0827001991138176,0.00869347081523796,-0.099739401911684,-0.0656609963159512,2.11333750300073e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,40411,-0.0262886028429868,0.0027648878543025,-0.0317077830374197,-0.0208694226485539,2.213868356254e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,37781,-0.0216078118469129,0.00227394886300576,-0.0260647516184042,-0.0171508720754216,2.39798942455563e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,39980,-0.0374395289409487,0.00394174378664359,-0.0451653467627702,-0.0297137111191273,2.4399319392802e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.0739038226726596,0.00778170445515251,-0.0891559634047585,-0.0586516819405607,2.45660590004197e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.0174665063389386,0.00183873963959065,-0.0210704360325363,-0.0138625766453409,2.46531342761723e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0600270838850453,0.00632255886400034,-0.072419299258486,-0.0476348685116047,2.53038160605557e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELP,P-selectin,40403,-0.0517390821227757,0.00545301015907316,-0.0624269820345591,-0.0410511822109923,2.67595269140401e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,37901,-0.073943435526372,0.00780056718825646,-0.0892325472153547,-0.0586543238373893,2.98413932233959e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.0207430227588195,0.00218887923899416,-0.0250332260672481,-0.016452819450391,3.05816049731528e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.0168019596481209,0.00177471162517254,-0.0202803944334591,-0.0133235248627827,3.33471719800428e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,37966,-0.0399629197505603,0.00422150815042209,-0.0482370757253876,-0.031688763775733,3.3660201176058e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,40305,-0.0840835322043363,0.00888550734950625,-0.101499126609369,-0.0666679377993041,3.40369248427835e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.0380190795054784,0.00402494142281837,-0.0459079646942024,-0.0301301943167544,4.00393686607635e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.0260631850879482,0.00276170934125186,-0.0314761353968018,-0.0206502347790945,4.44086328569139e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,40332,-0.034952551436922,0.00370714059793754,-0.0422185470088796,-0.0276865558649644,4.72468656259766e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0523401985305939,0.00555714876420336,-0.0632322101084325,-0.0414481869527553,5.32245912410681e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.0994763409722398,0.0105753546692993,-0.120204036124066,-0.0787486458204132,5.96476084717517e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.0991804197795035,0.0105433974366589,0.078515360803652,0.119845478755355,5.9793794352697e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.0316225457566042,0.00336741760956548,-0.0382226842713525,-0.0250224072418559,6.90277814279104e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBIN,Erbin,40305,-0.0907970814317602,0.00967128377919587,-0.109752797638984,-0.0718413652245363,6.90713880620437e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,40332,-0.0309425500840155,0.003299909670666,-0.0374103730385208,-0.0244747271295101,7.69928597336682e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,40341,-0.0747800275194154,0.0079752915938681,-0.0904115990433969,-0.0591484559954339,7.72229297126534e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.0301540301949725,0.00322375466363139,-0.0364725893356901,-0.023835471054255,9.77392665012794e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.0847818145876334,0.0090689546132215,-0.102556965629548,-0.0670066635457193,1.02591759587025e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.0948568100654749,0.0101542829018691,-0.114759204553138,-0.0749544155778114,1.09600824143264e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0343803470686088,0.00369243838213959,-0.0416175262976024,-0.0271431678396152,1.42871654716987e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0615066519800069,0.00660640525023581,-0.0744552062704691,-0.0485580976895447,1.44116124800003e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,40299,-0.024933382400571,0.00267861727626341,-0.0301834722620473,-0.0196832925390948,1.46555920369417e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.0413194677266276,0.00444125614637186,-0.0500243297735164,-0.0326146056797387,1.53168876110903e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,40471,-0.0196799539216516,0.00211654904962711,-0.0238283900589207,-0.0155315177843824,1.60981771839701e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0640613652062106,0.00688983854456661,-0.0775654487535611,-0.05055728165886,1.61785612034563e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,40332,-0.0665585591153041,0.00716560475661417,-0.0806031444382679,-0.0525139737923404,1.76139712390641e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0226383431506977,0.00243771391116863,0.0178604238848072,0.0274162624165882,1.79269211361189e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.0745014166683204,0.00802793981456217,-0.0902361787048622,-0.0587666546317785,1.904143461688e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPSE,Heparanase,37848,-0.081605935585933,0.00879309106019122,-0.0988403940639078,-0.0643714771079582,1.93894192419612e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,37628,-0.0647780681802726,0.00698088915741296,-0.078460610928802,-0.0510955254317432,1.96801476068623e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0675189771640945,0.00728282317601757,-0.0817933105890889,-0.0532446437391,2.11996043938975e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.0554336810037157,0.00598413951607204,-0.0671625944552169,-0.0437047675522145,2.27451376806409e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.0925321492308011,0.0099925733682635,-0.112117593032598,-0.0729467054290047,2.29827456177334e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,40341,-0.0713132502762921,0.00770193865298073,-0.0864090500361343,-0.0562174505164499,2.31896573418954e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,39980,-0.0332215257093955,0.00359415031180845,-0.04026606032054,-0.0261769910982509,2.6963351899908e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0320162076272808,0.0034652960163345,-0.0388081878192964,-0.0252242274352651,2.8605935326178e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.0179776783393159,0.00194646851691516,0.0141626000461621,0.0217927566324696,2.94405064835466e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.0255852923959068,0.00277549726406518,0.0201453177583391,0.0310252670334746,3.39034612352791e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0502777757198606,0.00546066196686082,-0.0609806731749078,-0.0395748782648134,3.76544403726121e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.0347275442614857,0.00377664856991671,-0.0421297754585224,-0.0273253130644489,4.29067596523881e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,37998,-0.0242486386115687,0.00264348857151035,-0.029429876211729,-0.0190674010114084,5.2573539145716e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,40471,-0.0521890343527925,0.00569786728986214,-0.0633568542409222,-0.0410212144646627,5.83759400612236e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.046005089699245,0.00502711281656031,-0.0558582308197032,-0.0361519485787868,6.29050876309826e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.0393657685039901,0.00430583979728795,-0.0478052145066745,-0.0309263225013057,6.83887669280594e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0412500441672439,0.00451221633399903,-0.050093988181882,-0.0324061001526059,7.00776081255911e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.0792091171798578,0.00866918761690752,-0.0962007249089965,-0.062217509450719,7.19054167251653e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,40471,-0.0305174199274374,0.00334657032791544,-0.0370766977701517,-0.0239581420847231,8.46366925648416e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,40516,0.0336371514328295,0.00368893729973306,0.0264068343253527,0.0408674685403063,8.50999661995794e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.0843966799853815,0.00925929615973856,-0.102544900458469,-0.0662484595122939,9.00716025854641e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0531853203935595,0.00583972466987937,-0.064631180746523,-0.0417394600405959,9.63012112681113e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.0763317258407155,0.00838843418618407,-0.0927730568456363,-0.0598903948357948,1.0317228905152e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0312089045884876,0.00343170205766759,-0.0379350406215161,-0.0244827685554591,1.08709337003779e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,37977,0.028917648473027,0.00318176017962116,0.0226813985209696,0.0351538984250845,1.14126454405792e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.025932919040398,0.002855890197695,-0.0315304638278802,-0.0203353742529158,1.22895927161936e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.0271260624718212,0.00298907640406153,0.0212674727198606,0.0329846522237818,1.26516852543804e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEP,Leptin,40359,-0.0547279783644258,0.00603568540829126,-0.0665579217646767,-0.042898034964175,1.35850610350251e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0381346460873235,0.00420577852148167,-0.0463779719894275,-0.0298913201852194,1.36455884286949e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.0725093701303007,0.00801404832571088,-0.088216904848694,-0.0568018354119074,1.65671948829334e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.0724970260179633,0.00801603148226967,0.0567856043127148,0.0882084477232119,1.68106859019388e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.0583673443246221,0.00646677513970193,-0.0710422235984379,-0.0456924650508064,2.03087704047515e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0637255041674366,0.00706205860892887,-0.0775671390409372,-0.049883869293936,2.06144002545563e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,-0.0380136398646992,0.00421955496531826,-0.046283967596723,-0.0297433121326754,2.31123103608481e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.065152228119854,0.00723066705690914,-0.0793243355513959,-0.0509801206883121,2.32349822843769e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.0587630622075932,0.00652744919709016,-0.0715568626338899,-0.0459692617812965,2.4992069612431e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0484357586509926,0.0053857530041966,-0.058991834539218,-0.0378796827627673,2.66443262513024e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,40396,-0.0248847770885388,0.00277483384190039,-0.0303234514186636,-0.019446102758414,3.34827361660748e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0323773187569099,0.00361589247318302,0.0252901695094712,0.0394644680043487,3.79512822576133e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.0346646246962808,0.00387215286436287,-0.042254044310432,-0.0270752050821295,3.92980455909307e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,39961,-0.0299468418396644,0.00335028341143692,-0.0365133973260808,-0.0233802863532481,4.37814848167333e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.0206212748358523,0.00230670874636334,-0.0251424239787245,-0.0161001256929801,4.40223791979649e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.105479494542097,0.0118031213410208,-0.128613612370498,-0.0823453767136961,4.44515516660058e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0633494146991857,0.00709851234984778,-0.0772624989048874,-0.0494363304934841,5.05617714634453e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.0964173327887713,0.0108045120176849,-0.117594176343434,-0.0752404892341089,5.08174218107904e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,40411,-0.0485870556908593,0.00544669814981189,-0.0592625840644906,-0.037911527317228,5.13876767493858e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,40303,-0.0230047052510194,0.00258070791150534,-0.0280628927575699,-0.0179465177444689,5.44430914181586e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.0702852261700846,0.0078850802486795,-0.0857399834574964,-0.0548304688826727,5.56408800265393e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,37934,-0.070912270630179,0.00795683127457546,-0.0865076599283469,-0.0553168813320111,5.64154158715565e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0297708465764425,0.00334958313782743,-0.0363360295265843,-0.0232056636263008,6.87671216677362e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0317722433707554,0.00357963773461028,-0.0387883333305916,-0.0247561534109193,7.6704645536873e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.0467575307314613,0.0052686159402479,-0.0570840179743472,-0.0364310434885754,7.74239176534843e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSG,Basigin,40502,-0.0169183864464091,0.00190783470479567,-0.0206577424678086,-0.0131790304250095,8.22882159845394e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,39924,-0.0570119087271461,0.00643115186764741,-0.069616966387735,-0.0444068510665572,8.47471030960987e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.0323189284843954,0.00364745931999921,-0.0394679487515938,-0.025169908217197,8.78644675892306e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.0812603740977031,0.00917248169611209,-0.0992384382220828,-0.0632823099733234,8.90278135147593e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0454009563583715,0.00512485965973228,-0.0554456812914468,-0.0353562314252963,8.92314638465762e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.054487116145074,0.006157798145855,-0.0665564005109498,-0.0424178317791982,9.96765121468107e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.060140285487355,0.0067986544418316,-0.0734656481933449,-0.046814922781365,1.00179822890443e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.115002756430055,0.0130057895831832,-0.140494104013094,-0.0895114088470155,1.03359939781197e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0567252602758067,0.00642278477651301,-0.0693139184377722,-0.0441366021138412,1.15882672019184e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.0838523530257945,0.00950301293082744,-0.102478258370216,-0.0652264476813727,1.24084073112692e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0565238353967813,0.0064109200265433,-0.0690892386488062,-0.0439584321447564,1.29656367509781e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.0713403266083884,0.00809418900398509,-0.0872049370561991,-0.0554757161605776,1.33274228220823e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,37936,-0.0629596985908935,0.00715308766778734,-0.0769797504197567,-0.0489396467620303,1.50916900314044e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0329865866552009,0.00375233816649086,-0.040341169461523,-0.0256320038488788,1.66127512287132e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.0628220588278087,0.00714917062951526,-0.0768344332616586,-0.0488096843939588,1.6865031218481e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0351907745632597,0.00400552722376354,-0.0430416079218362,-0.0273399412046832,1.7104915379238e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,40228,0.0352282773658881,0.00401278352325679,0.0273632216603048,0.0430933330714714,1.81577481106984e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,37901,-0.0236367029704534,0.00269353620397728,-0.0289160339302489,-0.018357372010658,1.90701126919166e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.0320511930721031,0.00365278986607392,-0.039210661209608,-0.0248917249345982,1.92226101378966e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.0787509797070503,0.00899277842489658,-0.0963768254198476,-0.061125133994253,2.20061019253408e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0287162280044256,0.00328139184855964,-0.0351477560276025,-0.0222846999812487,2.32075304873384e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.0333518830489894,0.00381741371741941,-0.0408340139351315,-0.0258697521628474,2.64011875056882e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,40290,-0.0361241803275712,0.00413742473239245,-0.0442335328030604,-0.028014827852082,2.77068653708315e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.0494722317736595,0.00567068330327074,-0.0605867710480702,-0.0383576924992489,2.99194759497017e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0321276455407075,0.00368353514530638,-0.039347374425508,-0.024907916655907,3.05215273916848e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0375960013749002,0.00432243175150719,-0.0460679676078543,-0.0291240351419461,3.707873067314e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.0916475942435953,0.0105424308120808,-0.112310758635274,-0.070984429851917,3.86593746652417e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.0194820379683604,0.0022455922165511,-0.0238833987128006,-0.0150806772239202,4.50368654262392e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,40376,-0.055427300780852,0.00639004846659206,-0.0679517957753725,-0.0429028057863316,4.56904513672665e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,40516,-0.0278671527081564,0.00321277310895173,-0.0341641880017018,-0.021570117414611,4.57105094798254e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGN,Biglycan,39956,0.0996992897224387,0.011494620299607,0.077169833935209,0.122228745509668,4.5980240395909e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,40185,-0.0475300199852809,0.0054834391745068,-0.0582775607673142,-0.0367824792032476,4.82383411673711e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.028129499582877,0.00324909554317676,-0.0344977268475034,-0.0217612723182505,5.28144007409693e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,37541,-0.0321702882391521,0.00371686340552157,-0.0394553405139743,-0.0248852359643298,5.48933007994229e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,39961,-0.0508333574949076,0.0058744808533639,-0.0623473399675008,-0.0393193750223143,5.49026577141794e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.036777249030779,0.00425062567594485,-0.0451084753556309,-0.0284460227059271,5.6334858187739e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,37562,-0.0384680058479099,0.0044470523487263,-0.0471842284514135,-0.0297517832444064,5.7327915368942e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,40489,-0.0899010583470403,0.0103959647489756,-0.110277149255033,-0.0695249674390481,5.74577874056624e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.0223486929036803,0.00258971623863641,-0.0274245367314077,-0.0172728490759529,6.83044633094103e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.043376710735948,0.00503070211676515,-0.0532368868848077,-0.0335165345870883,7.30097555009595e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0682997581402472,0.00792780456342266,-0.0838382550845557,-0.0527612611959388,7.63013508244875e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,40228,-0.0501262861941081,0.00581866611836272,-0.061530871786099,-0.0387217006021171,7.66525636339785e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.0840521780708131,0.00975482388655698,-0.103171632888465,-0.0649327232531614,7.68448927521594e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0504531438041613,0.00586096330934233,-0.0619406318904723,-0.0389656557178503,8.25244885915673e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.04967190536723,0.00578028469476688,-0.0610012633689731,-0.0383425473654869,9.22544112977269e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0631122871938999,0.00735820526903138,-0.0775343695212014,-0.0486902048665983,1.08046070223346e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,37441,-0.0582060051394155,0.00679872255321833,-0.0715315013437234,-0.0448805089351075,1.24041761401724e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,40359,-0.0975959717630492,0.0114037455470318,-0.119947313035232,-0.0752446304908669,1.24939654637383e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.0294229144038178,0.0034380627632412,0.0226843113878651,0.0361615174197706,1.25208024819567e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.0283812910861717,0.00331865706568291,-0.0348858589349102,-0.0218767232374332,1.32079559709362e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.0575481465309824,0.00673477920951589,-0.0707483137816335,-0.0443479792803312,1.40119598473202e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,-0.0239259715426515,0.00280057282021913,-0.029415094270281,-0.018436848815022,1.42364270497816e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.0428416579278894,0.00501696376848854,-0.0526749069141269,-0.0330084089416518,1.46916414502364e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI3,Elafin,40074,-0.043225401644126,0.00506297764927744,-0.0531488378367098,-0.0333019654515422,1.49576120827931e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.037892338385006,0.00443898953878959,-0.0465927578810336,-0.0291919188889785,1.53383758968394e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.0332175577572389,0.00389163492104049,-0.0408451622024782,-0.0255899533119995,1.54197228105696e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,40228,-0.0581634244463445,0.00681765445158262,-0.0715260271714464,-0.0448008217212425,1.5771078004044e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0456897602117341,0.00535606133811994,-0.0561876404344492,-0.035191879989019,1.61569240566233e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,40341,-0.0731329612971774,0.00858550847554603,-0.0899605579092476,-0.0563053646851072,1.7642345549243e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.0433967774417435,0.00509482287820373,-0.0533826302830228,-0.0334109246004642,1.80385002772904e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.0611362725826668,0.00718032082254951,-0.0752097013948639,-0.0470628437704698,1.84957144322306e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.0236005487317401,0.00277250283839145,0.0181664431684928,0.0290346542949873,1.85285033270581e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.0626967517696549,0.0073660289734213,-0.0771341685575606,-0.0482593349817491,1.86792667121221e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.04755079165865,0.00559409669901615,-0.0585152211887216,-0.0365863621285783,2.06050496008552e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,40516,-0.030199853607824,0.00355460753847765,-0.0371668843832402,-0.0232328228324078,2.13281149797644e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,40471,-0.105045314853875,0.0123680475293689,-0.129286688011438,-0.0808039416963115,2.18310310872054e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,37959,-0.0441181407773004,0.005197206864337,-0.0543046662314009,-0.0339316153231999,2.30338914821104e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.0576950134554955,0.00679855926920432,-0.071020189623136,-0.044369837287855,2.31571055398055e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,37598,0.0243965534407272,0.00287629639307838,0.0187590125102935,0.0300340943711608,2.4496848367164e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.0517072851444732,0.00610013416224899,-0.0636635481024812,-0.0397510221864652,2.56620225965057e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0657497513023561,0.00776562032502864,-0.0809703671394122,-0.0505291354653,2.78033222529568e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0628409155633871,0.00742454112744518,-0.0773930161731796,-0.0482888149535945,2.84888722551226e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,37628,-0.0407844222893027,0.00482238570276873,-0.0502362982667294,-0.031332546311876,3.02207808185669e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0468787850966312,0.00555115500535954,-0.0577590489071359,-0.0359985212861265,3.30208073644095e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0531225781215977,0.00629124347895006,-0.0654534153403398,-0.0407917409028556,3.3294369531592e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.0510636421181458,0.00605410002536108,-0.0629296781678535,-0.0391976060684381,3.60703277778918e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.0305046985873721,0.00362095454174866,-0.0376017694891994,-0.0234076276855447,3.92821549633686e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.0284568286795886,0.0033817085784644,-0.0350849774933788,-0.0218286798657984,4.33557632663957e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.0428439708937306,0.00509294557496753,-0.052826144220667,-0.0328617975667943,4.42721024223777e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,37567,-0.0342301746594629,0.00406977061142023,-0.0422069250578465,-0.0262534242610792,4.48890462846034e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0377084886734534,0.00448718709324917,-0.0465033753762218,-0.028913601970685,4.69206441697174e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,-0.0399875922309327,0.00475893459370072,-0.0493151040345861,-0.0306600804272793,4.7308268049505e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.0358361658645475,0.00427147067332141,0.0274640833448375,0.0442082483842574,5.27793426359376e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0518564011376044,0.00618417395605762,-0.0639773820914773,-0.0397354201837315,5.47879007567369e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0261690453207226,0.00312538124357908,0.0200432980833075,0.0322947925581376,6.160367743715e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.0533733306353373,0.00638520287738378,-0.0658883282750095,-0.0408583329956651,6.95831791659105e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,37882,-0.0365637968583066,0.00437493003960072,-0.045138659735924,-0.0279889339806892,7.02673031557063e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.0467322393186323,0.00560136951976369,-0.0577109235773691,-0.0357535550598954,7.84345579101183e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.0429202906820206,0.00514428847501296,-0.053003096093046,-0.0328374852709952,7.94084831015186e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.0229803115666936,0.00275481409742486,0.0175808759357409,0.0283797471976463,8.02189521946281e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.0624985634512024,0.00749266240660348,-0.0771841817681452,-0.0478129451342596,8.07057556222572e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.0815126753869441,0.00977707474315007,-0.100675741883518,-0.0623496088903699,8.22919072056192e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.0167351697053471,0.00200704087546858,0.0128013695894287,0.0206689698212655,8.26319451813779e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,37942,-0.0215902531874646,0.00259280413414724,-0.0266721492903932,-0.016508357084536,9.08552511181176e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,40204,-0.0404163814084195,0.00486332169445991,-0.0499484919295609,-0.0308842708872781,1.03040216963358e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB2,Calretinin,39961,-0.0247354624990665,0.00297913121618517,-0.0305745596827895,-0.0188963653153436,1.09896281870606e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,40403,0.023877504925945,0.00288120981775203,0.018230333683151,0.029524676168739,1.24957185729571e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.0308906919966812,0.003730253925348,0.0235793943029991,0.0382019896903633,1.31649234872255e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0333592678166928,0.00402839459777156,0.0254636144050605,0.041254921228325,1.33811445554053e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,40359,0.0240027240067079,0.00290066823480702,0.0183174142664862,0.0296880337469297,1.38667562611867e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,40139,-0.0598664014568679,0.00724323560767504,-0.074063143247911,-0.0456696596658248,1.50588023811206e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,40044,-0.0887243250901209,0.0107447637196503,-0.109784061980636,-0.0676645881996063,1.60651255087075e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0663117381865207,0.00803128177620819,-0.0820530504678888,-0.0505704259051527,1.61509904881802e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,40192,0.039635875457384,0.0048046713948711,0.0302187195234366,0.0490530313913314,1.71608889173308e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZN,Kazrin,37901,-0.0811319285683327,0.00983367665780115,-0.100405934817623,-0.0618579223190425,1.72423074194393e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,37901,-0.0548708356768017,0.00665224082649671,-0.0679092276967352,-0.0418324436568681,1.75234138596015e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0535156288912962,0.0064906840094379,-0.0662373695497945,-0.0407938882327979,1.77912779693966e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.0443089855242831,0.00537406595109368,-0.0548421547884267,-0.0337758162601395,1.80780413920753e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,37987,-0.0566426080800733,0.00687313260176046,-0.0701139479795238,-0.0431712681806228,1.86120899284372e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.0263067877689582,0.00319323812630174,-0.0325655344965096,-0.0200480410414068,1.88067347309158e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.0610176080970169,0.00740821189062871,-0.0755377034026491,-0.0464975127913846,1.91360058645961e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,37598,-0.0345745710974241,0.00420239672118059,-0.0428112686709381,-0.0263378735239102,2.09304455802747e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0337384870470358,0.00410458210941127,-0.0417834679814819,-0.0256935061125897,2.23046144862947e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.0137457004744459,0.00167391872671326,0.0104648197700879,0.0170265811788039,2.34725817140603e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,0.0319255187422845,0.00389658927027392,0.0242882037725476,0.0395628337120214,2.735014666286e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0567711938486473,0.00693397604960583,-0.0703617869058747,-0.0431806007914199,2.9067188123423e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.0595539615366741,0.00727550971436547,-0.0738139605768304,-0.0452939624965178,2.95911896533576e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0806997834078846,0.00985970612067988,-0.100024807404417,-0.061374759411352,2.97121676234578e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0346311268979982,0.00423714303990098,0.0263263265397923,0.0429359272562041,3.22597260429452e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.0794754407454034,0.00974869542374242,-0.0985828837759385,-0.0603679977148682,3.83174102862127e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,40442,-0.0563432890780195,0.00691632248097226,-0.0698992811407251,-0.0427872970153138,4.02318379758767e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,37901,-0.0455119713075779,0.00558649090170007,-0.05646149347491,-0.0345624491402457,4.06482283646655e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.0555759291974786,0.00682590986878217,-0.0689547125402916,-0.0421971458546655,4.24022799869632e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,38013,0.0235777367239753,0.00290138103924064,0.0178910298870636,0.0292644435608869,4.80345599535116e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,40346,-0.0396433632534846,0.00488674396576953,-0.0492213814263929,-0.0300653450805763,5.32149543056896e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.0259874622375984,0.00320483253019613,0.019705990478414,0.0322689339967828,5.4802662180635e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0365434171748727,0.00450600879082565,-0.045375194404891,-0.0277116399448544,5.49788014526398e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.0207900700869975,0.00256963772705135,-0.0258265600320182,-0.0157535801419769,6.43664221969081e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0501830214653826,0.00622513086511166,-0.0623842779610014,-0.0379817649697637,8.07383551049002e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.0420640390153249,0.0052211247867845,-0.0522974435974226,-0.0318306344332273,8.505184798342e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,39980,-0.0407971856834922,0.00506795976773355,-0.0507303868282499,-0.0308639845387344,8.87363966080608e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TF,Serotransferrin,38013,-0.0166682215822953,0.00207124021668205,-0.0207278524069921,-0.0126085907575985,9.15193136689098e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGN,Mimecan,40332,-0.0309717341724266,0.00385101470131195,-0.0385197229869981,-0.0234237453578552,9.42001786583319e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0478340713539082,0.00595531013898738,0.0361616634814929,0.0595064792263235,1.02447367107165e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.032823637144266,0.00408672941679158,-0.0408336268011775,-0.0248136474873545,1.04221852087077e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARC,SPARC,40411,-0.0536544533193654,0.00668331014836741,-0.0667537412101655,-0.0405551654285653,1.05820733644741e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,40250,-0.0217994718582618,0.00271537029356154,-0.0271215976336425,-0.0164773460828812,1.0584901521781e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.0434449153713901,0.00541423258131867,-0.0540568112307747,-0.0328330195120055,1.09442923654554e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0182827209872747,0.00228087717315328,0.0138122017278943,0.0227532402466552,1.17123432509889e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C3,Complement C3,37360,-0.0359048857954758,0.00447856558203449,-0.0446828743362634,-0.0271268972546882,1.17595630921907e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2,Brorin,40167,-0.0294076645136729,0.00367488563590409,-0.0366104403600449,-0.0222048886673009,1.30552174856502e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.0207874358632394,0.00259797770993643,-0.0258794721747148,-0.015695399551764,1.31484715683193e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNST,Consortin,40359,-0.081550329044952,0.0101933980234344,-0.101529389170884,-0.0615712689190205,1.32602604716243e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.0506462486858233,0.00633115123161626,-0.0630553050997911,-0.0382371922718554,1.33652930963953e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREH,Trehalase,37998,-0.0563674304159772,0.00704923357361358,-0.0701839282202598,-0.0425509326116946,1.38609836871826e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.0457810471466224,0.00573280609352497,-0.0570173470899314,-0.0345447472033135,1.5082096096534e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,39961,-0.0540962424007962,0.00678595078122375,-0.0673967059319947,-0.0407957788695976,1.67208316975693e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,40305,-0.068179726231422,0.00856394357432616,-0.0849650556371012,-0.0513943968257427,1.81772284146698e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGRN,Neugrin,37942,-0.016617629738355,0.00208807225752792,-0.0207102513631097,-0.0125250081136002,1.88182712716071e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.0353748791244839,0.00444699384214783,-0.0440909870550937,-0.0266587711938742,1.93621260392487e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,40359,-0.0318558345113752,0.00401519559293607,-0.0397256178735299,-0.0239860511492205,2.26568376526841e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,-0.0473388371221235,0.00596594327135602,-0.0590320859339813,-0.0356455883102657,2.27240392094308e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.0267299721769873,0.00336949740845597,-0.033334187097561,-0.0201257572564136,2.28492803034532e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,40192,-0.0484412201918588,0.00610868248923496,-0.0604142378707593,-0.0364682025129583,2.33969321623187e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.0500058363480143,0.00630672512507408,-0.0623670175931595,-0.0376446551028691,2.38566708794506e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0403501938712229,0.00510013816131235,-0.0503464646673951,-0.0303539230750507,2.70610218884639e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.025377398740931,0.00320770450183048,0.0190902979173432,0.0316644995645187,2.71356107307856e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,37628,-0.0310844749934446,0.00392846576311305,-0.0387842678891461,-0.023384682097743,2.72053180881906e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0418653821927843,0.00529303481401937,-0.0522397304282623,-0.0314910339573063,2.75289545019706e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,37990,-0.0481176675340288,0.0060826565124414,-0.0600396742984139,-0.0361956607696436,2.75856423726332e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.0497287490269213,0.00628925919609739,-0.0620556970512722,-0.0374018010025704,2.81478963775732e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,40203,-0.0395317326044098,0.0050005344385986,-0.049332780104063,-0.0297306851047565,2.84436318595082e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.0490266261484878,0.00620513923462298,-0.0611886990483488,-0.0368645532486267,2.95195571384651e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0449136895695833,0.00568794891614922,-0.0560620694452357,-0.0337653096939308,3.06470860859893e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.0180136950941394,0.00228892943603998,-0.0224999967887778,-0.0135273933995011,3.7781636797655e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.0325720835924452,0.00413877274502095,-0.0406840781726862,-0.0244600890122041,3.82327062531577e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,40341,-0.0611494548651554,0.00778780064788057,-0.0764135441350013,-0.0458853655953094,4.35617990992026e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0658855087656862,0.00840078978657431,-0.0823510567473718,-0.0494199607840006,4.74563922755265e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,37900,-0.0358740257014859,0.00457515792827204,-0.0448413352408991,-0.0269067161620727,4.80318482861316e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.0391217010624508,0.00500129330427434,-0.0489242359388285,-0.0293191661860731,5.57675539311685e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,37810,0.0793310196916567,0.0101420304417769,0.0594526400257739,0.0992093993575395,5.58759096693257e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.0528962425732139,0.00676347113428811,-0.0661526459964186,-0.0396398391500092,5.64217487232345e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.0232031264498647,0.00297061745507696,-0.0290255366618156,-0.0173807162379139,6.10741380852239e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,40332,-0.0183582988689174,0.00235229840506912,-0.0229688037428529,-0.0137477939949819,6.34875880384858e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.0176853767384015,0.00226820057400077,0.01323970361336,0.0221310498634431,6.72492355781447e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,37934,-0.0719138698618916,0.00922683554064962,-0.0899984675215649,-0.0538292722022184,6.96645430188233e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.0484719787284951,0.00622332835385638,-0.0606697023020536,-0.0362742551549366,7.25895994384287e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.0844571669627336,0.0108490552847081,-0.105721315320762,-0.0631930186047057,7.41453723384932e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0550034621809087,0.00706630963026767,-0.0688534290562334,-0.0411534953055841,7.47175515095682e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,37778,-0.0807401845418682,0.0103810297854716,-0.101087002921392,-0.060393366162344,7.92859231455851e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.0246017863201227,0.00316854215871782,-0.0308121289512096,-0.0183914436890358,8.70232234914766e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.0354162211904696,0.00456626836401631,-0.0443661071839415,-0.0264663351969976,9.2863164074635e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.0599419965683352,0.00772813037228099,-0.0750891320980059,-0.0447948610386645,9.3668932973763e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,37931,-0.0471676221081663,0.00610251751592917,-0.0591285564393875,-0.0352066877769451,1.15855786221397e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,37671,-0.051530198903109,0.0066668539011032,-0.0645972325492713,-0.0384631652569468,1.1591507889716e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOC,Myocilin,40332,0.0335100154271128,0.00433642189413874,0.0250106285146009,0.0420094023396247,1.161461882476e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.0470517725571897,0.00609255764003782,-0.0589931855316638,-0.0351103595827155,1.21798111733226e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.028392294625896,0.00368159475620746,-0.0356082203480626,-0.0211763689037294,1.31212225744982e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.0451198106004719,0.00585380602936942,-0.0565932704180359,-0.0336463507829078,1.36925860732286e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.0607244895868806,0.0078801830959018,-0.0761696484548482,-0.0452793307189131,1.37491884905967e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0437697177184654,0.00568250717080146,-0.0549074317732362,-0.0326320036636945,1.41382683418635e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0293889134110114,0.00381940649423436,-0.0368749501397107,-0.021902876682312,1.51996995689568e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.0422542802476595,0.00549281387866914,-0.053020195449851,-0.0314883650454679,1.52594813101537e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0530002189364497,0.00691162980938292,-0.0665470133628402,-0.0394534245100592,1.84404056943002e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,39665,-0.0163918533681675,0.00213880222493316,-0.0205839057290365,-0.0121998010072985,1.91029914154195e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,40228,-0.0952820663154628,0.0124407060218054,-0.119665850118201,-0.0708982825127242,1.98387157964211e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.0573944286678812,0.00751113991664757,-0.0721162629045104,-0.0426725944312519,2.29600615789473e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.0557812304168509,0.00730040807644251,-0.0700900302466782,-0.0414724305870235,2.3038265759911e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0572490795905754,0.0074966375454813,-0.0719424891797187,-0.042555670001432,2.35612989781242e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0587211430345316,0.00769325232123531,-0.0737999175841528,-0.0436423684849104,2.45527809894579e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,40536,-0.0382194890256759,0.00501651606644794,-0.0480518605159139,-0.0283871175354379,2.70403200697317e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.0201564270763618,0.00264689910022778,-0.0253443493128083,-0.0149685048399154,2.78127278645831e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0416657448464852,0.00547284796458352,-0.0523925268570689,-0.0309389628359015,2.82792844436407e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.0740100062106761,0.00972471645903988,-0.0930704504703942,-0.0549495619509579,2.91162617911918e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0320713885264704,0.00422202422169161,-0.040346556000986,-0.0237962210519548,3.22331327754737e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.0252726719723075,0.00332731918332222,-0.031794217571619,-0.0187511263729959,3.26797838512564e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.0356845231503524,0.00471074937284981,-0.0449175919211381,-0.0264514543795668,3.82662728785692e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.0149759818837845,0.00197871206398463,0.0110977062383746,0.0188542575291944,3.98476289830816e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.0210739709270538,0.00278515811316452,-0.0265328808288563,-0.0156150610252514,4.04451580187585e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0443953385430778,0.00587263540797228,-0.0559057039427035,-0.0328849731434521,4.30825950721501e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,40359,-0.024858531379608,0.00329926921741525,-0.0313250990457419,-0.0183919637134741,5.16303679748879e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.0319032074210143,0.00423651091049046,-0.0402067688055756,-0.023599646036453,5.38161303503721e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0584973816103156,0.00777397166618966,-0.0737343660760473,-0.0432603971445839,5.61624355763627e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.0138753182035587,0.00184707641753809,-0.0174955879819334,-0.0102550484251841,6.13051197315282e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.0636894016005919,0.00849160294327611,-0.0803329433694131,-0.0470458598317708,6.77538718851426e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,37562,-0.0423265309293515,0.00564342516847141,-0.0533876442595555,-0.0312654175991475,6.78424342131084e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,39897,-0.0333630856796778,0.00445049795622875,-0.0420860616738861,-0.0246401096854694,6.91065132785963e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0544461423487646,0.00726507462707475,-0.0686856886178311,-0.0402065960796981,7.09392495869138e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,39934,-0.0632691243779718,0.00845488384021903,-0.0798406967048011,-0.0466975520511425,7.64610112049309e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.045748033587815,0.00611516988230386,-0.0577337665571305,-0.0337623006184994,7.82553878631943e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,37990,-0.0214340213803213,0.00286628226123771,-0.0270519346123472,-0.0158161081482954,8.01070384583836e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.034730541261804,0.00464510832088509,-0.0438349535707388,-0.0256261289528692,8.09843871072411e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.0167719334527422,0.00224823492595292,-0.0211784739076099,-0.0123653929978745,9.09096057263117e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.030474467990714,0.00408632128900348,-0.0384836577171608,-0.0224652782642672,9.26170741776746e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0598314535408449,0.00802625160256699,-0.0755629066818762,-0.0441000003998136,9.58896998765132e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,37177,-0.0873805597661644,0.0117263205730607,-0.110364148089363,-0.0643969714429654,9.81231274075392e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.0680175688595065,0.00913089310268713,-0.0859141193407732,-0.0501210183782397,9.8787366018508e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.0210670404355904,0.00282963155176727,-0.0266131182770543,-0.0155209625941266,1.01795343755863e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLGN,Calmegin,37572,-0.0313989840080681,0.00422387148621039,-0.0396777721210404,-0.0231201958950957,1.12145467078466e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.0227592512596039,0.00306342800684137,-0.028763570153013,-0.0167549323661948,1.14696303517457e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.064679601031252,0.00871191619178558,-0.0817549567671517,-0.0476042452953522,1.19262184943135e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0592448515321846,0.00797967198281629,-0.0748850086185046,-0.0436046944458647,1.20156719284136e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.0262186832349378,0.00353636711338172,-0.0331499627771659,-0.0192874036927096,1.2870291027611e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.0638444898727694,0.00862423432433024,-0.0807479891484567,-0.0469409905970821,1.41112964745118e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,39980,-0.0677631762453079,0.00917530720380146,-0.0857467783647587,-0.049779574125857,1.59730892173933e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0502161580178598,0.00680480921510471,-0.063553584079465,-0.0368787319562546,1.68147913941811e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.0442239225293817,0.00599599853469646,-0.0559760796573868,-0.0324717654013767,1.7190423450495e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.0327393716798004,0.00443929403331333,0.0240383553745062,0.0414403879850945,1.72776340473264e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,37671,-0.079745104781479,0.0108130540037908,-0.100938690628909,-0.058551518934049,1.74270417624295e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,37882,-0.0250877485511587,0.00340694719790134,-0.0317653650590454,-0.0184101320432721,1.89290470274732e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0359370314100922,0.00488403126388615,-0.045509732687309,-0.0263643301328753,1.95925273723204e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,37671,-0.037858495709444,0.00514847202219585,-0.0479495008729479,-0.0277674905459401,2.04678852405036e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.0434622148189349,0.00591105275045794,-0.0550478782098325,-0.0318765514280374,2.05426838992456e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.04760512902,0.00647680234012424,-0.0602996616066436,-0.0349105964333565,2.09440017299032e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,40374,-0.0739855924988309,0.0100692733220153,-0.093721368209981,-0.0542498167876808,2.1148613968678e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,37987,-0.0474951004887681,0.00646813322162721,-0.0601726416031574,-0.0348175593743787,2.20886583911214e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,37921,-0.0221821263735692,0.00302136415467797,-0.028104000116738,-0.0162602526304004,2.22894642908943e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0351227534134094,0.00478625553030587,-0.0445038142528089,-0.0257416925740099,2.29068897392241e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,37671,-0.047263025912871,0.00644153190225343,-0.0598884284412878,-0.0346376233844543,2.30769379015077e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.0398233209220225,0.00543499986703226,-0.0504759206614057,-0.0291707211826392,2.46264826083545e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.0513589945157615,0.00700844237968836,-0.0650955415799507,-0.0376224474515724,2.46871371673062e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0467680708339186,0.00638970364248422,-0.0592918899731877,-0.0342442516946496,2.61516093633976e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,39961,-0.0464569813526051,0.00635471427604401,-0.0589122213336513,-0.0340017413715588,2.78862435893871e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,39809,-0.0537578248127134,0.00735901426233554,-0.068181492766891,-0.0393341568585357,2.90825327875937e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTD,Biotinidase,38013,-0.0143129620387369,0.00196104287426553,-0.0181566060722974,-0.0104693180051765,3.0683844275351e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.0378563688953861,0.00518772810868771,-0.048024315988414,-0.0276884218023582,3.10612234841939e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.0423533718811291,0.00580700651373696,-0.0537351046480535,-0.0309716391142046,3.18833254892031e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.0311146978734418,0.00428292227403717,-0.0395092255305546,-0.0227201702163289,3.94599839354235e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,37990,-0.0200891190572755,0.00276548177841551,-0.0255094633429699,-0.0146687747715811,3.95650845032418e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.0785133605351571,0.0108085736004874,-0.0996981647921124,-0.0573285562782017,3.96426784317506e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,37572,-0.0281946862037651,0.00389161169366153,-0.0358222451233417,-0.0205671272841885,4.5662321310244e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,37900,-0.0435538311602835,0.00601360620038251,-0.0553404993130332,-0.0317671630075338,4.64275741098474e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.0311493796813838,0.00430189613782781,-0.0395810961115263,-0.0227176632512413,4.66795133573549e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,40470,-0.0412175958449596,0.00569897916006832,-0.0523875949986935,-0.0300475966912257,4.95799273144702e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0406643422519874,0.00562524981690282,0.0296388526108579,0.051689831893117,5.13042331141054e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0614998876453014,0.00851341862392266,-0.0781861881481898,-0.044813587142413,5.33089391142437e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,38013,-0.0286318235631503,0.00396680426726136,-0.0364067599269826,-0.020856887199318,5.56217889659265e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.0320390115920718,0.00445387831852264,-0.0407686130963761,-0.0233094100877674,6.64654727197659e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.0179659424636587,0.00249927195815671,-0.0228645155016458,-0.0130673694256715,6.84214138930676e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.0127115637596164,0.00176813082048113,0.00924602735147338,0.0161771001677594,6.85574976669427e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.0663104021985924,0.00923818463465765,-0.0844172440825214,-0.0482035603146634,7.40169923910967e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,40341,-0.0273005466902372,0.00380377468379076,-0.0347559450704671,-0.0198451483100073,7.42860943059386e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.0407963000640162,0.00568486446265871,-0.0519386344108273,-0.0296539657172052,7.47690659361913e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,40374,-0.0200641012923202,0.0027982656837247,-0.0255487020324206,-0.0145795005522198,7.81843196443117e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.0361168313468367,0.00503750746962432,-0.0459903459873004,-0.026243316706373,7.91529526294893e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0317774631663808,0.00443350455457314,-0.0404671320933442,-0.0230877942394175,8.03199120546291e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.0534491815455713,0.00745933829002547,-0.0680694845940212,-0.0388288784971214,8.09790381657038e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0452683821748318,0.00631831063008728,-0.0576522710098029,-0.0328844933398607,8.2162199698261e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.0884632669919316,0.0123834492504595,-0.112734827522832,-0.064191706461031,9.56667083003816e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.0889158447764544,0.0124728643303923,-0.113362658864023,-0.0644690306888855,1.05625718198286e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,40341,-0.0328659582609601,0.0046127934726712,-0.0419070334673957,-0.0238248830545246,1.0858325676182e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,40305,-0.0401832316477439,0.00564893628544891,-0.0512551467672238,-0.0291113165282641,1.18046461487164e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0739483244724805,0.010401378104051,-0.0943350255564206,-0.0535616233885405,1.21427044191056e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.0259646277766983,0.00365457978860534,-0.0331276041623647,-0.0188016513910318,1.26756599420972e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.0992636326225211,0.0139772828732578,-0.126659107054106,-0.0718681581909358,1.29345210758265e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,37901,-0.0516785532592305,0.00727873891743502,-0.0659448815374032,-0.0374122249810579,1.31082809940265e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.0394678347065401,0.00556871426776222,-0.0503825146713541,-0.0285531547417262,1.43475721792183e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.026889705861244,0.00379772324840383,-0.0343332434281155,-0.0194461682943725,1.50738672576449e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0365526642551908,0.00516587767746185,-0.046677784503016,-0.0264275440073656,1.54926915072316e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,40333,-0.0605401894049787,0.00856021530544555,-0.077318211403652,-0.0437621674063054,1.58771309981872e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.0409040732074759,0.0057989636130644,-0.0522700418890821,-0.0295381045258697,1.81392942773406e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.0632472371531965,0.00897143517881469,-0.0808312501036733,-0.0456632242027197,1.86541419284281e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,38013,0.0151387341307884,0.00214821394716454,0.0109282347943459,0.0193492334672309,1.91472789004661e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.0398575933957784,0.00565838208101722,-0.0509480222745722,-0.0287671645169847,1.94528889043149e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,-0.0240026909368788,0.00340790026320977,-0.03068217545277,-0.0173232064209877,1.9569088692036e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0606998078341622,0.00862000943038075,-0.0775950263177084,-0.0438045893506159,1.99082615950367e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.0326510395900405,0.00464284287425669,-0.0417510116235837,-0.0235510675564974,2.11212783024174e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0570867526508906,0.00812155670349727,-0.0730050037897452,-0.0411685015120359,2.18185013879287e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.0376296109247175,0.00535725950727885,-0.048129839558984,-0.0271293822904509,2.2428380921601e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,-0.0189578782238581,0.00270364129857386,-0.0242570151690629,-0.0136587412786533,2.44464095330862e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0387438219723225,0.00552795565913157,-0.0495786150642204,-0.0279090288804246,2.50206532441988e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.0685914571119857,0.009787169876711,-0.0877743100703393,-0.0494086041536322,2.50871244140936e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.059255591138447,0.00846060950690672,-0.0758383857719842,-0.0426727965049098,2.59302388806155e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.0238635189600727,0.0034069919120415,-0.030541223107674,-0.0171858148124713,2.60026283115884e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,39980,-0.0306094913394132,0.00437199869013422,-0.0391786087720762,-0.0220403739067501,2.64070180920774e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.0738159982089289,0.0105477115537185,-0.0944895128542172,-0.0531424835636406,2.69451153325191e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,37901,-0.0446383101888273,0.00638624582929441,-0.0571553520142444,-0.0321212683634103,2.88341662989198e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,40332,-0.0308998044105867,0.00442277403329023,-0.0395684415158356,-0.0222311673053379,2.92978937909968e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.038711967681636,0.00554202414802186,-0.0495743350117588,-0.0278496003515132,2.9567721066267e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,37942,-0.0376512860078717,0.00539281726655582,-0.0482212078503211,-0.0270813641654222,3.05168515376161e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.039293279843805,0.00563413438936533,-0.050336183246961,-0.0282503764406489,3.20150279390767e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0379775131392426,0.00545371453967872,-0.0486667936370129,-0.0272882326414723,3.47437827448299e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.071624057801737,0.0103207302557358,-0.0918526891029791,-0.0513954265004949,4.10568817828082e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0215459407310597,0.00310585798731214,0.0154584590759279,0.0276334223861915,4.15433944421776e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.0442709914992398,0.0063830980079452,-0.0567818635948124,-0.0317601194036672,4.19921583065226e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,40444,0.0277619070947248,0.00401062600544963,0.0199010801240435,0.0356227340654061,4.61948025862373e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.0683110749009498,0.00987204360538832,-0.087660280367511,-0.0489618694343887,4.70061661192287e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,37942,-0.0408645440303805,0.00590902589680928,-0.0524462347881266,-0.0292828532726343,4.8681552649394e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,40516,-0.0332870741493248,0.00482386611588751,-0.0427418517364643,-0.0238322965621853,5.37571451611897e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.0518179276875203,0.00751040711362991,-0.066538325630235,-0.0370975297448057,5.41772298157489e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.0243483319472812,0.00353368486092213,-0.0312743542746886,-0.0174223096198738,5.77450570204293e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,40455,-0.0284802672476244,0.00413814054947225,-0.03659102272459,-0.0203695117706588,6.10443560831222e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.0213854730000596,0.00310997586906463,-0.0274810257034263,-0.0152899202966929,6.36661164941584e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.0229238325617223,0.00333420423957511,-0.0294588728712895,-0.0163887922521551,6.46745094602447e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0576476539150502,0.00838677409094557,-0.0740857311333035,-0.0412095766967969,6.48870151135516e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.0231784746307596,0.00337336215252745,-0.0297902644497134,-0.0165666848118058,6.66110085649518e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,37628,-0.0444540587571915,0.00647042183131818,-0.0571360855465751,-0.0317720319678078,6.69220466207213e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.0758108308573944,0.0110436749913817,-0.0974564338405025,-0.0541652278742863,6.95830681406528e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0188659085525295,0.00275045366794291,0.0134750193633614,0.0242567977416976,7.17740224002728e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.0650645439846468,0.00948851814618266,-0.0836620395511648,-0.0464670484181288,7.28173202596513e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0269274895946403,0.00392760839322183,0.0192293771439255,0.034625602045355,7.34346401630553e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.0396987387251283,0.00579255963695001,0.0283453218367063,0.0510521556135503,7.47405693191356e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.0230568762774904,0.00336659554291615,-0.0296554035416061,-0.0164583490133748,7.72510528982246e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.0232047276770072,0.0033904352739007,-0.0298499808138526,-0.0165594745401619,8.03392317282058e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.0174987953284222,0.00256207570027112,0.0124771269558908,0.0225204637009536,8.79996828815901e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,40453,-0.0201256039929705,0.00294670432195592,-0.0259011444640041,-0.014350063521937,8.80525837190912e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.0175897532275532,0.00257613762919835,-0.0226389829807819,-0.0125405234743244,8.92186204211354e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.0312471922312767,0.00457827807375311,-0.0402206172558328,-0.0222737672067206,9.16142895086628e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0438698516198514,0.00643817773183908,-0.056488679974256,-0.0312510232654468,9.90574510156265e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.0358182795736332,0.0052636312135852,-0.0461349967522602,-0.0255015623950062,1.0549106967181e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0314491369495608,0.00462646525280064,-0.04051700884505,-0.0223812650540715,1.10132558106228e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,37901,-0.0438645234606869,0.00645510965946916,-0.0565165383932464,-0.0312125085281273,1.12624329833302e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.0392209241640658,0.00577701789595789,-0.0505438792401433,-0.0278979690879883,1.16806625797303e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.0745497964357212,0.0109863229415326,-0.0960829894011251,-0.0530166034703172,1.19664598097319e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.0233163983262586,0.00343674333291166,-0.0300524152587654,-0.0165803813937517,1.20651651042229e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.028469192945429,0.0042011974628997,0.0202348459181456,0.0367035399727124,1.27478933146866e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.0318014866464661,0.00469533933977638,-0.0410043517524279,-0.0225986215405044,1.31366877654848e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,40291,-0.0262664127137101,0.00388885360854535,-0.033888565786459,-0.0186442596409612,1.4854043174109e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,37671,-0.0362034698146311,0.00536790166088128,-0.0467245570699584,-0.0256823825593037,1.60010800165856e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,40332,-0.0470424400410348,0.00697710866193221,-0.0607175730184219,-0.0333673070636477,1.61164279574471e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,37901,-0.0216143994545115,0.00320851976318893,-0.0279030981903618,-0.0153257007186612,1.68771428360599e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,40260,-0.0189033518735466,0.00280892820407041,-0.0244088511535246,-0.0133978525935686,1.75810392528764e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,40276,-0.0212898077799748,0.00316785044273223,-0.02749879464773,-0.0150808209122196,1.87177607287618e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,37810,0.0193508485443065,0.00288039519411103,0.0137052739638489,0.0249964231247641,1.9153715666008e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.0766294836015214,0.0114090677646792,-0.0989912564202926,-0.0542677107827502,1.92611417928517e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.0408301145848686,0.0060831227648178,-0.0527530352039115,-0.0289071939658257,1.98373435182645e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,40288,-0.0557881250511345,0.00831259328125718,-0.0720808078823986,-0.0394954422198704,1.994742476753e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.039559135745614,0.00589518418846544,-0.0511136967550063,-0.0280045747362218,2.0180842962293e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,40422,-0.0486140055793837,0.00724750743786005,-0.0628191201575894,-0.034408891001178,2.04373645131333e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.0259266114248496,0.00387126624644503,-0.0335142932678818,-0.0183389295818173,2.20887202295087e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.0376214533600026,0.00561904549195457,-0.0486347825242336,-0.0266081241957717,2.2254072622432e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.0196343106401288,0.00293291833247193,-0.0253828305717738,-0.0138857907084839,2.23731548190495e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.0184068138371077,0.00274965246884948,-0.0237961326760527,-0.0130174949981627,2.25405308095474e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.0165159291551655,0.00246767958197255,-0.0213525811358317,-0.0116792771744993,2.26052107757409e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,39961,-0.0523606319675415,0.00782365227509746,-0.0676949904267325,-0.0370262735083505,2.26744223552198e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.058097139843408,0.00870028421342693,-0.0751496969017248,-0.0410445827850912,2.51070602284161e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,37598,-0.026530560436309,0.00397290396005241,-0.0343174521980118,-0.0187436686746063,2.52174744170382e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0384370833709706,0.00576123105487795,0.0271450705034098,0.0497290962385314,2.62758779239508e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0296758290248012,0.00445713325359421,-0.0384118102018459,-0.0209398478477566,2.86496273667231e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,-0.0352556194339499,0.00530497307495627,-0.0456533666608642,-0.0248578722070356,3.11642941935635e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0436935751460736,0.00658814869212943,-0.0566063465826473,-0.0307808037094999,3.41415389517115e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.018244472140841,0.00275131887127911,-0.023637057128548,-0.0128518871531339,3.45663175136566e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.0228591103491417,0.00345443274578905,0.0160884221673951,0.0296297985308882,3.7989733839628e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0386385566733443,0.00584402859971828,-0.0500928527287921,-0.0271842606178965,3.92524985214326e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.0441311097432544,0.00668673387130837,-0.0572371081310188,-0.03102511135549,4.27414273589076e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.0651339064898993,0.00987249769214322,-0.0844840019665,-0.0457838110132986,4.31263651602462e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,40370,0.0176803064794491,0.00268213156769144,0.0124233286067739,0.0229372843521243,4.47924073961644e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.0420916048378385,0.00638467711797344,-0.0546055719890664,-0.0295776376866106,4.4825500422037e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.0196349264876644,0.00297974096185061,-0.0254752187728916,-0.0137946342024372,4.58211170688268e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.03838401231196,0.00583159315620667,-0.0498139348981251,-0.0269540897257949,4.78778063942971e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.0220880921752692,0.00335580234164961,-0.0286654647649024,-0.015510719585636,4.815808546278e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPTC,Opticin,40305,0.0280850593684021,0.00426788332407033,0.0197200080532243,0.03645011068358,4.83375078039621e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.0445806197153109,0.00677595526482206,-0.0578614920343621,-0.0312997473962597,4.87579514914024e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0484547051958338,0.00736630727324945,-0.0628926674514027,-0.0340167429402649,4.92451384930763e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.0231261610399249,0.0035215795302183,-0.0300284569191528,-0.016223865160697,5.29406179064744e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.0496218466183114,0.00756227209693939,-0.0644438999283126,-0.0347997933083102,5.51735706772901e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,40209,-0.0420429974882122,0.00640935410015445,-0.0546053315245149,-0.0294806634519095,5.56212370214935e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0416190408823502,0.00635697507812524,-0.0540787120354757,-0.0291593697292247,6.08960276066947e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,39961,-0.028242675757092,0.00431613643537072,-0.0367023031704186,-0.0197830483437654,6.19756055700819e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,40422,-0.0570851902497131,0.00872809278276387,-0.0741922521039303,-0.0399781283954959,6.32192237964813e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.050200320856071,0.0076810836635296,-0.0652552448365891,-0.035145396875553,6.5307078114644e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0329300599132878,0.00503862880638918,-0.0428057723738106,-0.023054347452765,6.5666721828954e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,37998,-0.0512458130059307,0.00784972163028922,-0.0666312674012976,-0.0358603586105638,6.88625223357195e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.0184968986181912,0.00283359015852208,-0.0240507353288945,-0.0129430619074879,6.91555618701911e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.0160468994930597,0.00245868445248156,0.0112278779661958,0.0208659210199236,6.93068378387135e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,40359,-0.0207784779035675,0.00318400349638795,-0.0270191247564879,-0.0145378310506472,6.96389886838805e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.0254820613471143,0.00390751896287233,-0.0331407985143441,-0.0178233241798846,7.18242597017397e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,-0.0299789396036085,0.00459774466361911,-0.038990519144302,-0.0209673600629151,7.22564395078657e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.0476626269264613,0.00732078550137692,-0.0620113665091601,-0.0333138873437625,7.71020381127608e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,40044,-0.0432307439544863,0.00664340887300836,-0.0562518253455827,-0.0302096625633899,7.88398829780058e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0487344865245996,0.00749110422342045,-0.0634170508025037,-0.0340519222466955,7.97160485790162e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0423808814900243,0.0065149702247596,-0.0551502231305531,-0.0296115398494955,7.99382278594865e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.0408078308940652,0.00627723272570661,-0.0531112070364501,-0.0285044547516802,8.26316924950476e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.0399783431326467,0.00616340371695743,-0.0520586144178833,-0.0278980718474101,9.10474755878777e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.0225441006212412,0.0034771736812084,-0.0293593610364097,-0.0157288402060727,9.28414385737941e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,37598,-0.0235554657783749,0.00363650081317827,-0.0306830073722043,-0.0164279241845455,9.65695161425335e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.0193271415246007,0.00298592645063109,-0.0251795573678376,-0.0134747256813637,9.90592750171998e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEXN,Nexilin,37987,-0.0419839673255999,0.00649212207268702,-0.0547085265880665,-0.0292594080631333,1.0346252128939e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.0156666562040474,0.00242297802292754,-0.0204156931289854,-0.0109176192791094,1.03678324876834e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0458802591491698,0.00710295113122534,-0.0598020433663715,-0.0319584749319682,1.0877466594951e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.0598420126957698,0.00926592960697808,-0.0780032347254468,-0.0416807906660927,1.0962243916614e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.0343971299414892,0.00532784622852448,-0.0448397085493972,-0.0239545513335812,1.11199133799469e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.0280192599712045,0.00434730775890873,-0.0365399831786656,-0.0194985367637434,1.19374890256224e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0549463900964074,0.0085317145075868,-0.0716685505312776,-0.0382242296615373,1.23304033035737e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,40411,0.0166940664203809,0.0025964367946623,0.0116050503028427,0.021783082537919,1.31568399595336e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.0332198858828958,0.00517693600881874,-0.0433666804601805,-0.023073091305611,1.43826389521327e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,40044,-0.0266535715603575,0.00415425572004587,-0.0347959127716474,-0.0185112303490675,1.43965779811691e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,40359,0.0423996442376775,0.00661082421731727,0.0294424287717356,0.0553568597036193,1.46066058557622e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.0577540012816616,0.00901011873963561,-0.0754138340113474,-0.0400941685519758,1.4975391260382e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.038184545412936,0.00595908739880366,-0.0498643567145912,-0.0265047341112808,1.51813873834731e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,37959,-0.0462681666995741,0.00723944948991425,-0.060457487699806,-0.0320788456993422,1.7008677009022e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,39980,-0.0260294912065837,0.00407796620243141,-0.0340223049633493,-0.0180366774498181,1.78626164952504e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0466854723601722,0.0073200251760676,0.0323382230150797,0.0610327217052647,1.84637992800812e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGMN,Legumain,40422,-0.021404854538959,0.00335893430965338,-0.0279883657858796,-0.0148213432920384,1.91049541614527e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.0353119508185848,0.00554741198556887,-0.0461848783102998,-0.0244390233268698,2.00969698389062e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.0481423802376937,0.00756622475245567,-0.0629721807525068,-0.0333125797228806,2.0353038719895e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.0559216504779245,0.00880633735004651,-0.0731820716840157,-0.0386612292718333,2.2197710324095e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0618114647577878,0.00974015460955028,-0.0809021677925064,-0.0427207617230693,2.28146134433679e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.0537967542969398,0.00847841148424338,-0.0704144408060568,-0.0371790677878228,2.29338082777469e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0588957531070308,0.00928356175818861,-0.0770915341530805,-0.0406999720609812,2.30862946706783e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAX,Protein max,39961,-0.0626857479463983,0.00988347653291821,-0.082057361950918,-0.0433141339418786,2.32358740271307e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,40471,0.0180116038276016,0.00284245454168841,0.0124403929258923,0.0235828147293108,2.41105883236755e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,40044,-0.0516035654291977,0.00814484637386268,-0.0675674643219685,-0.0356396665364268,2.42697034785377e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0547805931592291,0.00864642908232339,-0.0717275941605829,-0.0378335921578752,2.44077818524022e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,37562,-0.0402613538897579,0.00636157057985819,-0.0527300322262799,-0.0277926755532358,2.55055923250603e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.055540370009829,0.00877835579244802,-0.0727459473630272,-0.0383347926566309,2.5687641416059e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.0244171516979667,0.00386453218651396,0.0168426686123993,0.031991634783534,2.72821542421184e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.0135341557216296,0.00214934127310931,-0.0177468646169239,-0.00932144682633537,3.11611872506836e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.0247205176181038,0.00393460430821245,-0.0324323420622002,-0.0170086931740074,3.42855269071299e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.0238738622134594,0.00380037318130249,-0.0313225936488123,-0.0164251307781065,3.43030113196355e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.0325374039873249,0.00518116332278234,-0.0426924840999783,-0.0223823238746715,3.49304625400647e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.0550794606419065,0.00878019333009754,-0.0722886395688976,-0.0378702817149153,3.64624327523871e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.0126543941242976,0.00201893917767034,-0.0166115149125314,-0.00869727333606371,3.77458139400583e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0489403339093701,0.00781230832064451,-0.0642524582178333,-0.0336282096009069,3.85380060402979e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.0373104451058692,0.00595845827103013,-0.0489890233170882,-0.0256318668946501,3.90341757902119e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.0256591059476713,0.00409909558252578,-0.0336933332894218,-0.0176248786059208,3.97735088041108e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,-0.0199641922615639,0.00319145357540093,-0.0262194412693497,-0.0137089432537781,4.06281235642035e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,40332,-0.0316067147262803,0.00506066165799471,-0.0415256115759499,-0.0216878178766107,4.33003528689912e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.0690242988206001,0.0110560203873314,0.0473544988614305,0.0906940987797697,4.39838041059821e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.0169026534891523,0.00270879211319863,-0.0222118860310216,-0.011593420947283,4.51262115461576e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0328641041671855,0.00527249064200606,-0.0431981858255174,-0.0225300225088536,4.68778252145468e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,40267,-0.0203686321393901,0.00326976568941284,-0.0267773728906393,-0.013959891388141,4.80110613286259e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.0496748625544762,0.00797581575478065,-0.0653074614338463,-0.0340422636751061,4.85856406778035e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.0326487485921556,0.00525307776268163,-0.0429447810070116,-0.0223527161772996,5.25743614446821e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.028000294373747,0.00450492475814451,-0.0368299468997102,-0.0191706418477838,5.26709021625567e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,37900,-0.0188565969966208,0.00303383672585237,-0.0248029169792915,-0.0129102770139502,5.26964566903765e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.0148259025725453,0.00238535243208338,-0.0195011933394288,-0.0101506118056619,5.26983843183067e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,40360,0.0369396410977113,0.00594475335755962,0.0252879245168945,0.0485913576785282,5.29983669071339e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.0408085515036155,0.00656800370395844,-0.0536818387633741,-0.027935264243857,5.34625447794533e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,37598,-0.0257034028055498,0.00413753461565926,-0.033812970652242,-0.0175938349588577,5.38064521691102e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.0408915385423927,0.00658874056438358,-0.0538054700485845,-0.0279776070362009,5.56040163974653e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,37901,-0.0604077649823582,0.00973923786330756,-0.079496671194441,-0.0413188587702754,5.71958001309201e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.0217557245764727,0.00351282338641386,-0.0286408584138438,-0.0148705907391015,6.06844274442625e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,40489,-0.016729543449827,0.00270192072456461,-0.0220253080699737,-0.0114337788296804,6.09592089618442e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0410472144650777,0.00664039877800954,-0.0540623960699764,-0.028032032860179,6.53562116141664e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0233499369768268,0.00378176964208981,-0.0307622054753228,-0.0159376684783307,6.83514810836575e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,40490,-0.015728443256607,0.00254818889829434,-0.0207228934972639,-0.0107339930159501,6.88782214095004e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.0333941515550864,0.00541273129574957,-0.0440031048947555,-0.0227851982154172,7.01276471574756e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,-0.0284045666591797,0.00460715979139692,-0.0374345998503177,-0.0193745334680418,7.20344864395112e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0303011568256194,0.0049211857009747,-0.0399466807995298,-0.020655632851709,7.617576303573e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.0624619842447776,0.0101461936473576,-0.0823485237935984,-0.0425754446959568,7.6616574528385e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.0327771167989317,0.00532423028166745,-0.0432126081509999,-0.0223416254468635,7.66397187086524e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.0316154898960806,0.00513577804342468,-0.041681614861193,-0.0215493649309683,7.67462694331017e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,40332,-0.0153965753998344,0.00251003974733738,-0.0203162533046156,-0.0104768974950531,8.77293119315907e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.0266485737138684,0.00434531404107465,-0.0351653892343747,-0.0181317581933621,8.88042141651252e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.0196556790468361,0.00320510198485182,-0.0259376789371457,-0.0133736791565266,8.89200809149627e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,37959,0.025924437612585,0.00422772179409782,0.0176381028961533,0.0342107723290167,8.91940014020214e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,37671,-0.0628923477631221,0.0102566055751248,-0.0829952946903667,-0.0427894008358776,8.93168239143521e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.0366468050676789,0.00597855180073198,-0.0483647665971136,-0.0249288435382442,9.00945111623768e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.0604912315360912,0.00986963530669491,-0.0798357167372132,-0.0411467463349692,9.09341980382437e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.0605702793706726,0.00989198728904503,-0.0799585744572008,-0.0411819842841443,9.39073952472592e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.0267059481406145,0.00436235316126518,-0.0352561603366942,-0.0181557359445347,9.46134591714417e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,40433,-0.0344359027767327,0.00563999281733026,-0.0454902886987001,-0.0233815168547654,1.04741080791917e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.0517231565150671,0.00847812437267539,-0.0683402802855109,-0.0351060327446234,1.0800604066741e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPART,Spartin,37671,-0.0447350938456539,0.00733482089671028,-0.0591113428032061,-0.0303588448881018,1.09708976417954e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0494082415213938,0.00810500779686643,-0.065294056803252,-0.0335224262395356,1.11318288370175e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.0381252976120414,0.00625596741966398,-0.0503869937545828,-0.0258636014695,1.12504885197478e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,39961,-0.0303872785955082,0.00498900378162077,-0.0401657260074849,-0.0206088311835315,1.14963273677323e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,40324,-0.0592195409446492,0.00972444636576217,-0.0782794558215431,-0.0401596260677554,1.15686194436036e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0865530617220283,0.0142247343514567,-0.114433541050883,-0.0586725823931732,1.1939680807038e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,40305,-0.0784609943690522,0.0129033937375048,-0.103751646094561,-0.0531703426435428,1.22443307680842e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0341905311025425,0.0056341035899452,-0.0452333741388351,-0.0231476880662499,1.32102040814172e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.0347060361575325,0.00572941050032786,-0.0459356807381751,-0.0234763915768899,1.41894845796046e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0508900256748952,0.00841112225108261,-0.0673758252870171,-0.0344042260627733,1.47808268738699e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.0302166579892598,0.00499543081113474,-0.0400077023790839,-0.0204256135994357,1.49221750103444e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,-0.0127633882013706,0.00211177791977074,-0.0169024729241212,-0.00862430347861993,1.54379031302019e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.0148477454189455,0.00245669654649144,0.0100326201878223,0.0196628706500687,1.54495160271851e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,40359,-0.0387585498738897,0.0064150319911808,-0.051332012576604,-0.0261850871711753,1.55769606558061e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.0724893477015431,0.012002851287776,-0.0960149362255841,-0.0489637591775021,1.58185411880703e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,-0.0161892345712903,0.00268924299116342,-0.0214601508339706,-0.01091831830861,1.78931960334604e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0532378622548626,0.00886308774252188,-0.0706095142302055,-0.0358662102795197,1.94332385273615e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANG,Angiogenin,40309,-0.0196245426384588,0.00326753305271717,-0.0260289074217844,-0.0132201778551331,1.94404973287771e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.0612992517859626,0.0102201594767056,-0.0813307643603055,-0.0412677392116196,2.05021964614685e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.0493378879566464,0.00824120855989314,-0.0654906567340369,-0.0331851191792558,2.19669749170615e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,40332,0.0179278762611748,0.00299828915566477,0.0120512295160718,0.0238045230062777,2.28804856235367e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.0290999989513964,0.00487690898596415,-0.0386587405638861,-0.0195412573389066,2.47070039192899e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,37562,-0.0223249720193529,0.00374271754785873,-0.029660698413156,-0.0149892456255498,2.51075475110246e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELL,L-selectin,38013,0.0131280068486306,0.00220356682036934,0.00880901588070668,0.0174469978165545,2.62284316133769e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.0298826938713982,0.00501711142451221,-0.0397162322634421,-0.0200491554793543,2.64822451305119e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,37901,-0.0198792738667225,0.00333864279279541,-0.0264230137406015,-0.0133355339928435,2.67702437080861e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,40442,-0.0393395311293252,0.00661140649017108,-0.0522978878500605,-0.0263811744085899,2.73320570684283e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0492830920589349,0.00828341642331704,-0.0655185882486363,-0.0330475958692335,2.75580999147826e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,40260,-0.0318877372416628,0.0053605482462554,-0.0423944118043233,-0.0213810626790022,2.76157714695971e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,37990,-0.0316957910965495,0.00532869342265848,-0.0421400302049601,-0.0212515519881388,2.77903307934076e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.0664928848090408,0.0112294231120605,-0.0885025541086793,-0.0444832155094023,3.27145601390703e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,37643,-0.0794130949012263,0.0134229639119076,-0.105722104168565,-0.0531040856338874,3.37608008371771e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.0230932477971024,0.00390630373950207,-0.0307496031265265,-0.0154368924676784,3.46612445105233e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.0283915497951827,0.00480619088025898,-0.0378116839204903,-0.0189714156698751,3.56192070627025e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,40536,0.0170007927953043,0.00287865803178152,0.0113586230530126,0.0226429625375961,3.5800104257722e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.0564684363801946,0.00956285287452957,-0.0752116280142726,-0.0377252447461167,3.59937260946104e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.0617785096089791,0.0104620779418588,-0.0822841823750223,-0.0412728368429359,3.59989262415619e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.047848330020313,0.00810868845994758,-0.0637413594018103,-0.0319553006388158,3.70248761780795e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.0165706861958132,0.00281133349177639,-0.022080899839695,-0.0110604725519315,3.84199158570631e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,37541,-0.0307580042951741,0.00521882388499979,-0.0409868991097737,-0.0205291094805745,3.87016946288228e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,40514,0.0234147256001379,0.00397384429613469,0.0156259907797139,0.0312034604205619,3.88684772993662e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,40411,-0.0321664118530608,0.00546831114989246,-0.04288430170685,-0.0214485219992715,4.12619272069152e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.0402963201687201,0.00685697626939066,-0.0537359936567258,-0.0268566466807144,4.26917728661289e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,40411,-0.0169694721983649,0.00289149741830459,-0.0226368071382419,-0.0113021372584879,4.47796764266044e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,37942,-0.0371208716232568,0.00635103476183437,-0.0495688997564522,-0.0246728434900615,5.18726613382688e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.0309683330108857,0.00531083761513181,-0.0413775747365441,-0.0205590912852274,5.61147556470055e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.0270999264153645,0.00465053902769441,-0.0362149829096456,-0.0179848699210835,5.74592007388023e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.0219471569114963,0.00376951917829605,-0.0293354145009565,-0.014558899322036,5.9373154226345e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.0197890535719508,0.00339927029913295,-0.0264516233582514,-0.0131264837856502,5.94470372333043e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.0441117657530531,0.0075888352281571,-0.0589858828002411,-0.0292376487058652,6.28954988116065e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.0144650811173321,0.00248888393635997,-0.0193432936325977,-0.00958686860206657,6.29545383458715e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.0534215725203439,0.00919594325380477,-0.0714456212978013,-0.0353975237428866,6.39526319255174e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.0281249144216596,0.00484606043549257,-0.0376231928752251,-0.0186266359680942,6.6343004074547e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,40341,-0.0316639194878154,0.00545724702524655,-0.0423601236572986,-0.0209677153183321,6.6704743198992e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,37622,-0.0364862934037397,0.00629020139565332,-0.0488150881392202,-0.0241574986682592,6.7637642843214e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0527310467840735,0.00910164739089742,-0.0705702756702325,-0.0348918178979146,7.0208802063325e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,40497,0.0261325673940973,0.00451343740777706,0.0172862300748543,0.0349789047133404,7.17241738561098e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0370684395214644,0.0064080177612786,-0.0496281543335704,-0.0245087247093583,7.43019026977041e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.0362339806837677,0.00626966598447561,-0.0485225260133399,-0.0239454353541955,7.64663881388963e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,37598,-0.0315537284707417,0.00546498980173761,-0.0422651084821474,-0.020842348459336,7.92576698997052e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.0505931940865674,0.00876303813270777,-0.0677687488266746,-0.0334176393464601,7.94071554940763e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.0176333066032744,0.00307100167386297,-0.0236524698840458,-0.011614143322503,9.56443166229202e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLG,Plasminogen,37705,-0.0122417135731299,0.00213372826081511,-0.0164238209643275,-0.00805960618193231,9.83352873140434e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,37942,0.0199380732509272,0.00348801090331543,0.013101571880429,0.0267745746214255,1.11256320127123e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0367283522640397,0.00642789851685391,-0.0493270333570734,-0.024129671171006,1.12394164594651e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.0264392759123565,0.00462683168679681,0.0173706858062348,0.0355078660184783,1.12515720451293e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.034597091083737,0.00605830986298205,-0.0464713784151818,-0.0227228037522922,1.14585009730004e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,37942,-0.0379344357483231,0.00664880033322308,-0.0509660844014403,-0.0249027870952058,1.18470547181162e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,40028,-0.0230427907940363,0.00404186683376147,-0.0309648497882088,-0.0151207317998638,1.21246206799719e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,37572,-0.0370796313953519,0.00650490257754381,-0.0498292404473378,-0.024330022343366,1.2220145600751e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.016972910442816,0.00297757920613825,0.011136855198785,0.022808965686847,1.22216613401823e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,37942,-0.0577624791123713,0.0101351645326325,-0.0776274015963311,-0.0378975566284116,1.2287896665133e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,37900,-0.0204552643000516,0.00359012440367533,-0.0274919081312553,-0.0134186204688479,1.24018622538831e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.0318172612015376,0.00558608378836059,-0.0427659854267244,-0.0208685369763509,1.25360041898292e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.0339767768508277,0.00597440429420953,-0.0456866092674783,-0.022266944434177,1.32007689314634e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH1,Somatotropin,40330,0.0941184499929189,0.0165774283776354,0.0616266903727535,0.126610209613084,1.39063122759026e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.0520178343925647,0.00916729526372842,-0.0699857331094724,-0.034049935675657,1.42134542769941e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.0304955441524775,0.00537654957928094,-0.0410335813278682,-0.0199575069770869,1.44153037712121e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,40042,-0.0400628801661549,0.00706932218485492,-0.0539187516484705,-0.0262070086838392,1.4776403782828e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,40271,-0.0290623053006887,0.00513169585124337,-0.0391204291691257,-0.0190041814322517,1.51075393978739e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMD,Dystrophin,37628,-0.0279717061704755,0.00494628563565912,-0.0376664260163673,-0.0182769863245836,1.5899905592458e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,39961,-0.0242928125323708,0.00429802045607598,-0.0327169326262798,-0.0158686924384619,1.61294834103078e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0260014678757775,0.00460524354859439,-0.0350277452310225,-0.0169751905205325,1.67042740152516e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,40305,-0.01563016903349,0.0027697774384099,-0.0210589328127734,-0.0102014052542066,1.69858723113716e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,37628,-0.0499393695482681,0.00884927440000013,-0.0672839473722684,-0.0325947917242679,1.70231272929506e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,40489,0.0239226354483514,0.00424076346841569,0.0156107390502566,0.0322345318464461,1.71804987987124e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0423293093129197,0.00750709297035989,-0.0570432115348251,-0.0276154070910143,1.75047814823196e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,39961,0.0392650240283353,0.00696822513217426,0.0256073027692737,0.0529227452873968,1.78239514378565e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,-0.0106228800973656,0.00188571080818026,-0.0143188732813989,-0.0069268869133323,1.80267355596998e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.0263810836112582,0.00468552608445506,-0.0355647147367901,-0.0171974524857263,1.83509828688186e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.0383405602022985,0.00681074226721043,-0.051689615046031,-0.0249915053585661,1.83927145309421e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,40359,-0.0147552754223971,0.00262842970787859,-0.0199069976498392,-0.00960355319495509,2.0132697314589e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0451399837866584,0.00805061902318269,-0.0609191970720965,-0.0293607705012203,2.09369355241432e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.0376741435988253,0.0067254106248805,-0.0508559484235911,-0.0244923387740596,2.15703496597674e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,37987,-0.0482341992221997,0.00861280032204393,-0.0651152878534058,-0.0313531105909936,2.18157165512406e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.0348620966344318,0.00623333793901265,0.022644754273967,0.0470794389948966,2.27719131139386e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.0612379368353705,0.0109676087517589,-0.0827344499888179,-0.0397414236819231,2.39557201926995e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.0458750701830775,0.00821619430180454,-0.0619788110146144,-0.0297713293515406,2.40299882586115e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,37901,-0.0184816510696143,0.00331151373550493,-0.024972217991204,-0.0119910841480247,2.43723662629031e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.0475225647611908,0.00851616940888966,-0.0642142568026145,-0.030830872719767,2.44748472108688e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.0172113420826578,0.0030872863089462,0.0111602609171233,0.0232624232481923,2.52509582184026e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,-0.0142909929343092,0.00256532358424344,-0.0193190271594264,-0.0092629587091921,2.57628173361424e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.0348124406555914,0.00624924761319008,-0.047060965977444,-0.0225639153337389,2.57887484856564e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0299106614675909,0.00537579451728634,-0.0404472187214721,-0.0193741042137097,2.689341827863e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,40453,-0.0272394499474046,0.00490486298244566,-0.0368529813929981,-0.0176259185018111,2.84365654804336e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,40411,-0.0334519825764952,0.00603092415829668,-0.0452725939267567,-0.0216313712262337,2.95664135857391e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,39903,-0.0602009321175623,0.010856025906442,-0.0814787428941886,-0.038923121340936,2.98102822676798e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0461224663642814,0.0083204029087753,-0.062430456065481,-0.0298144766630818,3.02416627599289e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0359603402449235,0.00648788095794941,-0.0486765869225043,-0.0232440935673426,3.03433648198842e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0332852561024933,0.00601317717519082,-0.0450710833658673,-0.0214994288391193,3.16319227158193e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0288358265104976,0.00521396764847561,-0.0390552031015098,-0.0186164499194854,3.24363603406822e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,37671,-0.0299628354736381,0.00541770013414003,-0.0405815277365525,-0.0193441432107236,3.25297684757828e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.0202099649837788,0.00365647492631172,-0.0273766558393498,-0.0130432741282078,3.30681686548922e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.0201328140421819,0.00364914438170594,-0.0272851370303255,-0.0129804910540383,3.51109259912483e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.0620789818469369,0.011262802354819,-0.0841540744623822,-0.0400038892314916,3.61714854021306e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0437409300738107,0.00794582994563595,-0.0593147567672572,-0.0281671033803642,3.75111455026962e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,40314,-0.0210525203627766,0.00383003127092723,-0.028559381653794,-0.0135456590717593,3.92940850158739e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.0253128393509204,0.0046098567530348,-0.0343481585868686,-0.0162775201149722,4.05887729589184e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,40435,-0.0229380281171761,0.00418868285030059,-0.0311478465037653,-0.014728209730587,4.41134573874125e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.0115772608442613,0.0021141149613761,-0.0157209261685584,-0.00743359551996413,4.41232908013976e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.0317799615966039,0.00580365081551548,-0.0431551171950142,-0.0204048059981935,4.42020794113372e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,-0.0220789072018436,0.00404006886564738,-0.0299974421785124,-0.0141603722251747,4.69894306008883e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.0487839861100044,0.00894597315644789,-0.0663180934966422,-0.0312498787233665,5.03511509645123e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,-0.0137176810040389,0.00251881437604835,-0.0186545571810937,-0.00878080482698418,5.22465306459346e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.0238349002942412,0.00437832986638476,-0.0324164268323553,-0.0152533737561271,5.30576859806373e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,37942,-0.0702712399029712,0.0129289957625319,-0.0956120715975338,-0.0449304082084086,5.56967365324519e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,-0.0251120506950998,0.00462302292351351,-0.0341731756251863,-0.0160509257650133,5.65753993543858e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.0373444103005403,0.00687650769280942,-0.0508223653784468,-0.0238664552226338,5.69470091888973e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.0320439540487233,0.00590265257707901,0.0204747549976485,0.0436131530997982,5.77709391759833e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.0116438595897529,0.00214552716500327,-0.0158490928331593,-0.00743862634634651,5.8142168735033e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,-0.0160345018034124,0.0029546303027526,-0.0218255771968075,-0.0102434264100173,5.81690131093571e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,-0.0133450835669804,0.00245960358858206,-0.0181659066006012,-0.00852426053335951,5.87192171534481e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.025656915174168,0.00472911799731546,-0.0349259864489063,-0.0163878438994297,5.87226431379066e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.0139476889540536,0.00257132897932663,-0.0189874937535338,-0.00890788415457341,5.90253993144586e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,-0.0139488917703236,0.00257138912896724,-0.0189888144630994,-0.00890896907754779,5.90653697686886e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0333348083134332,0.00614761102873086,-0.0453841259297457,-0.0212854906971207,5.98128956700028e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,40305,-0.0422418566379799,0.00779406975958001,-0.0575182333667567,-0.0269654799092031,6.05566087632124e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.0333190387792857,0.00614826340741103,-0.0453696350578113,-0.0212684425007601,6.08743214959188e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.018901796229567,0.00350128214882512,-0.0257643092412642,-0.0120392832178697,6.83181616971755e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,37900,-0.0334457233997929,0.00619634215813916,-0.0455905540297457,-0.0213008927698402,6.86627237304489e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,37901,-0.0157802865463149,0.00292395547921585,-0.0215112392855779,-0.0100493338070518,6.89529839786735e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOST,Sclerostin,40330,-0.0197391226681155,0.00365937246332249,-0.0269114926962276,-0.0125667526400034,6.98431263753075e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.0390822857511695,0.00725197315165108,-0.0532961531284056,-0.0248684183739334,7.17801770656596e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.0407415339854493,0.007560443461025,-0.0555600031690583,-0.0259230648018403,7.21628555326452e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.0298880031051736,0.00554697320898308,-0.0407600705947804,-0.0190159356155667,7.22023681423335e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0606651747465345,0.0112793433767543,-0.082772687764973,-0.038557661728096,7.6201151900551e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.0505391189802587,0.00939880662836936,-0.0689607799718627,-0.0321174579886547,7.69188069579571e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,37998,-0.0459975730598624,0.00856896979065471,-0.0627927538495456,-0.0292023922701792,8.0961318265729e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.018997074800992,0.0035428101979187,0.0120531668130713,0.0259409827889126,8.34355521756203e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0284649366374189,0.00531147487376478,-0.0388754273899979,-0.0180544458848399,8.48079437895814e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.0249240727576891,0.00465951261902105,-0.0340567174909703,-0.0157914280244078,8.98538942302293e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.0418661855890025,0.00782689753503716,-0.0572069047576753,-0.0265254664203296,8.99131204984496e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,37905,-0.0488371376166682,0.00913750553906514,-0.0667466484732358,-0.0309276267601005,9.20499137547582e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0332986413419821,0.0062340216416829,-0.0455173237596806,-0.0210799589242836,9.37139742609333e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.0220373704914216,0.0041279498696942,-0.0301281522360222,-0.013946588746821,9.52025308910254e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.023062994931497,0.00432150702250729,0.0145928411673827,0.0315331486956113,9.58980626226049e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.0342397404635907,0.00641992054789662,-0.0468227847374681,-0.0216566961897133,9.77308925815897e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.0389292827176743,0.00730509370669687,-0.0532472663828001,-0.0246112990525484,1.00315734242941e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.0265933657967099,0.00499119320515125,-0.0363761044788063,-0.0168106271146134,1.0065566775789e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,-0.0144734648210298,0.00271741091086892,-0.0197995902063329,-0.00914733943572672,1.01670287461558e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.01573509848121,0.00295518781480063,-0.0215272665982192,-0.00994293036420075,1.02582835463866e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.0219846796306662,0.00413346504444669,-0.0300862711177817,-0.0138830881435506,1.05951258394069e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,40207,-0.0226299170526946,0.00425857425289706,-0.0309767225883728,-0.0142831115170163,1.08725061456428e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.0349816294792284,0.00658629954905023,-0.0478907765953669,-0.02207248236309,1.10367842100251e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.035890654031595,0.00675899991431501,-0.0491382938636524,-0.0226430141995376,1.11331799289357e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0445316743557497,0.0083968760094263,-0.0609895513342253,-0.0280737973772742,1.15492016658735e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRN,Progranulin,40262,-0.0121748641930052,0.00229787357704809,-0.0166786964040194,-0.00767103198199089,1.18441825062933e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.0269871086260423,0.00510008414997236,-0.0369832735599881,-0.0169909436920964,1.22963765302683e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,37987,0.0124089391691094,0.00234549506134897,0.00781176884886538,0.0170061094893533,1.23855885422389e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.0152945583040268,0.00289846018576514,-0.0209755402681264,-0.00961357633992711,1.33496604328902e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,40042,-0.015256018712849,0.00289295125428217,-0.020926203171242,-0.00958583425445595,1.35623402115685e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0314034493867726,0.00595545520934383,-0.0430761415970865,-0.0197307571764586,1.36302735307289e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,-0.0117790995139195,0.00223577839738271,-0.0161612251727896,-0.00739697385504936,1.39744127259376e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.0169497033295613,0.00322045487525263,0.0106376117740661,0.0232617948850564,1.43457283680811e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,40228,0.0170160450119075,0.00323645704930957,0.0106725891952607,0.0233595008285542,1.47838955464857e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0357552428409684,0.00680283632972955,-0.0490888020472383,-0.0224216836346985,1.49514473764821e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,40044,-0.0257993090310436,0.00490989159457672,-0.0354226965564139,-0.0161759215056732,1.50334276687761e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,37942,-0.0417382206964175,0.00794294823926036,-0.0573063992453678,-0.0261700421474672,1.50482290762537e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,40042,-0.0420087473782255,0.00800399389059334,-0.0576965754037884,-0.0263209193526625,1.5537546641375e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,39961,-0.0334479149132457,0.00637459511040229,-0.0459421213296341,-0.0209537084968572,1.56575834295922e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.0159792371009426,0.003046946491952,-0.0219512522251685,-0.0100072219767167,1.59266597286563e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0177528758586756,0.00338949865588045,-0.0243962932242013,-0.0111094584931499,1.65186408872756e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0165003907685165,0.00315328153849127,-0.0226808225839594,-0.0103199589530736,1.69500790402103e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,40291,-0.0349676507372169,0.00668718191217094,-0.0480745272850719,-0.0218607741893619,1.72544251485213e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,40305,0.0376418457693902,0.00720971363211853,0.0235108070504378,0.0517728844883425,1.80216527690084e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.0533786289995257,0.0102348787430386,-0.0734389913358813,-0.03331826666317,1.86178093988347e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,40341,-0.0332572197610309,0.00638648410829249,-0.0457747286132842,-0.0207397109087776,1.93854302324777e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,40359,-0.019743368800191,0.00379146218007818,-0.0271746346731442,-0.0123121029272377,1.9397131192803e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.0366014688884293,0.00704863358623741,-0.0504167907174546,-0.0227861470594039,2.10265303952352e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0162201502866217,0.00312792491056972,-0.0223508831113384,-0.0100894174619051,2.18451713738317e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,40015,-0.0237002424887139,0.0045709082620526,-0.032659222682337,-0.0147412622950908,2.18699212741461e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,40536,0.014472023187399,0.00279168860672781,0.00900031351821253,0.0199437328565856,2.19844811690851e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0224054931084058,0.00432366297984166,-0.0308798725488955,-0.0139311136679162,2.22621505399251e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.0139949610583129,0.00270383001232556,0.00869545423415482,0.019294467882471,2.2951016598761e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.0165264810641838,0.00319646496994809,-0.022791552405282,-0.0102614097230855,2.37199028651333e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,-0.0186910431972687,0.00361892481565284,-0.0257841358359483,-0.0115979505585892,2.44187894613009e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0282348851826996,0.00546899648717121,-0.0389541182975552,-0.017515652067844,2.46846923484515e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.0459350105832171,0.00890123461130445,-0.0633814304213739,-0.0284885907450604,2.49229625148633e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.0218433771243347,0.004237587157617,-0.030149047953264,-0.0135377062954053,2.57676249597636e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.0240823033377234,0.00467315693678228,-0.0332416909338167,-0.0149229157416301,2.59046725153089e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,0.0143089768166969,0.00277816013936141,0.00886378294354857,0.0197541706898453,2.63433044495037e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0441411259372528,0.008570585906219,-0.060939474313442,-0.0273427775610635,2.63723419253521e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0394095773523029,0.00765351564193787,-0.0544104680105011,-0.0244086866941046,2.64706242034309e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0481747630182718,0.00935699604013651,-0.0665144752569394,-0.0298350507796042,2.65744220025517e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,40536,-0.0428898520483588,0.00833903573315948,-0.0592343620853514,-0.0265453420113663,2.73178258984185e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,-0.0374644202652799,0.00730077791751379,-0.0517739449836069,-0.0231548955469529,2.90725200049412e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,37562,-0.0195292512437271,0.00380968514965431,-0.0269962341370495,-0.0120622683504046,2.99839802481914e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,40332,-0.0439657990243389,0.00858070349365794,-0.0607839778719085,-0.0271476201767694,3.02950056705717e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.0405233244879527,0.00791095664595446,-0.0560287995140234,-0.025017849461882,3.05136545743251e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.0329815162028913,0.00644489294971726,-0.0456135063843371,-0.0203495260214454,3.13921829647336e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,40042,-0.0243385018062061,0.00475642420202905,-0.033661093242183,-0.0150159103702291,3.14163335988321e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.0124855793793945,0.00244067341327654,-0.0172692992694166,-0.00770185948937251,3.16974360645206e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.0139261321467107,0.00272309825756582,0.00858885956188166,0.0192634047315397,3.19734824992784e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.0270474694849167,0.00529191907821675,-0.0374196308782215,-0.0166753080916118,3.24752589961156e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORT1,Sortilin,40330,-0.017561782331448,0.0034385919966294,-0.0243014226448416,-0.0108221420180544,3.30648190365718e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,40332,-0.0320109619609972,0.00628065240410168,-0.0443210406730365,-0.0197008832489579,3.49488012342226e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,40522,-0.0163026803880885,0.00320047144613171,-0.0225756044225066,-0.0100297563536703,3.54860566986016e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,-0.026707912333129,0.00525373048484033,-0.0370052240834161,-0.016410600582842,3.75304637953688e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.0233114130990221,0.00458711237199701,-0.0323021533481363,-0.014320672849908,3.78590563334566e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.044724678900761,0.00880917199267563,-0.0619906560064052,-0.0274587017951168,3.87740407821686e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.0142036292867269,0.00280724011481589,-0.019705819911766,-0.00870143866168771,4.24820271773902e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.0509840687943041,0.0100921528672587,-0.0707646884141311,-0.0312034491744772,4.43363348043487e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.0337746141813753,0.00668636048228261,-0.0468798807266492,-0.0206693476361014,4.44642621600609e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,-0.0492984713422917,0.00976047465797021,-0.0684290016719133,-0.0301679410126701,4.44778291088646e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.0166935888639206,0.00330524125116677,-0.0231718617162075,-0.0102153160116338,4.4617824907899e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.0225124763107476,0.00446010790087978,-0.0312542877964719,-0.0137706648250232,4.52666166439729e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,37572,-0.0233275135884258,0.00462657799979251,-0.0323956064680191,-0.0142594207088325,4.66675291041587e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,39980,-0.0281942900520515,0.00559864002812132,-0.0391676245071693,-0.0172209555969338,4.80895915416829e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,37598,-0.024058637038462,0.00477820532869451,-0.0334239194827033,-0.0146933545942208,4.8397958715276e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.0132716006531371,0.0026362828027731,-0.0184387149465724,-0.00810448635970186,4.85985577845698e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,37714,-0.0261207339850188,0.00519474277439073,-0.0363024298228246,-0.015939038147213,5.01304565874142e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,-0.0167333261294343,0.00332860346555507,-0.0232573889219223,-0.0102092633369464,5.03282532002856e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0322150662635842,0.00641474022772322,-0.0447879571099218,-0.0196421754172467,5.1798320396016e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.0393723337701461,0.00784163019940024,-0.0547419289609706,-0.0240027385793216,5.20735079557828e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,40332,-0.0574223038837499,0.0114436703746238,-0.0798518978180126,-0.0349927099494873,5.28253332759688e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,40032,-0.0206206545916029,0.00411071706032018,-0.0286776600298305,-0.0125636491533754,5.32513698096431e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.0232541539137469,0.00463644693310417,-0.0323415899026311,-0.0141667179248627,5.35824535179931e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,40310,-0.0221275531870548,0.00441697783554004,-0.0307848297447133,-0.0134702766293963,5.511297655051e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,-0.0183913294353199,0.00367899417066575,-0.0256021580098248,-0.011180500860815,5.82402263594344e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,40471,-0.0140624748252124,0.00282006127455122,-0.0195897949233328,-0.00853515472709198,6.20986229863427e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.033509135838222,0.00672158949144723,-0.0466834512414585,-0.0203348204349854,6.26313258096271e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,-0.0118942391784272,0.00238761603535729,-0.0165739666077274,-0.00721451174912688,6.37075438645541e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,-0.00893575976570029,0.0017937348408914,-0.0124514800538474,-0.00542003947755315,6.37077201706303e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.028922755550904,0.00581074780120356,-0.040311821241263,-0.017533689860545,6.52360154513704e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,0.0139691964313595,0.00281160495458961,0.00845845072036388,0.0194799421423552,6.82013734827375e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.0131439352996951,0.00265633312822308,-0.0183503482310124,-0.00793752236837791,7.58520533122911e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.0273024499487562,0.00552297870697447,-0.0381274882144262,-0.0164774116830863,7.75488833871194e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.0279047466606679,0.0056457871191719,-0.0389704894142448,-0.016839003907091,7.80218178142947e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.0102421754808127,0.0020766301057556,0.00617198047353168,0.0143123704880936,8.23334122254011e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.038553424095454,0.00782246353152329,-0.0538854526172396,-0.0232213955736683,8.38451572268992e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,40516,-0.0356393111362231,0.00724066114179099,-0.0498310069741334,-0.0214476152983127,8.64662361388742e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0465334457763229,0.00946619071497594,-0.0650871795776758,-0.0279797119749701,8.94822300636153e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.00943192698599137,0.00192042860155973,0.00566788692693431,0.0131959670450484,9.1534924826018e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,-0.0210836729894772,0.00430388347442158,-0.0295192845993435,-0.0126480613796109,9.7591264530453e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0299159544493864,0.00610948397608068,-0.0418905430425045,-0.0179413658562682,9.84698730450387e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.0152654610569431,0.00311774757314501,-0.0213762463003073,-0.00915467581357891,9.8601444539036e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.0406304890430293,0.00829817274146262,-0.0568949076162961,-0.0243660704697626,9.86103551781539e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,40258,-0.0194579328300644,0.00397662755386313,-0.0272521228356361,-0.0116637428244926,1.00250972180282e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0281761306406131,0.00575984783330916,-0.0394654323938991,-0.0168868288873272,1.01093939196553e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.0160561945967216,0.00329042452502729,-0.0225054266657751,-0.00960696252766815,1.07299749396863e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.0370379519850215,0.00760235433571317,-0.0519385664830193,-0.0221373374870237,1.11780753987412e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.0264042907549426,0.0054211846227256,-0.0370298126154848,-0.0157787688944005,1.1256617012885e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,-0.0095375938923167,0.0019627939823817,-0.0133846700977848,-0.00569051768684856,1.19006544001662e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.0129972357490109,0.00267614578680793,0.00775199000686737,0.0182424814911544,1.20489114838796e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.0226322770927884,0.00466250506147694,-0.0317707870132832,-0.0134937671722936,1.22104307615993e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0206053895961209,0.00425516399855912,-0.0289455110332967,-0.012265268158945,1.29462340433225e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0402475490373384,0.00831884775233443,-0.0565524906319138,-0.0239426074427629,1.32307633837112e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,37608,-0.0190919570113865,0.00394870382403451,-0.0268314165064941,-0.0113524975162789,1.34655913506646e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0279043913906691,0.00577948569672203,-0.0392321833562443,-0.0165765994250939,1.39053907656491e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,37628,-0.0137521139042738,0.0028526517450782,-0.0193433113246271,-0.00816091648392054,1.44567257558486e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.0196636933239631,0.00408360745668417,0.0116598227088622,0.0276675639390641,1.48634912720194e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.0301460096459296,0.00626420832571575,-0.0424238579643324,-0.0178681613275267,1.50509063097155e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.0205080206733817,0.00427049816009701,-0.0288781970671719,-0.0121378442795916,1.58318817977863e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.0307748283427192,0.0064136064623556,-0.0433454970089362,-0.0182041596765023,1.61440084264879e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.0422532740173749,0.00880720169241837,-0.0595153893345149,-0.0249911587002349,1.6204976788068e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0300002462771694,0.00625950187311686,-0.0422688699484784,-0.0177316226058603,1.66036322761962e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.0236388808046847,0.00493413062255727,-0.0333097768248969,-0.0139679847844724,1.67536616307861e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,40305,-0.033897771126846,0.0070760348019986,-0.0477667993387633,-0.0200287429149287,1.67868649016931e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,0.0114063447915989,0.00238155856297594,0.00673849000816611,0.0160741995750318,1.69057659348451e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0385868042392339,0.00806019303568095,-0.0543847825891685,-0.0227888258892992,1.70536905480068e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,40396,-0.0390994549215804,0.00816753689548455,-0.0551078272367301,-0.0230910826064306,1.70660436937431e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.0331850464730427,0.00693783814856512,-0.0467832092442304,-0.0195868837018551,1.74060592290323e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.0303048510808785,0.00634010264014818,-0.042731452255569,-0.0178782499061881,1.77259015395548e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,37942,-0.01698526240161,0.00355530948755113,-0.0239536689972102,-0.0100168558060097,1.79414319829589e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,40172,-0.0318224708984729,0.00666395910325159,-0.044883830740846,-0.0187611110560998,1.81048195830724e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.0288628806533052,0.00605031588666535,-0.0407214997911693,-0.0170042615154411,1.85766994173474e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.020993959108185,0.00440141434609422,-0.0296207312265297,-0.0123671869898403,1.86067138715932e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,37812,-0.0453389003657535,0.00950907127612678,-0.063976680066962,-0.026701120664545,1.88061525679688e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,40359,-0.0309578956518487,0.00650383746266105,-0.0437054170786643,-0.018210374225033,1.95351501893265e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,40516,-0.0274059985222484,0.00576310159633088,-0.0387016776510569,-0.0161103193934398,1.99748206329763e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.0303632257732383,0.00638912319288674,-0.0428859072312964,-0.0178405443151803,2.03195775098403e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0330706141893165,0.00696056287594329,-0.0467133174261653,-0.0194279109524676,2.04393207698831e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.021780948337245,0.00458815031879114,-0.0307737229620756,-0.0127881737124144,2.08046278050465e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,-0.0148504060805404,0.00313339513268414,-0.0209918605406013,-0.00870895162047949,2.16246996780594e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.0312986827157193,0.0066116219984361,-0.0442574618326541,-0.0183399035987846,2.22494440829787e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.0347835717813449,0.0073506218238729,-0.0491907905561358,-0.020376353006554,2.24564070327578e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.0213802945607997,0.00452201451700543,-0.0302434430141304,-0.0125171461074691,2.28980628019196e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.0240430852288308,0.00509224205277022,-0.0340238796522604,-0.0140622908054011,2.36444183643257e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,40305,-0.0144381800489777,0.00306043677831844,-0.0204366361344819,-0.00843972396347357,2.40577048132975e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,39980,-0.0307200829992939,0.00652624008992954,-0.0435115135755558,-0.017928652423032,2.5335571348172e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.0234460457277662,0.00498473763654618,-0.0332161314953967,-0.0136759599601357,2.57856677197289e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0314277287693191,0.0067028241337897,-0.0445652640715469,-0.0182901934670913,2.77247665141419e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.0170026165955764,0.00362902603958808,-0.0241155076331691,-0.00988972555798377,2.82098034315806e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,-0.0175565628274512,0.00375081765475969,-0.0249081654307802,-0.0102049602241222,2.88628311973642e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,-0.013101271633946,0.0028099508812138,-0.0186087753611251,-0.00759376790676696,3.14997155028259e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.0271897192327976,0.00584336465710292,-0.0386427139607193,-0.0157367245048759,3.30213094472545e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,40042,-0.0208526968746553,0.00449079787809364,-0.0296546607157188,-0.0120507330335917,3.45471811286547e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,40355,-0.0173964896584887,0.0037542828936778,-0.0247548841300972,-0.0100380951868802,3.61912474217801e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),37735,0.0776306600541709,0.0167601322794172,0.0447808007865132,0.110480519321829,3.65827163434493e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.0235705133238077,0.0050952221806176,-0.0335571487978182,-0.0135838778497972,3.75738444012402e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,-0.0265495884190071,0.00574400404887856,-0.0378078363548091,-0.0152913404832051,3.82762318500598e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.011733183114588,0.00253921183186372,0.00675632792413514,0.0167100383050409,3.85807927111072e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.0120338934543799,0.00260570933749253,-0.0171410837558653,-0.00692670315289453,3.90497994137755e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,-0.0416255935909718,0.00904404668115639,-0.0593519250860383,-0.0238992620959053,4.21185815829347e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0163751282504261,0.00356241294764211,0.00939279887304751,0.0233574576278046,4.32742922677911e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0177719469945923,0.00387785432056334,0.0101713525262882,0.0253725414628965,4.62024579432317e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,37541,-0.0278945955924031,0.00608922240930634,-0.0398294715146435,-0.0159597196701626,4.67078537639639e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.033522293273383,0.00733859308834777,-0.0479059357265446,-0.0191386508202214,4.96966644879171e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0301328785185393,0.00659848056601986,-0.0430659004279382,-0.0171998566091403,5.00119841833927e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,37901,-0.0307727779809658,0.00675719638807734,-0.0440168829015974,-0.0175286730603343,5.30787498607454e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.0151908779926521,0.00334239224327984,-0.0217419667894806,-0.00863978919582364,5.54483041408877e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.0408254038137692,0.00898430598172773,-0.0584346435379556,-0.0232161640895829,5.56646543076797e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.0187917290489861,0.00414974875316565,-0.0269252366051908,-0.0106582214927814,5.98752938022765e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.0327271479128283,0.00724900157942292,-0.0469351910084972,-0.0185191048171593,6.38694173356367e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.0218397372123809,0.00484987409409494,-0.031345490436807,-0.0123339839879548,6.7439415861617e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.0360016836452702,0.00800913604819173,-0.051699590299726,-0.0203037769908144,7.00477230507572e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFB,Complement factor B,37770,-0.0140293303626172,0.00312511716523091,-0.0201545600064698,-0.0079041007187646,7.20853643952676e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.0158436989410236,0.00352959941345961,-0.0227617137914044,-0.00892568409064277,7.21382065653625e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.0400871764261136,0.0089434933194882,-0.0576164233323105,-0.0225579295199168,7.43697105292419e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.0319815082059211,0.00713542202337372,-0.0459669353717336,-0.0179960810401086,7.44495422421776e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.0313507040099393,0.00701405457002405,-0.0450982509671864,-0.0176031570526922,7.88770486676461e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.0221882662228133,0.00496511430082099,-0.0319198902524224,-0.0124566421932041,7.92856988356927e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.030983961501161,0.00693704997844282,-0.044580579458909,-0.0173873435434131,8.00915359127399e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,37987,0.00948433556688627,0.00212663962800731,0.00531612189599194,0.0136525492377806,8.27062258202485e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,37987,0.0201343910728813,0.00452706023474202,0.0112613530127869,0.0290074291329757,8.75415973525445e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.0218012890909099,0.0049133261880303,-0.0314314084194492,-0.0121711697623705,9.18716360468011e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,40341,-0.0222876502848275,0.0050249305623318,-0.0321365141869978,-0.0124387863826572,9.25122944214786e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,-0.0113513564520436,0.0025628384220009,-0.0163745197591654,-0.00632819314492187,9.52120848022757e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.0320824182465013,0.00724420127534702,-0.0462810527461815,-0.0178837837468212,9.54401884445054e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,40042,-0.0187873094233714,0.00424586010889471,-0.0271091952368051,-0.0104654236099378,9.71621589510995e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.0257678274616808,0.0058288416536202,-0.0371923571027763,-0.0143432978205852,9.91515778403143e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.0367138424082179,0.00830515899224112,-0.0529919540330106,-0.0204357307834253,9.92087554605473e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,-0.0358579581666184,0.00812622647451578,-0.0517853620566693,-0.0199305542765674,1.02800506934821e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.017428229457955,0.00395027421070441,-0.0251707669109356,-0.00968569200497431,1.03279043921369e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,-0.0364821023166128,0.00828938539075279,-0.0527292976824883,-0.0202349069507373,1.08551959440954e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.0169629693841734,0.00385661168042142,-0.0245219282777994,-0.00940401049054745,1.09902978277465e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.0150668626837302,0.00342712084962371,-0.0217840195489927,-0.00834970581846772,1.10936931876847e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.0292222487480913,0.00664802604299459,-0.0422523797923607,-0.0161921177038219,1.11311818757645e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.0288557975102262,0.0065708596281578,0.015976912639037,0.0417346823814155,1.13441825712235e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.0198968428861636,0.00454413557611237,-0.0288033486153438,-0.0109903371569833,1.20356885263814e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,40332,0.00804935354937319,0.00183923726715668,0.0044444485057461,0.0116542585930003,1.21390635573593e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.0210445089476162,0.00481052439521108,0.0116158811330025,0.03047313676223,1.22525746444738e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.0167622106770496,0.00383186625724341,-0.0242726685412467,-0.00925175281285255,1.22669517399921e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.0336351824934613,0.0076977739824814,-0.0487228194991248,-0.0185475454877977,1.25334099828609e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.0414177561006645,0.00948701814132465,-0.0600123116576608,-0.0228232005436682,1.27671566717426e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.0313461750262821,0.00718211056429945,-0.045423111732309,-0.0172692383202551,1.28251905993723e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,40171,-0.0241771553419793,0.00553970534873319,-0.0350349778254964,-0.0133193328584623,1.28320895525805e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.0456158085089975,0.0104600690786055,-0.0661175439030642,-0.0251140731149308,1.30311447667065e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.0216758510266545,0.00498648410419482,-0.0314493598708763,-0.0119023421824327,1.38936783008099e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.0159510333551839,0.00368390010738596,-0.0231714775656604,-0.00873058914470743,1.50228460968742e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,-0.0109497748810369,0.0025299322744098,-0.0159084421388801,-0.00599110762319371,1.51491429071855e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,37628,-0.0119607348685044,0.00277050606674836,-0.0173909267593312,-0.00653054297767763,1.59199741131983e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,-0.0164674872387755,0.00381901399449349,-0.0239527546679827,-0.00898221980956823,1.62948132091108e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,40312,-0.0274203049714589,0.00636465974748723,-0.0398950380765339,-0.0149455718663839,1.65569864580429e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,-0.0087893952861187,0.00204169950821244,-0.0127911263222151,-0.00478766425002231,1.68212906205821e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,-0.0406188214615074,0.00945800196120404,-0.0591565053054673,-0.0220811376175475,1.76005372233556e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.0184496850192901,0.00430052850441686,-0.0268787208879471,-0.010020649150633,1.79640909156398e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,40341,-0.0124683073693304,0.00291206626999132,-0.0181759572585134,-0.00676065748014741,1.86641579991368e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0298857797437876,0.0069830479863242,-0.043572553796983,-0.0161990056905921,1.88415717578527e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.0484146745023176,0.0113172185683947,-0.0705964228963712,-0.0262329261082639,1.89708786998922e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.0226872159471874,0.00532002170660708,-0.0331144584921373,-0.0122599734022375,2.01749646999426e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.024996411417605,0.00587478082560718,-0.0365109818357951,-0.013481840999415,2.10624886225862e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,40471,-0.0118484620563904,0.00278650763033463,-0.0173100170118463,-0.00638690710093454,2.12991465299478e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.0189355320590484,0.00446179233007312,0.0101904190921051,0.0276806450259917,2.20885158959099e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,40305,0.0115311026879757,0.00271843781832794,0.00620296456405289,0.0168592408118984,2.22980243500189e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.0165242637839992,0.00389766105293536,0.00888484812024595,0.0241636794477526,2.25253262116122e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0309395464557298,0.00734296633354097,-0.0453317604694701,-0.0165473324419895,2.53135127248104e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSPN,Persephin,40341,-0.0396181702111362,0.00940382240503219,-0.0580496621249993,-0.0211866782972731,2.53406986576388e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,0.0102568419220673,0.00243501744277703,0.00548420773422434,0.0150294761099103,2.54253317320313e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,-0.0364614567893486,0.00868985946057059,-0.0534935813320669,-0.0194293322466302,2.73615930966053e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLU,Clusterin,38013,0.0131963498779856,0.00314923021756599,0.00702385865155631,0.019368841104415,2.80299078093827e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,39896,-0.0121539007452191,0.00290342299110682,-0.0178446098077885,-0.00646319168264974,2.8541116090327e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.0211381137109394,0.00505534014516428,-0.0310465803954614,-0.0112296470264175,2.91665376388312e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.0243033617767558,0.00581733704889916,-0.0357053423925982,-0.0129013811609135,2.96316473664643e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,40341,-0.0248627664292615,0.00595369631123605,-0.0365320111992841,-0.0131935216592388,2.98233440708898e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,39934,-0.0245909106382192,0.00590027089932157,-0.0361554416008895,-0.0130263796755489,3.09279331168613e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.0226668822991213,0.00543886889265977,-0.0333270653287345,-0.0120066992695082,3.09784390080966e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0187319283360574,0.00449543106814993,0.00992088344248357,0.0275429732296313,3.10716974009849e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0193563569344788,0.00465458347671641,-0.0284793405488429,-0.0102333733201146,3.22290500763087e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.0130511793167446,0.00314183035208955,-0.0192091668068401,-0.00689319182664906,3.28770840281659e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,39980,0.0332902745641431,0.00801802561227094,0.017574944364092,0.0490056047641941,3.31444438493253e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.0165071722534458,0.00398134890526269,-0.0243106161077607,-0.00870372839913094,3.39936891979641e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.0165289997995431,0.00399182012148664,-0.0243529672376569,-0.0087050323614293,3.48377840165353e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNC,Tenascin,40403,0.0185679758656401,0.00448642881206463,0.00977457539399343,0.0273613763372868,3.51075029669135e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.0235958097383405,0.00570539105872002,-0.0347783762134317,-0.0124132432632492,3.55721453814591e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,-0.0492090954742459,0.0119086980859767,-0.0725501437227603,-0.0258680472257315,3.6152473449566e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,37819,-0.0174707142497968,0.00423998741767494,-0.0257810895884397,-0.00916033891115388,3.80389465829337e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,0.017698309194976,0.00430197183033558,0.00926644440751822,0.0261301739824337,3.9116804692708e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,37942,-0.0283316730498726,0.00689018277931238,-0.0418364312973249,-0.0148269148024203,3.94758467988476e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.0229716735007363,0.00559100473858751,0.0120133042131048,0.0339300427883678,3.99896125705472e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,39961,-0.0281748461255871,0.00686642035942093,-0.0416330300300521,-0.0147166622211221,4.09415477648312e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.0264784110363567,0.00645699361454114,-0.0391341185208573,-0.013822703551856,4.13931140961884e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,40434,-0.0239685939521226,0.00584755276155513,-0.0354297973647706,-0.0125073905394745,4.1715031687786e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.041027230700511,0.0100147660957535,-0.0606561722481878,-0.0213982891528343,4.21577123345398e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.00853799687502218,0.00208457978056742,-0.0126237732449343,-0.00445222050511004,4.23190588264601e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.0118547372003573,0.00289533454392586,-0.017529592906452,-0.00617988149426262,4.25744758309443e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.018408610498219,0.00450373130567607,-0.0272359238573441,-0.00958129713909388,4.38796631992865e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.0135132095455183,0.00331883431357173,-0.0200181248001189,-0.00700829429091771,4.69070373912532e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,37562,0.0142973826209184,0.00351312189159276,0.00741166371339662,0.0211831015284402,4.73479146240456e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.010333624314271,0.00254426130808062,0.00534687215043295,0.015320376478109,4.90324685881104e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,-0.0109994231165597,0.00271051839224525,-0.0163120391653604,-0.00568680706775902,4.97176648694279e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,39961,-0.0236317501854938,0.00582619852048103,-0.0350510992856366,-0.012212401085351,5.0139059618116e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,37598,0.0133634695431262,0.00329681322898624,0.00690171561431312,0.0198252234719392,5.07582552084661e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.0144571664305242,0.0035672166164794,-0.0214489109988238,-0.00746542186222455,5.08950386928036e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.0201047237482116,0.00497090651199719,-0.0298477005117261,-0.0103617469846971,5.26934731987107e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.0299170525175779,0.00740716841398809,-0.0444351026089945,-0.0153990024261612,5.3947286223081e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBN1,Drebrin,37598,-0.0198330972500013,0.00491209778654142,-0.0294608089116224,-0.0102053855883801,5.43066438825805e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,40341,-0.0245714700009201,0.00609033230246394,-0.0365085213137494,-0.0126344186880907,5.49737467100279e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.0159648951903125,0.00395709209862718,-0.0237207957036217,-0.00820899467700318,5.50212915033034e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,40471,-0.00989923689332333,0.00245567404300784,-0.0147123580176187,-0.00508611576902797,5.57568646221182e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,-0.0113733698845605,0.00282860193784499,-0.0169174296827367,-0.00582931008638436,5.82557411216549e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2,Complement C2,40372,-0.00914254643675817,0.002275012540387,-0.0136015710159167,-0.00468352185759966,5.87944161251148e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,40288,-0.0412918841503293,0.0102895591772929,-0.0614594201378234,-0.0211243481628352,6.02305739838521e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.00908571557032946,0.00226491084699689,0.00464649031021556,0.0135249408304434,6.0606256709702e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.0146895562649861,0.00366268990067764,-0.0218684284703143,-0.00751068405965789,6.09015410636208e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,37959,-0.0314893363769264,0.00785221668052935,-0.0468796810707639,-0.0160989916830889,6.09813499937239e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,-0.0149472267181201,0.00372956806103693,-0.0222571801177525,-0.0076372733184877,6.16269292666989e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.0251930244313712,0.00629469054849653,-0.0375306179064244,-0.012855430956318,6.30231610390209e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,-0.0277793352797559,0.00694818509218152,-0.0413977780604317,-0.0141608924990801,6.41501883295746e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.0153126791598071,0.00383174734742636,0.00780245435885141,0.0228229039607627,6.47016392374889e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,0.0124084738449625,0.00310515964952571,0.00632236093189209,0.0184945867580329,6.47404149100521e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,40489,0.0119013195268867,0.00297911676040328,0.00606225067649631,0.0177403883772772,6.50063049615456e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,40379,0.0126337696613068,0.00316292899616588,0.00643442882882165,0.0188331104937919,6.51700510741113e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.0290444260999848,0.00727638365789867,-0.0433061380694662,-0.0147827141305034,6.59301999045497e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0106734314663867,0.00267601052862769,-0.015918412102497,-0.0054284508302764,6.67735650198788e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,40359,-0.0288363971807407,0.00723103857105411,-0.0430092327800068,-0.0146635615814747,6.69690223971762e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0186665634133938,0.00468711281380249,-0.0278533045284467,-0.00947982229834094,6.84889861987746e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0147998736385912,0.00372432751213368,0.00750019171480921,0.0220995555623732,7.11005565163833e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.0461030125495307,0.0116066741436693,-0.0688520938711226,-0.0233539312279388,7.16189998548086e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.035838001109988,0.00902915336478128,-0.0535351417049594,-0.0181408605150167,7.24461882342919e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,40305,-0.0105831139716972,0.00266647414228967,-0.0158094032905849,-0.00535682465280945,7.25068316756205e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.0446081137303699,0.0112432911460804,-0.0666449643766874,-0.0225712630840524,7.29380919157443e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.0100851856423144,0.00254447002828174,0.00509802438688217,0.0150723468977466,7.42254474691618e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,40536,-0.00728929799735917,0.00183921483904151,-0.0108941590818805,-0.00368443691283781,7.42506228211421e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.0189371731442513,0.00477873251869027,-0.0283034888808842,-0.00957085740761836,7.44656165726812e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.0205811196383829,0.00520432360608084,-0.0307815939063013,-0.0103806453704644,7.69897421526307e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,-0.00961620594148268,0.00243226258935784,-0.0143834406166241,-0.00484897126634131,7.73834196884218e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00652996028178418,0.00165643510629796,0.00328334747344019,0.00977657309012818,8.10909938561533e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,40536,0.00870028694177294,0.00221511052495952,0.00435867031285228,0.0130419035706936,8.61205557846953e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.0323011609896427,0.00824161644753569,-0.0484547292268127,-0.0161475927524728,8.91861514704654e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,40309,-0.0100397417689586,0.00257143104288279,-0.0150797466130088,-0.00499973692490832,9.48739330716454e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0317797531140897,0.00814278146692292,-0.0477396047892586,-0.0158199014389207,9.54729954621852e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.0175789252939872,0.00451526256134152,-0.0264288399142166,-0.00872901067375785,9.93347719061318e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.028060998783629,0.00721554445544392,-0.0422034659162991,-0.0139185316509589,0.000101163794273696
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,37541,0.013455611396084,0.00346447870047545,0.00666523314315215,0.0202459896490159,0.000103309279316738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.0390431355074065,0.0100585879938541,0.0193283030394525,0.0587579679753605,0.000104276550241145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,39990,-0.0330367420161741,0.00851535726160075,-0.0497268422489116,-0.0163466417834367,0.000105031482834548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,37990,-0.0357538001198132,0.00923056176210697,-0.0538457011735429,-0.0176618990660835,0.00010782579982794
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,39946,-0.0206829761825854,0.00534107599525051,-0.0311514851332764,-0.0102144672318944,0.000108195498648554
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.0193488223948826,0.00499667161609119,-0.0291422987624213,-0.00955534602734382,0.000108236244884067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0322034961336817,0.00831616405607622,-0.0485031776835911,-0.0159038145837723,0.000108291706959545
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.0234358952948847,0.00605733136194184,-0.0353082647642907,-0.0115635258254787,0.00010971245921916
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB1,Calbindin,40305,-0.0155469353345908,0.0040194061137237,-0.0234249713174893,-0.00766889935169239,0.000110184608998375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.0118093647864573,0.00305332778589283,-0.0177938872468073,-0.00582484232610738,0.00011030829165458
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.0192858290131134,0.00499156454823215,-0.0290692955276484,-0.00950236249857838,0.00011212882503694
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.0151026422372644,0.00391449861976256,-0.022775059531999,-0.00743022494252974,0.000114806246017147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,40070,-0.0201380179773556,0.00522108727547502,-0.0303713490372866,-0.00990468691742456,0.000115222286379776
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.0102373736283891,0.00265524816932268,0.00503308721651668,0.0154416600402616,0.000116034364312061
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00940793578293221,0.00244079082642233,0.00462398576314444,0.01419188580272,0.000116537744525007
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.0175493843314053,0.00456691664945736,-0.0265005409643417,-0.00859822769846884,0.000122239354673143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.0251591766101547,0.00655397028369874,-0.0380049583662043,-0.0123133948541052,0.00012423332751543
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.0322391750814967,0.00840443578967298,-0.0487118692292558,-0.0157664809337377,0.000125636433619702
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.0136976268131822,0.00357204151745701,-0.020698828187398,-0.00669642543896649,0.00012630096709113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.0190565639032754,0.00497409379314123,-0.0288057877378322,-0.0093073400687186,0.000128132125015984
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,40489,0.0164873759597695,0.00430755015148273,0.00804457766286335,0.0249301742566756,0.000129915085541035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.0150488607569258,0.00393372974814886,-0.0227589710632976,-0.00733875045055408,0.000131064843251198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.0147178810403067,0.00385260697620417,-0.0222689907136668,-0.00716677136694648,0.000133841355135222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,37986,-0.0132214642858117,0.00346688451449915,-0.02001655793423,-0.00642637063739336,0.000137540449561204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.0371548027892887,0.00974332410356983,-0.0562517180322855,-0.0180578875462918,0.00013771518538147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.0269057036908856,0.00706123033679524,-0.0407457151510043,-0.0130656922307669,0.000139401294230181
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.0193945450163785,0.00509253249239801,-0.0293759087014786,-0.00941318133127841,0.000140483247739857
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,40332,0.0120352157651501,0.00316527836521598,0.00583127016932674,0.0182391613609734,0.000143917637584815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0266551166898536,0.00701433532006064,-0.0404032139171724,-0.0129070194625347,0.000145194736450968
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FST,Follistatin,40396,-0.0186941431440115,0.00492307865469133,-0.0283433773072065,-0.00904490898081648,0.000146854653701529
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,-0.012379804265738,0.00326669169110955,-0.0187825199803127,-0.00597708855116326,0.000151383709551007
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.0111661903030061,0.00294653373123358,-0.0169413964162239,-0.00539098418978831,0.00015154421204408
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENG,Endoglin,40536,0.00612451897197525,0.00161692093846368,0.00295535393258644,0.00929368401136406,0.000152560932398584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,37562,-0.0288745418721913,0.00762291035326261,-0.043815446164586,-0.0139336375797966,0.000152627295271279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.0106328676799245,0.00280873099929268,-0.0161379804385381,-0.00512775492131085,0.00015398837114438
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,37714,0.0106206004489711,0.00281012704725512,0.00511275143635107,0.0161284494615911,0.000157893743509045
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,39980,-0.0269811822712769,0.00714148178485082,-0.0409784865695845,-0.0129838779729693,0.000158624052052398
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.0151385093606528,0.00400953368880509,-0.0229971953907108,-0.00727982333059481,0.000160197666697368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.0183799112389347,0.00487327494819756,-0.0279315301374019,-0.00882829234046749,0.000162934881294441
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0132367809485547,0.00351273915477645,0.00635181220519288,0.0201217496919166,0.000165131131329159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,40044,-0.0168478860529164,0.00447812822168972,-0.0256250173674283,-0.00807075473840459,0.00016900077723612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,40228,-0.0119473690832589,0.0031769001617649,-0.0181740934003181,-0.00572064476619965,0.000170050480860611
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.0216189285764583,0.00575719475841795,-0.0329030303029575,-0.0103348268499591,0.000173992178132346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,37901,-0.0199569609650087,0.00531743274349586,-0.0303791291422606,-0.00953479278775685,0.000175382095569353
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.0222946647589688,0.00594284347892031,-0.0339426379776526,-0.010646691540285,0.000176406078209206
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.041665748256022,0.0111131091616936,-0.0634474422129415,-0.0198840542991025,0.000178131463593396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0215370079758972,0.00574597145291975,0.0102749039281745,0.0327991120236199,0.000178744296050324
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0155602584071649,0.00415677594914395,-0.023707539267487,-0.00741297754684275,0.000182337630240061
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.00581497923690296,0.00155505330883262,-0.00886288372221489,-0.00276707475159102,0.00018521283349447
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.029673287408624,0.00793834302037489,-0.0452324397285587,-0.0141141350886892,0.000186178447841043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.00997012372136953,0.00267686109908525,0.00472347596716244,0.0152167714755766,0.000196333873959847
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.0121758719330322,0.0032694009277694,0.00576784611460416,0.0185838977514602,0.00019676548625455
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0110921815800922,0.00298701487474987,-0.016946730734602,-0.00523763242558249,0.000205279636810383
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.0153778798345549,0.00414865164990466,-0.0235092370683681,-0.00724652260074179,0.000210802026231964
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.020947144015134,0.00565241049898702,-0.0320258685931485,-0.0098684194371194,0.000211526025789677
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.0120661516444476,0.00326307129731583,0.00567053190170854,0.0184617713871866,0.000218369525786589
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00518652899985908,0.00140294125477582,0.00243676414049848,0.00793629385921968,0.00021911469926887
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,37598,-0.0414297016237612,0.0112136128081078,-0.0634083827276524,-0.01945102051987,0.000221135229139044
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,40257,-0.0232818617513709,0.00631872579219127,-0.0356665643040658,-0.010897159198676,0.00022984334401939
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.0390627378353232,0.0106357821153892,-0.059908870781486,-0.0182166048891603,0.000240745907606757
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00999044778567437,0.00272009143150041,0.00465906857993355,0.0153218269914152,0.000240828349924463
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,-0.00993943494431472,0.00271140161223477,-0.0152537821042949,-0.00462508778433457,0.000247545241351429
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0240602332486008,0.00656522266575224,-0.0369280696734752,-0.0111923968237264,0.000248338584851413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,40250,0.0176277183259404,0.004825076508536,0.00817056836920979,0.0270848682826709,0.000259673180691128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAT,Catalase,37786,-0.018942543398115,0.00518618020230668,-0.0291074565946361,-0.00877763020159388,0.000260690413534058
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,37598,-0.00909544599792595,0.00249112617288846,-0.0139780532967873,-0.00421283869906457,0.000262093631541142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,-0.0277612550306343,0.00760543931923335,-0.0426679160963317,-0.0128545939649369,0.000262911989043162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,40379,-0.0083272647097857,0.00228229216823895,-0.012800557359534,-0.00385397206003735,0.000264473134400268
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.0200115095855462,0.0054876219659777,-0.0307672486388625,-0.00925577053222994,0.000266536138651582
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0331403146663828,0.00909490967056178,-0.0509663376206839,-0.0153142917120817,0.000269641736439918
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,-0.0214146422348703,0.0058773672276628,-0.0329342820010894,-0.00989500246865118,0.000269907535201462
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0287436674492428,0.00789399291856999,-0.04421589356964,-0.0132714413288456,0.000272240630496758
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,40042,-0.0441405829020863,0.0121709859998938,-0.0679957154618782,-0.0202854503422944,0.000287975897415727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.0178429715528819,0.00492323081563361,-0.0274925039515238,-0.00819343915424003,0.000290881054137985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPL,Periplakin,37598,-0.0113510043115279,0.00313531813004533,-0.0174962278464167,-0.00520578077663902,0.000295290437743958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.0281456949719642,0.00778808387469813,-0.0434103393663725,-0.0128810505775559,0.000302506226592312
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,37562,-0.0130938161687021,0.00363281609825376,-0.0202141357212795,-0.00597349661612475,0.000314136525457316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.0108792647106699,0.00301893912116587,-0.016796385388155,-0.00496214403318476,0.000314730636988313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.0153436176006099,0.00425971537315564,-0.0236926597319949,-0.00699457546922483,0.000316897515153951
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.0231435098132582,0.00643074471783095,-0.0357477694602069,-0.0105392501663095,0.000320578948035504
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.0129214639442096,0.00359168281231817,-0.0199611622563533,-0.00588176563206601,0.000322337054407513
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.0115511544100809,0.00321876596009046,0.00524237312830357,0.0178599356918582,0.00033334194876471
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,-0.0117744702832592,0.00328135375277898,-0.018205923638706,-0.00534301692781237,0.000333839629952518
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,37748,-0.00965559202211316,0.0026909369165371,-0.0149298283785259,-0.00438135566570045,0.000334178733723064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.0196896949366567,0.00548866432765286,0.00893191285445705,0.0304474770188563,0.0003352950281356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,-0.0165925982088099,0.0046261577935381,-0.0256598674841446,-0.00752532893347523,0.000335905139957568
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.0184300429676746,0.00513928194328331,-0.0285030355765099,-0.00835705035883929,0.000336834211925525
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.018630052775972,0.00519511574052192,-0.0288124796273949,-0.00844762592454902,0.000336888044587633
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.0144832940623369,0.00404209732771304,-0.0224058048246545,-0.00656078330001938,0.000340722739992354
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.024726911522485,0.00690668104307434,-0.0382640063669107,-0.0111898166780593,0.000344609819092588
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.0198821882619176,0.00555499093126726,-0.0307699704872015,-0.00899440603663382,0.000345916703958897
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.0426452270223594,0.0119263423252104,-0.0660208579797719,-0.019269596064947,0.000350488690705676
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.010289173992507,0.00287885431305453,0.00464661953892011,0.0159317284460939,0.000352769702748157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,40341,0.0140613864023855,0.00393450003483213,0.00634976633411449,0.0217730064706564,0.000352787316902617
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.00901835975168857,0.00252364685262586,0.00407201192054188,0.0139647075828353,0.000353237609617957
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.0209931083174713,0.00590194961743456,-0.032560929567643,-0.00942528706729952,0.000376461487077317
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.010604153025936,0.00298817631366181,0.0047473274511589,0.0164609786007132,0.000388247648317965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,39903,-0.0143665480605547,0.00404872398684247,-0.0223020470747659,-0.00643104904634344,0.000388708251417462
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0246516865879001,0.00695430044759189,-0.0382821154651802,-0.01102125771062,0.000394015661896534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.0172016437364734,0.00485515222571139,-0.0267177420988677,-0.00768554537407905,0.000396992989951688
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,-0.0315601077325195,0.00892491869700128,-0.049052948378642,-0.014067267086397,0.000407124925217813
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,40305,0.00508971171810259,0.00144064595239466,0.00226604565140905,0.00791337778479613,0.000412138698978836
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,37352,0.0130015004310067,0.0036959671040924,0.00575740490698562,0.0202455959550278,0.000436713728138243
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.0197697630501395,0.00563682940810311,-0.0308179486900216,-0.00872157741025742,0.000454039523438429
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.0125184399399874,0.00357211799627066,-0.0195197912126779,-0.0055170886672969,0.000459015067074449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MB,Myoglobin,40536,-0.0163271305113977,0.00466035338683053,-0.0254614231495855,-0.00719283787320985,0.000460588863799805
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,-0.0240020258726704,0.00686459364640042,-0.0374566294196152,-0.0105474223257256,0.000472921835929592
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.017975495354749,0.00514568884036775,-0.0280610454818698,-0.00788994522762823,0.000478602695712387
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,40044,-0.0164940304594305,0.00472999394822024,-0.0257648185979422,-0.00722324232091884,0.000489606820817538
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,-0.00967339672936173,0.00278473724876433,-0.0151314817369398,-0.00421531172178365,0.000514647562891171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0232216903032244,0.00668522463307717,-0.0363247305840557,-0.0101186500223932,0.000515213023255154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,-0.0373579591978322,0.0107628157211952,-0.0584530780113748,-0.0162628403842896,0.000520110655386493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,-0.0116158060869225,0.00334733435080856,-0.0181765814145072,-0.00505503075933768,0.000521760511911333
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,40278,-0.0195786415600305,0.00564422518030643,-0.0306413229134311,-0.0085159602066299,0.000524195354572449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.0094551478440865,0.00272599400275501,-0.0147980960894863,-0.00411219959868668,0.000525018501097202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,40341,-0.0184042087445563,0.00531812657772588,-0.028827736836899,-0.00798068065221356,0.000540275464942255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.0149253909242853,0.00433755917634735,-0.0234270069099261,-0.0064237749386445,0.000581449375576753
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.0779833066846936,0.0226815478761951,-0.122439140522036,-0.0335274728473513,0.000587400845895785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.0108714216901744,0.00317351164310066,0.00465133886969716,0.0170915045106517,0.000615155222106903
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,-0.0213392279302052,0.00625730591502522,-0.0336035475236546,-0.00907490833675577,0.000650540913612945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.00665714388969436,0.00195207705585482,0.00283107286021892,0.0104832149191698,0.000650550153457844
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.0316801226034479,0.00929092423807016,-0.0498903341100654,-0.0134699110968304,0.000652032938066493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,-0.0294149299576436,0.00862796898374874,-0.0463257491657911,-0.012504110749496,0.000653313992230656
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.0227615308621604,0.00668539544718001,-0.0358649059386333,-0.00965815578568762,0.000664437871863001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,37628,-0.0378882180982836,0.0111420532293072,-0.0597266424277258,-0.0160497937688414,0.000674697353377098
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0112131146350659,0.00329922295983048,0.00474663763379816,0.0176795916363336,0.000678703811469441
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,-0.0193270172197602,0.00569286591273485,-0.0304850344087205,-0.00816900003079989,0.00068837661729937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,37655,0.0119389028240759,0.00352951235091172,0.00502105861628897,0.0188567470318629,0.000720135514235523
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.0212418831196952,0.00628367252535119,0.00892588497000687,0.0335578812693835,0.000725680510717199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,37628,-0.00724111746031905,0.00214219873790419,-0.0114398269866113,-0.00304240793402685,0.000726362611610086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCN,Decorin,40042,0.00727911540734321,0.00216211509436535,0.00304136982238713,0.0115168609922993,0.000762671194887232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,40182,0.0221328443607442,0.00658331252034512,0.0092295518208678,0.0350361369006207,0.000775752370914921
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,37714,0.0112578592406799,0.0033496759828179,0.00469249431435686,0.017823224167003,0.000779138626568773
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.0318011613781947,0.0095099339378698,-0.0504406318964195,-0.0131616908599699,0.00082772475594256
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.0310317263296946,0.00929643557787691,-0.0492527400623334,-0.0128107125970559,0.000845699932607166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,37541,0.0140085760080871,0.00419744537029887,0.00578158308230135,0.0222355689338729,0.00084800210546709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,37901,-0.0144135388760635,0.00432418606502511,-0.0228889435635127,-0.00593813418861428,0.000860733712285687
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,37598,-0.0197520100277689,0.00593311541448909,-0.0313809162401676,-0.00812310381537033,0.000873626365111791
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.0136359486949374,0.00409662856613818,-0.0216653406845682,-0.00560655670530651,0.000875282032140552
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,37901,-0.019012286631532,0.00573129478509733,-0.0302456244103227,-0.00777894885274119,0.000911408176441072
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.00643384887674943,0.00194687808703702,-0.010249729927342,-0.00261796782615687,0.000953322966310006
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00983868716388313,0.00297958842314934,-0.0156786804732558,-0.00399869385451042,0.000962000681103056
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,-0.0130826110727606,0.00396480508598164,-0.0208536290412846,-0.00531159310423655,0.000970101808173768
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,37942,-0.0300506968713277,0.00911371714164558,-0.047913582468953,-0.0121878112737023,0.000978701082235975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.0274096339066282,0.00832187641787784,-0.0437205116856687,-0.0110987561275876,0.000991037621313091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,-0.0100500230419355,0.00305696268416075,-0.0160416699028905,-0.00405837618098038,0.00101271031006279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.00969555000255182,0.00294926260689504,0.00391499529303755,0.0154761047120661,0.00101358030171929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,-0.0197685644295748,0.00601401616716155,-0.0315560361172114,-0.00798109274193817,0.00101495362955603
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,-0.00757064342949293,0.00230445553698479,-0.0120873762819831,-0.00305391057700274,0.00102123623267597
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.0111702874213869,0.00340047309234143,-0.0178352146823761,-0.00450536016039771,0.0010223204167873
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.0235959057264943,0.00719527322354201,0.00949317020835201,0.0376986412446367,0.001043137466942
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.0207826578262287,0.0063404609591651,-0.0332099613061923,-0.00835535434626514,0.00104899582332586
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.0131775731866654,0.0040242483166434,0.00529004648604435,0.0210650998872865,0.00106099458004395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,37541,-0.014152481428785,0.00433343069990585,-0.0226460056006005,-0.00565895725696953,0.00109403620805446
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0161746700880958,0.00495402991458567,0.00646477145550789,0.0258845687206837,0.00109763418754196
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.0213263428350639,0.00653320365455359,-0.0341314219979889,-0.00852126367213883,0.00110012561685461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,37671,-0.0111442104563327,0.00341672755013453,-0.0178409964545964,-0.00444742445806904,0.00111041812824823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.0191741367476693,0.00589079720214827,-0.0307200992638799,-0.00762817423145872,0.00113698385747875
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,-0.0112834368430148,0.00346711298059773,-0.0180789782849863,-0.00448789540104325,0.0011391032543727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,40209,0.0391894910068226,0.0120675270882887,0.0155371379137767,0.0628418440998685,0.00116660525024119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,0.00867560584739042,0.00267728077148835,0.00342813553527325,0.0139230761595076,0.00119591094994058
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.0268878206849426,0.00829969434164043,-0.0431552215945579,-0.0106204197753274,0.00119985720269987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0213421691649524,0.00660092400335753,0.00840435811837165,0.0342799802115332,0.00122659444714726
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.0185798685818449,0.00574796263569693,-0.0298458753478109,-0.00731386181587887,0.00122995652904649
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.0125079668201893,0.00388525820151474,-0.0201230728951582,-0.00489286074522044,0.0012875050979909
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.0440602525652899,0.0137459064303451,0.0171182759618135,0.0710022291687664,0.00135217853893163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,-0.0132019213688616,0.00414189000703026,-0.0213200257826409,-0.00508381695508224,0.00143834053131686
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.0138383736858424,0.00436199292241528,-0.0223878798137763,-0.00528886755790843,0.00151433075156377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.0305296342187122,0.00962439351163217,-0.0493934455015112,-0.0116658229359131,0.00151684657388213
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,-0.0067307984505541,0.00212475546702721,-0.0108953191659274,-0.00256627773518077,0.00153938666837761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,37628,-0.0158656123031751,0.00501294606183032,-0.0256909865843626,-0.00604023802198769,0.00155474368344802
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,40497,-0.00895956710878521,0.00283205847748917,-0.014510401724664,-0.00340873249290644,0.00156108804076234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.00959125120842572,0.00304226318748383,0.0036284153609574,0.015554087055894,0.00162091357837809
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0104142248663294,0.00330336337541501,0.00393963265051598,0.0168888170821428,0.00162113684687524
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.00776409394749367,0.00246575331364324,0.00293121745275292,0.0125969704422344,0.00164328472793286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.00986274581708353,0.00313448169087236,0.00371916170297371,0.0160063299311933,0.0016552074983145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,37562,0.0122284807295425,0.00391317332716878,0.00455866100829169,0.0198983004507933,0.00178221840834331
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.0177221408613199,0.00570311891118522,-0.028900253927243,-0.00654402779539692,0.00189051234480893
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,39980,-0.0239624068568563,0.00771292169261216,-0.0390797333743761,-0.00884508033933644,0.00189473486861184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,-0.0093391815632958,0.0030072123515376,-0.0152333177723095,-0.00344504535428211,0.00190230834005933
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,-0.0161276839847613,0.00521430202536909,-0.0263477159544848,-0.00590765201503793,0.001985695440158
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,-0.0129455287361778,0.00418941810551184,-0.021156788222981,-0.00473426924937458,0.00200473782297758
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.011173498181894,0.00362763623340096,-0.0182836651993599,-0.00406333116442815,0.00207344927757815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.0155278466093475,0.00505400317630776,-0.0254336928349107,-0.00562200038378428,0.00212780849295441
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,-0.0107656799536126,0.00351171573363504,-0.0176486427915373,-0.00388271711568792,0.00217564440277451
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,40013,-0.0210385393884106,0.00686539143553366,-0.0344947066020566,-0.00758237217476467,0.00218455375174196
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.0114277291759536,0.0037471644152875,-0.0187721714299171,-0.00408328692199012,0.00229515259608552
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.00802202292144562,0.00263429380640302,-0.0131852387819955,-0.00285880706089571,0.0023295257127177
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,39951,-0.0319230220502209,0.0104935781187539,-0.0524904351629785,-0.0113556089374632,0.0023528891611072
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,-0.00630700365046912,0.002081467801746,-0.0103866805418913,-0.00222732675904697,0.00244886990372495
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,40305,0.00812898589606437,0.00268528340927009,0.00286583041389499,0.0133921413782337,0.00247197777928955
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.0151691107945908,0.00502130139003087,-0.0250108615190513,-0.00532736007013035,0.00252451694741081
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,37628,-0.0196583458163876,0.00651269529484305,-0.03242322859428,-0.00689346303849526,0.00254544147336666
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F3,Tissue factor,40393,0.00801924254618391,0.0026573079513141,0.00281091896160828,0.0132275661307595,0.00255013043947007
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.0255729494279766,0.0085009229719757,-0.042234758453049,-0.0089111404029042,0.00263254774790549
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,40316,-0.0363492964943569,0.0121098810011074,-0.0600846632565275,-0.0126139297321863,0.00268962403856402
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.00838229288650512,0.0027991004327948,0.00289605603822731,0.0138685297347829,0.00275282177817557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,39725,0.00896690659786459,0.00299750757197345,0.00309179175679663,0.0148420214389326,0.00278095374563574
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.0168391471543144,0.00563622974312329,-0.0278861574508361,-0.00579213685779279,0.00281635044448646
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.00902534515046881,0.00302257089962773,0.00310110618719846,0.0149495841137392,0.00283191417494459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LXN,Latexin,40183,0.0187697372736754,0.00629005127933153,0.00644123676618563,0.0310982377811652,0.00284910494474896
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0219923082451071,0.00736978397378207,-0.0364370848337199,-0.0075475316564942,0.00284924049316793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,37598,-0.00478907816354929,0.00160533299273521,-0.0079355308293103,-0.00164262549778828,0.00285746888042077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,37698,0.0087503106917084,0.00293466274133761,0.00299837171868667,0.0145022496647301,0.00287165538887953
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,-0.0251795163820298,0.0084647189976929,-0.0417703656175079,-0.00858866714655172,0.00293859770972896
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,-0.0135300916152387,0.00456202710772082,-0.0224716647463715,-0.00458851848410591,0.00302420278820565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,0.00918579010798504,0.00310211232476866,0.00310564995143846,0.0152659302645316,0.00307033712425242
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,-0.011658957217879,0.00393988567860272,-0.0193811331479403,-0.00393678128781764,0.00308892238807832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,-0.0314035003958689,0.0106198661137956,-0.0522184379789084,-0.0105885628128295,0.00311144527506092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,-0.0122623526383944,0.00415162504858681,-0.0203995377336245,-0.00412516754316421,0.00314533869556489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.0108321008221819,0.00366857163758081,-0.0180225012318403,-0.00364170041252351,0.0031557689266913
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.0100540088405277,0.00341519253619496,-0.0167477862114698,-0.0033602314695856,0.00324669499418677
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.00575721652757733,0.00195621559345139,0.00192303396441261,0.00959139909074206,0.00325479612405952
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,40341,-0.0191803975152844,0.00651843983354641,-0.0319565395890354,-0.00640425544153347,0.00326062186169311
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,-0.0159293310112848,0.00543252943251821,-0.0265770886990205,-0.0052815733235491,0.00337050195421341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,40354,-0.0108819170828774,0.00371538865321007,-0.0181640788431691,-0.00359975532258563,0.00340671658459387
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,37900,0.0326889716062145,0.0111632977551548,0.0108089080061111,0.0545690352063179,0.00341443133205656
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.0104284712561063,0.00356457523946988,-0.0174150387254673,-0.00344190378674535,0.0034438290995326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',37562,-0.0119562765427886,0.00410408237861133,-0.0200002780048668,-0.00391227508071035,0.0035827575629675
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,-0.0146608698281996,0.00503265791925298,-0.0245248793499354,-0.00479686030646374,0.00358410352093348
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.0156964726258524,0.00540523395278018,-0.0262907311733016,-0.00510221407840327,0.00369005705154286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.0090689511246478,0.00312577844970617,-0.0151954768860719,-0.0029424253632237,0.00372168546495152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,37714,0.00980835010759158,0.00338286609563664,0.00317793256014378,0.0164387676550394,0.00374466925801546
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,40173,-0.0284773453565938,0.00982299283319908,-0.047730411309664,-0.00922427940352357,0.00374813208446434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,37900,-0.0214342245230541,0.00740548507218568,-0.035948975264538,-0.00691947378157019,0.00380529256475862
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFD,Complement factor D,38013,-0.00524251757176586,0.00181278017204632,-0.00879556670897665,-0.00168946843455507,0.00383435164518092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.00800423976150756,0.00276882504943951,0.00257734266460611,0.013431136858409,0.00384833068531364
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",40489,-0.0202026126980946,0.00699408134888619,-0.0339110121419115,-0.00649421325427766,0.00387565269121164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,-0.010344194978634,0.0035855142380832,-0.017371802885277,-0.00331658707199088,0.00391939874305846
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,-0.0158936397153439,0.00552138219262898,-0.0267155488128967,-0.00507173061779108,0.00400025311261987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.00955052999993054,0.0033332495954299,-0.0160836992069731,-0.00301736079288794,0.00417264447873386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.0144011992504627,0.00503168691534035,-0.0242633056045298,-0.00453909289639559,0.00421491602516194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,37562,0.0100223240475921,0.00350216231543736,0.00315808590933489,0.0168865621858493,0.00421971736696932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-0.010676819743444,0.00373366160901678,-0.0179947964971169,-0.00335884298977111,0.00424810827168817
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.0149224966981173,0.00524436752165704,-0.0252014570405651,-0.00464353635566945,0.00444092012895477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,37714,0.00932832812833422,0.00329010368135209,0.00287972491288413,0.0157769313437843,0.00458564205997193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.00829984145557727,0.00293679002079926,0.00254373301481072,0.0140559498963438,0.00471697398923828
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,0.00568358730061898,0.00201302039107592,0.00173806733411018,0.00962910726712777,0.00475745944284186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,-0.00699282286421738,0.00247783987544007,-0.0118493890200799,-0.00213625670835485,0.00477622222149098
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00791309520653429,0.00280644858150668,0.0024124559867812,0.0134137344262874,0.00481515995440911
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.010043533502092,0.0035880248570089,0.00301100478235454,0.0170760622218294,0.0051307102717048
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,38013,0.0199657002651045,0.00713596329458807,0.00597921220771192,0.0339521883224971,0.00515088270615544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.0106592207766592,0.00381092836172536,-0.0181286403656409,-0.00318980118767753,0.00516524182734714
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0182920775320455,0.00656514434077928,-0.0311597604399729,-0.00542439462411809,0.00533998183776872
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,37482,0.00952797961963662,0.00341979821443346,0.00282517511934703,0.0162307841199262,0.00534196808386294
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,39831,-0.0156184294562868,0.00561502133473358,-0.0266238712723646,-0.00461298764020898,0.00541668457217835
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,-0.00837222037464031,0.0030175426592955,-0.0142866039868595,-0.00245783676242113,0.00553481535432731
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,38013,-0.00683442856785836,0.00247372315072047,-0.0116829259432705,-0.00198593119244623,0.00573832277511837
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.00877549253689489,0.00318282048729551,0.00253716438179568,0.0150138206919941,0.00583759181133945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.0101167047404608,0.00367194927365538,-0.0173137253168253,-0.00291968416409624,0.00587473971144915
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.00549103988209198,0.00199411946819806,0.00158256572442379,0.00939951403976017,0.0059007450595923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,40305,-0.0107748754328565,0.00391309393581771,-0.0184445395470592,-0.00310521131865381,0.00590210219065327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.0156863186087593,0.00570123591239352,0.00451189622046801,0.0268607409970506,0.00594245940034464
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,-0.00854887023559719,0.00310724616591952,-0.0146390727207995,-0.00245866775039492,0.00594317706263047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,40379,0.00858092581025538,0.00311974670437598,0.00246622226967846,0.0146956293508323,0.00595679305232168
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.00844203012476789,0.00307645517027405,0.00241217799103075,0.014471882258505,0.00607637613523244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,-0.0309314620386293,0.011280505682021,-0.0530412531753904,-0.00882167090186823,0.00611294825127495
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.0157323950484397,0.00574116193954935,-0.0269850724499564,-0.00447971764692298,0.00614697575976137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0199341724770862,0.00728581744729239,-0.0342143746737793,-0.00565397028039313,0.0062257120931089
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,37998,0.0130160283277762,0.00475889119571037,0.00368860158418384,0.0223434550713685,0.00624430540411279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,37942,0.0101502968345904,0.00372050634431138,0.00285810439974009,0.0174424892694407,0.00637628302732764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.00954005068495425,0.00349757405193683,0.00268480554315807,0.0163952958267504,0.00638771138650457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.00837427407277218,0.00307074606862293,0.00235561177827123,0.0143929363672731,0.0063960465764363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,-0.0101930686104649,0.00375665596947599,-0.0175561143106379,-0.00283002291029201,0.00666820118824043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.00737039411848466,0.00272102662684971,-0.0127036063071101,-0.00203718192985923,0.00676384349672325
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.012240767796502,0.00452039399736603,-0.0211007400313394,-0.00338079556166454,0.0067785138523267
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.0134086119269945,0.00495646659230425,-0.0231232864479108,-0.00369393740607816,0.00683357161205341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.0105107913448016,0.00389313663207768,-0.0181413391436738,-0.0028802435459293,0.00694625310504548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,37562,-0.0154995342487553,0.0057417219069777,-0.0267533091864315,-0.00424575931107897,0.00695416927277337
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,40332,0.00605784914831269,0.00224418012060947,0.00165925611191812,0.0104564421847073,0.00695466016489945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0103701861740472,0.00384946073150439,0.00282524314029857,0.0179151292077958,0.00707045467214873
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,-0.0144460924259024,0.0053662904070428,-0.0249640216237063,-0.00392816322809849,0.00711133469753184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,37981,0.00376775386558595,0.00140104378301512,0.00102170805087632,0.00651379968029558,0.00717010353588736
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,-0.0114574807129694,0.00426793159667686,-0.0198226266424561,-0.00309233478348279,0.00727025158202237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,-0.00745614661429291,0.00278333946328826,-0.0129114919623379,-0.00200080126624793,0.00739510975553161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.0123723802071672,0.00461909107947051,-0.0214257987229294,-0.00331896169140497,0.00740353215095662
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.0132724700210242,0.00497079888747126,0.00352970420158054,0.0230152358404679,0.00759248991238788
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.012573283473086,0.00471387674661831,-0.0218124818964579,-0.00333408504971412,0.0076559179978656
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00571274738844097,0.00214199107519554,0.00151444488105772,0.00991104989582423,0.00766021899212613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,37562,0.00811790037736153,0.00304942737308318,0.0021410227261185,0.0140947780286046,0.00777480447222876
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,40228,0.0141091816977943,0.00530234320423586,0.00371658901749197,0.0245017743780965,0.00780032608926475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,40305,-0.0471971065913361,0.0177638147637183,-0.082014183528224,-0.0123800296544482,0.00789362100433647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,-0.00713035676555451,0.00268576867048742,-0.0123944633597099,-0.00186625017139916,0.00794349097558635
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,37482,0.00804122801180508,0.00302912402499899,0.00210414492280706,0.0139783111008031,0.00794900166973593
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,37482,0.0115321295790924,0.00435829014397737,0.00298988089689674,0.020074378261288,0.00815424603276448
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,0.00993171562377614,0.00375372815887141,0.00257440843238818,0.0172890228151641,0.00815716179494567
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.0136034531700121,0.00514600874464828,0.00351727603050143,0.0236896303095227,0.00821523789884522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.00924120920065711,0.00350888949170183,-0.0161186326043927,-0.00236378579692151,0.00845676058724119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.0110601603683731,0.00419989254613391,0.00282837097795061,0.0192919497587955,0.00846242510666981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,40279,-0.0178801708676605,0.00680168012884787,-0.0312114639202023,-0.00454887781511866,0.00857727002282323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.0185514127959011,0.00705764279304514,-0.0323843926702696,-0.00471843292153261,0.00858469429508152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,-0.00752953789288433,0.0028661174711405,-0.0131471281363197,-0.00191194764944896,0.0086204096690118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.0218245112818496,0.00831663721390401,-0.0381251202211015,-0.00552390234259777,0.00869538463443667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.0153492116952696,0.00586622212261801,0.00385141633493829,0.0268470070556009,0.00889277030626533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRNN,Cornulin,39857,0.016403055748671,0.00628977243624091,0.00407510177363879,0.0287310097237032,0.00911892159630261
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,-0.0161287040777276,0.00618477372976307,-0.0282508605880632,-0.00400654756739194,0.00912124488697307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.00788524642859408,0.00302671931430717,0.00195287657255202,0.0138176162846361,0.00919210478371496
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,40221,0.00707489293778234,0.00272259534994243,0.00173860605189517,0.0124111798236695,0.00936962189136225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,37562,0.0104503785593151,0.00402181434770525,0.00256762243781285,0.0183331346808174,0.0093757597140812
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2,Prothrombin,38013,0.00363541630148232,0.00139992510024516,0.000891563105001808,0.00637926949796282,0.00941804857762199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,39801,-0.00869441199793281,0.00335218989657373,-0.0152647041952173,-0.0021241198006483,0.00950528880563479
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.00631867030600048,0.00243625689568713,0.00154360679045371,0.0110937338215473,0.00950837752950642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,-0.0132615040252196,0.00512093479970162,-0.0232985362326348,-0.00322447181780446,0.0096175595455616
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,-0.00200382593091864,0.000773947288711177,-0.00352076261679255,-0.000486889245044739,0.00963320840782292
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,40471,-0.0160993691003238,0.00622045188439919,-0.0282914547937462,-0.00390728340690137,0.00965842897703089
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRTN,Neurturin,40044,-0.0121402946007114,0.00469276216810383,-0.0213381084501949,-0.00294248075122788,0.00968981434277318
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,0.00795256012176226,0.00307858944512803,0.00191852480931132,0.0139865954342132,0.00979819229409032
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.0173909538625787,0.00677506963937319,-0.0306700903557501,-0.00411181736940721,0.0102717843302373
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.00856338435701289,0.00334415004290862,0.00200885027291199,0.0151179184411138,0.0104553581222453
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.0232373083893016,0.00908819527773359,0.00542444564494381,0.0410501711336595,0.0105731318390972
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.0127277573453014,0.00497844091808402,0.00297001314585675,0.0224855015447461,0.0105819866598809
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.00890719948234493,0.0034893481328591,-0.0157463218227488,-0.00206807714194109,0.010700974560883
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.00718331639353953,0.00281539258718126,-0.0127014858644148,-0.00166514692266426,0.0107388796031426
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,-0.0167092943575076,0.00656345619046297,-0.0295736684908151,-0.00384492022420022,0.0109117953537508
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.0102412933052912,0.0040301809702391,-0.0181404480069599,-0.00234213860362261,0.0110602245361709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,37598,0.0108132885653459,0.00425710009634636,0.00246937237650699,0.0191572047541847,0.0110947632186259
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,-0.0071556885290114,0.00282406493619483,-0.0126908558039533,-0.00162052125406954,0.0112921034031582
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,37457,0.00981206334029138,0.00387329150296503,0.00222041199447992,0.0174037146861028,0.0113122839314046
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCT,Secretin,37572,-0.0110591124347408,0.0043765949485143,-0.0196372385338289,-0.00248098633565283,0.0115198687132785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,40471,0.00739547808302735,0.00292821653322206,0.00165617367791211,0.0131347824881426,0.0115599399321333
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.0153046246073246,0.00606367777022993,-0.0271894330369753,-0.00341981617767398,0.0116131736308095
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,37562,0.00960412824102824,0.00382149160428359,0.00211400469663241,0.0170942517854241,0.0119764375429273
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,37942,0.00629799041780448,0.00251390438214428,0.00137073782880169,0.0112252430068073,0.0122477440896404
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.0119598884864753,0.0047859344837355,-0.0213403200745968,-0.00257945689835368,0.0124674507573827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,-0.0109632962112711,0.00439427156560399,-0.0195760684798549,-0.00235052394268723,0.0126111812221419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,40489,-0.0105937449294426,0.00426018496997002,-0.0189437074705838,-0.00224378238830131,0.0129039858527534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.00711994520873652,0.00286605397594449,-0.0127374110015877,-0.00150247941588532,0.0129951162792606
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_DRA,,40288,-0.00846819416673275,0.0034126559780786,-0.0151569998837668,-0.00177938844969868,0.01309672028498
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.0132510432721068,0.00534212455768328,0.00278047913904761,0.0237216074051661,0.0131329463755518
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,37998,0.0214415728084133,0.00866094307531658,0.00446612438079281,0.0384170212360338,0.0133110525370069
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,-0.0144238123078638,0.00582679156300642,-0.0258443237713564,-0.00300330084437121,0.0133198252381086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.00600920344209194,0.00243380270111237,0.0012389501479117,0.0107794567362722,0.0135591031408297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.00782493104385985,0.0031700046593017,-0.0140381401760912,-0.00161172191162852,0.0135814648056198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,38013,-0.00487034815156808,0.00197325640978591,-0.00873793071474846,-0.0010027655883877,0.0135925203730524
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.0100085403874424,0.00406336190062299,0.00204435106222131,0.0179727297126634,0.0137861716626133
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,-0.00553353560057708,0.00225109349746434,-0.00994567885560719,-0.00112139234554697,0.0139760025496517
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.00643604521789605,0.00261847503246267,-0.0115682562815229,-0.00130383415426923,0.0139846469444118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.0111733214901955,0.00454873100676572,-0.0200888342634563,-0.00225780871693465,0.014047790426398
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.0073011503324714,0.00298768908904547,-0.0131570209470005,-0.00144527971794227,0.0145487508290707
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,40516,-0.00945578173313344,0.00387896677166279,-0.0170585566055925,-0.00185300686067437,0.0147915471317889
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,40536,-0.0165122627278016,0.00678289351043952,-0.0298067340082631,-0.00321779144734013,0.0149273846073542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,-0.00849485750782276,0.00350021289679687,-0.0153552747855446,-0.00163444023010091,0.0152371595366821
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,0.0108183349472711,0.0044589913701634,0.00207871186175085,0.0195579580327914,0.0152719383047667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,-0.0139782999165045,0.00576997034429718,-0.0252874417913269,-0.00266915804168198,0.0154212923442284
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.00701865938867078,0.0029029907807334,0.00132879745843332,0.0127085213189082,0.0156286375104432
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.010378465107836,0.00430342551931934,-0.0188131791257019,-0.00194375108997006,0.0158927254190384
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,37562,-0.0143027737595428,0.00593062644983734,-0.025926801601224,-0.00267874591786165,0.0158928605166533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.00621994652665246,0.00258410398358029,0.00115510271883508,0.0112847903344698,0.0160953125917639
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.00892436928827606,0.00372189100459847,-0.0162192756572891,-0.00162946291926306,0.0165074976036958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,36179,-0.0237253409951189,0.00991909041801833,-0.0431667582144348,-0.00428392377580297,0.0167776671255732
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,37482,0.0105244022381179,0.00441990502952563,0.00186138838024768,0.0191874160959881,0.0172735410957937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.00790136649559875,0.0033196534482793,-0.0144078872542262,-0.00139484573697132,0.0173162185802313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,-0.0197577699297151,0.00831601507923716,-0.0360571594850199,-0.00345838037441025,0.0175215815810204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,-0.0275229527541994,0.0115879918032846,-0.0502354166886372,-0.00481048881976151,0.0175547083082223
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.014959491701183,0.00630257171403982,-0.027312532260701,-0.00260645114166493,0.0176298820658629
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00852403303069798,0.00360086082157752,0.00146634582040604,0.0155817202409899,0.0179366702916042
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0214520804529913,0.00910491166836359,-0.0392977073229839,-0.00360645358299862,0.0184826332044865
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0204889817090105,0.00869882746000702,0.00343927988739675,0.0375386835306243,0.0185188026445576
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,-0.00513114278585451,0.00218015123240652,-0.00940423920137129,-0.000858046370337723,0.0186060235430761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.0095492019295716,0.00406435915135262,0.00158305799292047,0.0175153458662227,0.0188135437769365
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,40489,-0.00452126958531623,0.00193009808682566,-0.00830426183549451,-0.000738277335137945,0.0191668014386531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,37598,-0.00933071360849445,0.0039852985455717,-0.017141898757815,-0.00151952845917392,0.0192324277329065
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,-0.0102625245524626,0.00438470182665571,-0.0188565401327078,-0.00166850897221738,0.0192689484356573
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,40456,0.00956612347462964,0.00408945228846568,0.00155079698923692,0.0175814499600224,0.01933634954879
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.0101036161663081,0.00432048211515071,-0.0185717611120035,-0.00163547122061275,0.0193742496389734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,40228,-0.00959681355459991,0.00410514411384843,-0.0176428960177428,-0.00155073109145698,0.0194124904868924
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,37671,-0.00849908312353727,0.00363623560463185,-0.0156261049086157,-0.00137206133845884,0.0194368693838541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,37482,0.00833077335054096,0.00357543559112158,0.00132291959194266,0.0153386271091393,0.0198212183958038
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.0177130270343758,0.00760274610548121,-0.032614409401119,-0.00281164466763263,0.019828386452571
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.018297460551799,0.00787318674615601,-0.0337289065742647,-0.00286601452933317,0.0201394348619199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,-0.0174436236067207,0.00751596299185309,-0.0321749110707527,-0.00271233614268862,0.0203060342016769
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,-0.0223842377601823,0.00968846938481197,-0.0413736377544137,-0.00339483776595081,0.0208810875057173
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,37562,0.0117318044473228,0.00508343141407485,0.00176827887573612,0.0216953300189095,0.0210228935199484
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.0103462548101536,0.00449162649706203,-0.0191498427443952,-0.00154266687591201,0.0212688851950936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,39961,0.0114697971500712,0.00498885963407768,0.00169163226727897,0.0212479620328635,0.0215135129998126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00899668969508484,0.00391854843101717,-0.0166770446198785,-0.00131633477029118,0.0216959262436378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,40044,-0.00841419681613953,0.00366684358107057,-0.0156012102350378,-0.00122718339724121,0.0217652521167005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.0172816718178969,0.00754172991469807,-0.0320634624507051,-0.0024998811850887,0.0219514458727321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,37628,-0.0183805061008297,0.00803654082674022,-0.0341321261212406,-0.0026288860804189,0.0222047969366522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.0105417349302607,0.00461364707506403,0.00149898666313524,0.0195844831973862,0.0223344287996355
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,40359,-0.0170073091334981,0.00747175520292414,-0.0316519493312294,-0.00236266893576681,0.022846471095312
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.006389625458509,0.0028285890686759,0.000845590883904238,0.0119336600331138,0.023903154903768
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSND,Barttin,37482,0.00737293346107979,0.0032714879115997,0.000960817154344371,0.0137850497678152,0.0242319598561949
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,37562,0.00775280370145668,0.00346132977965555,0.000968597333331797,0.0145370100695816,0.0251184015687126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,-0.00433848779886673,0.00194136130726699,-0.00814355596111003,-0.000533419636623429,0.0254465052846873
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,37900,-0.0094686949935679,0.0042450679950462,-0.0177890282638585,-0.00114836172327734,0.0257295921015832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00533873335494963,0.00239557989685728,0.000643396757109354,0.0100340699527899,0.0258558938947368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.0120208123261986,0.00540276088682689,-0.0226102236643793,-0.00143140098801793,0.0260996589017293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,-0.00787578123302776,0.00354017512592737,-0.0148145244798454,-0.000937037986210118,0.0261163192377308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.0150301164550655,0.00678427279073272,0.00173294178522937,0.0283272911249016,0.0267473551444557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.0124646359972278,0.00562733807122998,-0.0234942186168386,-0.00143505337761703,0.0267735377265612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.0613953682145159,0.0277568494623655,-0.115798793160752,-0.00699194326827941,0.0269877524946294
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,-0.0155146015207317,0.00701681323462121,-0.0292675554605893,-0.00176164758087413,0.0270483064522918
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,37598,0.00708578917098915,0.00320525060494189,0.000803497985303049,0.0133680803566753,0.0270750323814763
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,37900,-0.011078016713408,0.00501396312633098,-0.0209053844410168,-0.0012506489857993,0.0271613106626834
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,-0.00976443371569398,0.00442042927406062,-0.0184284750928528,-0.00110039233853516,0.0271963084098881
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,40359,0.00794157974631986,0.00359557638203411,0.000894250037533003,0.0149889094551067,0.0272091333078957
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,37541,0.0193155969976742,0.00875226133941064,0.00216116477242937,0.0364700292229191,0.0273364909250817
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.0120832730337994,0.00551553630161395,0.00127282188263603,0.0228937241849627,0.0284859911613338
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.015404836113762,0.00703304800336874,0.0016200620271593,0.0291896102003648,0.02851621829072
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,40359,0.0173565652481141,0.00795047146215406,0.0017736411822921,0.032939489313936,0.0290440226803831
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.00540827926738241,0.00248385042805279,0.000539932428398941,0.0102766261063659,0.0294701192163273
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.00953259914246877,0.00438575147104183,0.000936526259226782,0.0181286720257108,0.0297576866931548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,-0.00840434342715121,0.00387370052180818,-0.0159967964498952,-0.00081189040440718,0.0300557946476006
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,40359,0.0243346085027477,0.0112213889414254,0.00234068617755384,0.0463285308279416,0.0301284824100505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.0113630261360496,0.00524474816457104,-0.0216427325386089,-0.00108331973349038,0.0302870024276207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,-0.0112077945856598,0.00518553780476708,-0.0213714486830033,-0.00104414048831633,0.0306830018427512
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,40042,-0.0078158550495446,0.00361664297473976,-0.0149044752800345,-0.000727234819054678,0.0307043323291861
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.00621811815476594,0.00287778268494072,0.000577664092282139,0.0118585722172497,0.0307341856314486
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,-0.00939282571886768,0.00434909149956366,-0.0179170450580125,-0.000868606379722898,0.030809505624334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,0.00818094381310515,0.00379973771624838,0.000733457889258331,0.015628429736952,0.0313314380132748
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,37959,0.00740834587721147,0.0034480026358148,0.000650260711014455,0.0141664310434085,0.0316845936867499
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.013619155273346,0.00634076136818881,-0.026047047554996,-0.0011912629916959,0.031741842983166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,39947,-0.0177021785479697,0.00824361383639345,-0.0338596616673009,-0.00154469542863856,0.0317784388044611
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,-0.0159132377214169,0.00741923556759618,-0.0304549394339054,-0.00137153600892836,0.0319820979476076
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.0119998385664085,0.0055959169021859,-0.0229678356946929,-0.00103184143812413,0.0320192423520196
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,-0.0117324999020485,0.00547569155521299,-0.022464855350266,-0.00100014445383109,0.032159433454526
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,37572,-0.0156652752594979,0.00733391451883322,-0.030039747716411,-0.0012908028025848,0.0326974924733972
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00841503183532952,0.0039431927420151,0.000686374060979916,0.0161436896096791,0.032855945203489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,37562,0.01036044522889,0.0048587830905573,0.000837230371397688,0.0198836600863823,0.0329996731478036
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.0125005821769701,0.00586683108972665,-0.0239995711128343,-0.00100159324110586,0.0331303496857796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.0112522906898926,0.00528217876770672,-0.0216053610745977,-0.000899220305187409,0.0331706469969512
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.0136203601979863,0.0064170688148247,-0.0261978150750428,-0.00104290532092994,0.0338125896129532
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,37598,0.00574142228552863,0.00270601470189101,0.000437633469822243,0.011045211101235,0.0338793909787781
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.00655959513245915,0.00309215942344083,-0.0126202276024032,-0.000498962662515133,0.033907013753605
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00657891722311058,0.00312295900385094,0.00045791757556273,0.0126999168706584,0.0351656537654632
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,37934,-0.00934157981142148,0.00444054056780001,-0.0180450393243095,-0.000638120298533469,0.0354228119153991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,37598,0.00546364903056405,0.00259915525801158,0.00036930472486135,0.0105579933362667,0.0355646773800736
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.0061941076021197,0.00295485186906884,0.000402597938744771,0.0119856172654946,0.0360789387485707
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,40003,-0.012449074169219,0.00593976612127321,-0.0240910157669145,-0.000807132571523485,0.0361084054121593
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.0059037085905227,0.00282879547698691,0.000359269455628352,0.011448147725417,0.0369069902474477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00686660900947936,0.00329353565794966,0.000411279119898026,0.0133219388990607,0.0371001001470569
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,37824,-0.00580214327376958,0.00278446419310929,-0.0112596930922638,-0.000344593455275371,0.0372013310385174
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,37598,0.00690172980201651,0.00331254918367739,0.00040913340200882,0.0133943262020242,0.0372240190505497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.0089438086413686,0.0042963647872702,0.000522933658319003,0.0173646836244182,0.0373878122949668
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.0123017156506488,0.0059593161064353,0.00062145608203565,0.023981975219262,0.0390105066297519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.0172216014136107,0.00835301875821567,-0.0335935181797134,-0.000849684647507946,0.0392538358915565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,37959,-0.00930844551917372,0.00452037541514195,-0.0181683813328519,-0.000448509705495505,0.0394923350309001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.0121189361249275,0.00589813923202038,0.000558583230167586,0.0236792890196875,0.0399273140644705
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,37482,-0.0143726624757575,0.00699920854054058,-0.028091111215217,-0.000654213736297954,0.0400469635067613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.0051640765710821,0.0025164255101155,0.000231882571255716,0.0100962705709085,0.0401752561034893
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.0140261193300084,0.00683568810574868,-0.0274240680172758,-0.000628170642740967,0.0401993866152018
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.00517560327716502,0.00252272948556335,0.000231053485460853,0.0101201530688692,0.0402259916716991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.0204513924003183,0.0099823383245151,0.000886009284268657,0.0400167755163678,0.0405050532612398
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,-0.0113532082794683,0.00557021428771245,-0.0222708282833847,-0.000435588275551874,0.0415468214094042
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,40044,-0.017351031911837,0.00851810589116335,-0.0340465194585172,-0.000655544365156822,0.0416710122500599
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,-0.0151701072382639,0.00745104232720207,-0.02977415019958,-0.000566064276947869,0.0417731476786618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0233635926896983,0.011500954809727,0.000821721262633468,0.0459054641167632,0.0422265548492052
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.0104633667498717,0.0051536512248911,-0.0205645231506582,-0.000362210349085105,0.0423474337396188
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.00791370246281103,0.00390231921686994,0.000265156797745946,0.0155622481278761,0.0425851772782128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,-0.00501757710937228,0.00247513482758866,-0.00986884137144606,-0.000166312847298497,0.0426623167740075
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.00864165442830114,0.00429721934020577,-0.0170642043351045,-0.000219104521497837,0.0443434780764086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,0.00634648408489006,0.00315632532566113,0.000160086446594253,0.0125328817231859,0.0443719163634008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,-0.00700078403537152,0.00348350220555024,-0.01382844835825,-0.00017311971249305,0.0444837005117987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.0121307190406701,0.00604512712043567,-0.023979168196724,-0.000282269884616179,0.0447990574967813
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,-0.00673364151086059,0.00336152832198367,-0.0133222370219486,-0.000145045999772603,0.0451782792094699
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,37231,0.0132898880337602,0.00663964051652434,0.000276192621372457,0.0263035834461479,0.0453491372916284
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.00575104752686862,0.0028764817609527,-0.0113889517783359,-0.000113143275401324,0.0455895619735281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,37541,0.00952667345181905,0.00478332670997162,0.000151353100274683,0.0189019938033634,0.0464311180818929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,39961,-0.00738786051764699,0.0037100078863725,-0.0146594759749371,-0.000116245060356884,0.0464618198333187
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00359829184964371,0.00180971748948264,5.12455702577231e-05,0.00714533812902969,0.046796722806923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,40044,0.00607248263148783,0.00305707416424085,8.06172695757591e-05,0.0120643479933999,0.0470096522212594
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.00924899777121639,0.00467537925353755,8.52544342827971e-05,0.01841274110815,0.0479231137087246
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.00718660452625891,0.00364143378466566,4.93943083142157e-05,0.0143238147442036,0.0484522470221612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,37598,-0.00554324212988625,0.00281881202476397,-0.0110681136984236,-1.83705613488643e-05,0.0492599108485047
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,37959,-0.0119229517955232,0.00607291526091985,-0.0238258657069261,-2.00378841203035e-05,0.0496318641549988
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00527745283127593,0.00268820049537727,-0.0105463258022154,-8.57986033647555e-06,0.0496444200332314
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.0119351387742999,0.00608146108797134,1.54750418760643e-05,0.0238548025067237,0.0497202613324538
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.0325344455396281,0.0165793892074979,3.88426929322783e-05,0.065030048386324,0.0497402464867704
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00883306599741414,0.00451351215172301,-1.34178199629707e-05,0.0176795498147912,0.0503647980997739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00287825973797032,0.00147248695079689,-7.81468559159009e-06,0.00576433416153222,0.0506366313793779
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,39961,-0.00818609594347477,0.00418942499376749,-0.016397368931259,2.51770443095139e-05,0.0507203083757371
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,40359,-0.00491984724026604,0.00251829300056556,-0.00985570152137455,1.60070408424598e-05,0.0507608722781857
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.0113539568265449,0.00582467237360398,-0.0227703146788087,6.24010257189341e-05,0.0512790923364353
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.00627315919090509,0.00322221302396152,-0.0125886967178697,4.23783360594971e-05,0.0515709589519375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.00849449570423406,0.00436974290666909,-7.02003928373576e-05,0.0170591918013055,0.0519246104769803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,40044,-0.00528004559295706,0.0027178479906927,-0.0106070276547148,4.69364688006416e-05,0.0520667335289762
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.0060544162158071,0.00312181601126796,-6.43431662780934e-05,0.0121731755978923,0.0524753917456536
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.00592872814714551,0.00306343171613544,-7.55980164799447e-05,0.011933054310771,0.0529722022162802
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,-0.0123228942408452,0.0063760770753316,-0.0248200053084952,0.000174216826804692,0.0532975761095684
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.0149924374876981,0.00783253429846838,-0.0303442047126961,0.000359329737299954,0.055626266038529
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,37998,-0.00793290181607193,0.00415861208797359,-0.0160837815085002,0.000217977876356303,0.0564661320251825
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,37934,-0.00468011058087834,0.00245690321289657,-0.00949564087815561,0.000135419716398927,0.0568166758000706
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.00953493085605822,0.00501155322543492,-0.0193575751779107,0.000287713465794219,0.0571159420705338
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALLD,Palladin,37598,0.00751289441548975,0.00395364525615659,-0.000236250286577169,0.0152620391175567,0.0574228394268321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00910797582913327,0.00480743288336252,-0.000314592622257271,0.0185305442805238,0.0581724835534264
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0173953748607303,0.00919779426298456,-0.03542305161618,0.000632301894719436,0.0586123299224952
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.00510110539622332,0.0027024050530013,-0.0103978193001059,0.000195608507659224,0.0590989145268589
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,37959,-0.0123214561246922,0.00652871627101641,-0.0251177400158844,0.000474827766499956,0.0591453228397411
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,37998,-0.00840431467055116,0.004472082276599,-0.0171695959326852,0.00036096659158287,0.0602271142469824
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.010002841061923,0.00532742362398142,-0.0204445913649266,0.000438909241080598,0.0604528462383286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,37714,-0.00411066139516635,0.00219171303139526,-0.00840641893670107,0.000185096146368361,0.0607394243219695
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.0253106168921941,0.0135060553144276,-0.0517824853084722,0.00116125152408394,0.0609464634452247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,-0.0194049362651829,0.0103645923282525,-0.0397195372285578,0.000909664698192061,0.0611927001788257
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,-0.0130272878851097,0.00697185574109656,-0.026692125137659,0.000637549367439538,0.061706492013067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,37562,0.00845906785153473,0.00452851699024268,-0.000416825449340928,0.0173349611524104,0.0617905768605427
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00882253040272806,0.00472577867974393,-0.0180850566150262,0.000439995809570047,0.0619350723215094
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.00717445991163029,0.00384920903123996,-0.000369989789600035,0.0147189096128606,0.0623574784043636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,0.00441097945547464,0.00237326675892042,-0.000240623392009387,0.00906258230295867,0.0631039982517375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00403554362168344,0.00218387489516683,-0.000244851172843541,0.00831593841621042,0.0646411662153916
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,40391,0.00691272122005556,0.00375761601865539,-0.000452206176509004,0.0142776486166201,0.0658373279837793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,37990,0.00451056646149874,0.00245878042763101,-0.000308643176658039,0.00932977609965552,0.0666057354745315
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.00593578308370506,0.00325551300085246,-0.000445022397965763,0.0123165885653759,0.0682803229811542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,37562,0.00823177239695987,0.00451817032670828,-0.000623841443388362,0.0170873862373081,0.0684889747946704
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.0069853782083333,0.00383631963965754,-0.0145045647020621,0.000533808285395481,0.0686518276769854
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,37714,0.00727039922135395,0.00399336753752915,-0.00055660115220319,0.0150973995949111,0.0686873786135987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,-0.00504458202761322,0.00277277028335616,-0.0104792117829913,0.000390047727764851,0.0688798751524845
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,39953,0.0153451977215193,0.00844857411764985,-0.00121400754907438,0.031904402992113,0.0693427186356592
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,-0.00824478700205305,0.00453960233038262,-0.017142407569603,0.000652833565496893,0.0693602814220528
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,37714,0.00683212859543074,0.00376544671279049,-0.000548146961638632,0.0142124041525001,0.0696345796006572
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,37541,0.0170087599278182,0.00937734995059107,-0.00137084597534028,0.0353883658309767,0.0697293979550297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,40372,-0.00433637560990466,0.0023947190179243,-0.00903002488503628,0.000357273665226968,0.0701894676891975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.00840901606823934,0.00464965237826137,-0.000704302593152953,0.0175223347296316,0.0705436088017183
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.00650631739247734,0.00359951810994826,-0.0135613728879759,0.000548738103021256,0.0706984388860757
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00517197267563701,0.00286482250247527,-0.000443079429214514,0.0107870247804885,0.0710447888827763
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.00656161195484779,0.00363479241546944,-0.000562581179472312,0.0136858050891679,0.0710626791948796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARTN,Artemin,40044,-0.00761670427545625,0.00422125479715423,-0.0158903636778785,0.00065695512696604,0.0711926577286181
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,37648,-0.00982358199533566,0.00545012806330333,-0.0205058329994102,0.00085866900873886,0.0714974816781888
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.0098209913573334,0.00545136255056493,-0.000863679241773869,0.0205056619564407,0.0716360479035497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,37541,0.008307745860987,0.00461468838531549,-0.000737043374231356,0.0173525350962054,0.0718389510057685
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,40536,-0.00685103044554165,0.00381136493418716,-0.0143213057165485,0.000619244825465184,0.0722707840435308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,40044,-0.00553535219341965,0.00308018139281013,-0.0115725077233275,0.000501803336488203,0.0723412437138091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C5,Complement C5,38013,-0.00261453261830289,0.00145575170772455,-0.00546780596544301,0.000238740728837233,0.0725164895165064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,39961,0.0056118438007929,0.00312883171662647,-0.000520666363794993,0.0117443539653808,0.0728979795784475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,-0.00460110080426838,0.00257062489665271,-0.00963952560170769,0.000437323993170937,0.0734931863934633
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,-0.00514280649634644,0.00287433345940696,-0.0107765000767841,0.000490887084091206,0.0735993703533278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,0.0146641508149222,0.00821042494333442,-0.00142828207401327,0.0307565837038576,0.0741124195116302
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.0082810768803483,0.00464570463254224,-0.0173866579601311,0.00082450419943448,0.0746870649977638
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,40184,0.00791565219098109,0.0044452830884863,-0.000797102662452047,0.0166284070444142,0.0749830962107689
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.00784738284823049,0.00441424411084724,-0.000804535609030098,0.0164993013054911,0.0754695732628956
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.00449127759840933,0.00252690079144575,-0.000461447952824348,0.00944400314964301,0.0755238628748366
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00796407688911798,0.00448216987558466,-0.000820976067027948,0.0167491298452639,0.075618694837832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,37628,-0.00484614686276471,0.00272769315491183,-0.0101924254463919,0.00050013172086248,0.0756494654801366
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00610147518686308,0.00344421366044564,-0.000649183587610369,0.0128521339613365,0.0764983737373384
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,40341,-0.0148802912379146,0.00840490851615909,-0.0313539119295864,0.00159332945375724,0.0766749237541534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAG,S-arrestin,37541,0.00901308749639172,0.00510071118354447,-0.000984306423355445,0.0190104814161389,0.0772472323403937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.00792828706721862,0.00451001916599426,-0.0167679246325674,0.000911350498130124,0.0787831664932076
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.0123755441058512,0.00705354143541985,-0.0262004853192741,0.00144939710757168,0.0793657026873783
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGN,Cingulin,37572,-0.00699830397444881,0.00400413749322333,-0.0148464134611665,0.000849805512268926,0.0805275748956974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,-0.00637959403485709,0.00365378654497622,-0.0135410156630105,0.000781827593296302,0.0808263875884618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,-0.0128144019092763,0.00734910661130538,-0.0272186508674349,0.00158984704888222,0.081239752035558
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00473851168996829,0.00271984691741207,-0.0100694116480959,0.000592388268159359,0.0814942043347735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,37482,0.00762283431009553,0.00438167694351385,-0.000965252499191611,0.0162109211193827,0.0819340812709614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0104533492655117,0.00606361663679306,-0.00143133934260267,0.0223380378736261,0.0847369234771727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00449976423525439,0.00261322041427266,-0.000622147776720011,0.0096216762472288,0.0851028616200954
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,40500,-0.00991814547194065,0.00579209038928126,-0.0212706426349319,0.00143435169105061,0.0868496141854482
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,40236,-0.0112341103694912,0.0065642897181801,-0.0241001182171242,0.00163189747814184,0.0870273666939275
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,-0.0175482241912884,0.0103041587840004,-0.0377443754079291,0.00264792702535236,0.0885880057375644
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,37572,-0.00989147954139525,0.00581236222704757,-0.0212837095064085,0.001500750423618,0.0888165099752885
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,-0.0173488628676615,0.0102486055021709,-0.0374361296519165,0.00273840391659353,0.0905168013853088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00473877886891538,0.00280669953890395,-0.0102399099651671,0.000762352227336363,0.0913610992185668
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.0105072469005098,0.00622962415854321,-0.00170281645023487,0.0227173102512545,0.0916929172101409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.0114565553315855,0.00680597913424887,-0.0247962744347133,0.00188316377154228,0.0923395457654039
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,-0.00560059215330837,0.00333206752129343,-0.0121314444950435,0.000930260188426754,0.0928217480336533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,-0.00670224460176241,0.00400311029279615,-0.0145483407756429,0.00114385157211804,0.0941029032427132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,-0.0165128415487532,0.00989379716390293,-0.0359046839900029,0.00287900089249655,0.0951393543092826
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,-0.00751511981210978,0.00450851079727792,-0.0163518009747745,0.00132156135055494,0.0955596119552101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.00945123442915177,0.00567329199903673,-0.0205708867472638,0.00166841788896023,0.0957535346864395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.00556650854352894,0.00335065403203693,-0.0121337904463213,0.00100077335926343,0.0966732997835318
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,40411,-0.00338412914518446,0.00203771010422148,-0.00737804094945856,0.000609782659089631,0.0967831049302943
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,37900,0.0092504615236539,0.00557148283525343,-0.00166964483344282,0.0201705678807506,0.0968727894430584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,40341,0.00548680756096948,0.00330803047465118,-0.000996932169346826,0.0119705472912858,0.097209563563182
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.0123956684640451,0.00748141359485819,-0.00226790218187699,0.0270592391099671,0.0975713279260971
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,-0.00375216532167907,0.00226837791290439,-0.00819818603097168,0.000693855387613534,0.0981232847442184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FN1,Fibronectin,38013,-0.00411450870941706,0.00249295736240315,-0.00900070513972723,0.00077168772089312,0.098873496415292
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,-0.00700447879463084,0.00424972641763194,-0.0153339425731894,0.00132498498392777,0.099331685869137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.0128125819602084,0.00783349418879361,-0.00254106664982708,0.0281662305702439,0.101944352437622
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.00846565646848323,0.00517961296735228,-0.0186176978844937,0.00168638494752725,0.102194691892427
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,-0.0102802381184198,0.00630732820484878,-0.0226426013999234,0.00208212516308382,0.103144965851728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,-0.00834499904267454,0.00513906597697506,-0.0184175683575457,0.00172757027219657,0.104431166069319
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.00560720216718359,0.00345721710804189,-0.00116894336457852,0.0123833476989457,0.104847995144363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCIN,Adseverin,37541,-0.0113721634002282,0.00701547223620941,-0.0251224889831986,0.00237816218274228,0.105039191779452
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,39961,-0.00547739923659453,0.00337992586039281,-0.0121020539229644,0.00114725544977539,0.105130678567681
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.00954658792821765,0.00590391002187335,-0.0211182515710894,0.00202507571465412,0.105902999677172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,-0.00931773365592286,0.00576471086630238,-0.0206165669538755,0.00198109964202981,0.106044784502131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,-0.0136941631820131,0.00847373667795145,-0.0303026870707979,0.00291436070677176,0.106102946474126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.0080087829674545,0.00496840367816185,-0.00172928824174273,0.0177468541766517,0.106998439932495
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,37598,0.00859310394719167,0.00533400893257871,-0.00186155356066261,0.0190477614550459,0.10720309435969
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,37959,-0.00583422176634803,0.00363700190561324,-0.01296274550135,0.00129430196865392,0.108708907821172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.0092171967915058,0.00576463707265535,-0.00208149187089868,0.0205158854539103,0.109862389586728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.00517361660638616,0.00323601475089807,-0.00116897230537404,0.0115162055181464,0.109897688015838
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.0100172968230022,0.00627912183173721,-0.0223243756132072,0.0022897819672027,0.110661660760885
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00592156205050396,0.00371661026954666,-0.0013629940778075,0.0132061181788154,0.111123837339938
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.00983949471794961,0.00617880945463589,-0.021949961249036,0.00227097181313674,0.111305329582596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCLN,Nicalin,40044,-0.00806094574755783,0.00506436379186373,-0.0179870987796108,0.00186520728449508,0.111472493588805
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.00583574959271361,0.00366781801135002,-0.00135317370953242,0.0130246728949596,0.111618316892728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,-0.00938198267755531,0.00590750428743079,-0.0209606910809197,0.00219672572580903,0.112277353177417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,37643,-0.0125218270749978,0.0079086482924586,-0.0280227777282167,0.00297912357822102,0.113375225674093
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.00935887852708965,0.00594232364849662,-0.021005832878143,0.00228807582396372,0.115291646353506
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,40396,0.0123209836814464,0.00785586873439258,-0.0030765190379631,0.0277184864008558,0.116812430882582
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.00958900966865526,0.00615135159112755,-0.0216456587872653,0.00246763944995473,0.119056911607967
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,-0.00376870637263694,0.00242614533850991,-0.00852395123611637,0.000986538490842482,0.120354270823451
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.00317112960844194,0.00205070416700172,-0.00719050977576531,0.000848250558881428,0.12204140085276
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERVV_1,,37562,0.00709477474368354,0.00460111959629826,-0.00192341966506104,0.0161129691524281,0.123105740058444
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIT,Vitrin,37990,0.00538907363741467,0.00350345605959642,-0.00147770023939431,0.0122558475142237,0.124019078187672
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,-0.00998400606312226,0.0065023964560291,-0.0227287031169393,0.00276069099069477,0.124700576455875
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,40398,-0.0217155155417756,0.0141522829982991,-0.0494539902184418,0.0060229591348907,0.124946730262127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,37942,-0.00779387791973169,0.00510687750690005,-0.0178033578332558,0.0022156019937924,0.126995136288925
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,37572,0.00507927065786793,0.00333592766956555,-0.00145914757448055,0.0116176888902164,0.127883871839237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.00567437366025658,0.00374031745053857,-0.00165664854279901,0.0130053958633122,0.129269712093425
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,0.00525180749532539,0.00347359922127843,-0.00155644697838035,0.0120600619690311,0.130578220610927
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.011093857229944,0.00740608589802508,-0.0256097855900732,0.00342207113018513,0.134169695872696
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,37874,-0.00809009199945286,0.00541916631883887,-0.0187116579843771,0.00253147398547133,0.13549563338474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.01120557822055,0.00756944498682392,-0.00363053395362485,0.0260416903947249,0.13879858064147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.0110941117868431,0.00749632807178266,-0.0257869148075371,0.0035986912338509,0.138913364450498
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,37562,0.00486247790627131,0.00328908686273487,-0.00158413234468904,0.0113090881572317,0.139333562623275
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,40396,0.00427421665163994,0.00289309250820356,-0.00139624466443904,0.00994467796771892,0.139591736937827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,37901,-0.0364802226519693,0.0247429857896985,-0.0849764747997784,0.0120160294958398,0.14040641858055
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,0.00626124193015025,0.00425894244752277,-0.00208628526699439,0.0146087691272949,0.141547968251823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,-0.00578117740753375,0.00394569540919659,-0.0135147404095591,0.00195238559449157,0.142890354843709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEO1,Neogenin,37959,0.00297383642480169,0.00202992315247468,-0.00100481295404869,0.00695248580365207,0.142944326566682
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,37598,-0.00660850070231499,0.00451312128668549,-0.0154542184242186,0.00223721701958856,0.143139709283469
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.00744309142152664,0.00508638877881675,-0.00252623058495418,0.0174124134280075,0.143395998662056
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,37482,0.00666298821164907,0.00455723120281256,-0.00226918494586354,0.0155951613691617,0.143746314419072
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,-0.00607482906625249,0.00415729304739388,-0.0142231234391445,0.00207346530663951,0.143967648055722
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,0.00361777151514842,0.00248011773124325,-0.00124325923808836,0.00847880226838519,0.144668337892969
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,-0.00666352284554227,0.00457359616573342,-0.0156277713303798,0.00230072563929524,0.145148762833231
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,-0.00545196905477573,0.00376685901306767,-0.0128350127203884,0.00193107461083691,0.147818210167982
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.00742509102621244,0.0051328480173836,-0.0174854731402843,0.00263529108785942,0.148037620908359
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.00739399963116148,0.00511700364079603,-0.00263532750479874,0.0174233267671217,0.148484960855474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00799120367464433,0.00553343084156945,-0.0028543207748318,0.0188367281241205,0.148715663141094
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.0110564358617659,0.00769294435675453,-0.0261346068010048,0.00402173507747294,0.15067631656123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,0.00977209784602079,0.00684814722695818,-0.00365027071881723,0.0231944664108588,0.153612475347966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,39961,-0.00654242021024491,0.00458813757243728,-0.015535169852222,0.00245032943173215,0.153905076822247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,40042,-0.00659297931579983,0.00463201210752792,-0.0156717230465545,0.00248576441495489,0.154654425023636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,39961,-0.00927394731795483,0.00652724877504492,-0.0220673549170429,0.00351946028113321,0.155393577907497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,40044,0.00405734769759648,0.00285861463474094,-0.00154553698649577,0.00966023238168873,0.155819743183414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,-0.00925930478940071,0.00653121854121657,-0.0220604931301852,0.00354188355138377,0.156302184564432
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,40411,0.00496691731260243,0.00350808083509633,-0.00190892112418637,0.0118427557493912,0.156838853436626
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,40475,-0.00289960509799103,0.00206127907386877,-0.00693971208277382,0.00114050188679176,0.159535209934217
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,37482,0.00564601462160104,0.00403381792176161,-0.00226026850505171,0.0135522977482538,0.161635916923693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,37482,0.00802892323267843,0.00574414381490717,-0.00322959864453964,0.0192874451098965,0.162209531787981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.0058107008283446,0.00416031714246169,-0.0139649224275695,0.0023435207708803,0.162528403860598
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,37572,0.00499948524775403,0.00358691971447845,-0.00203087739262373,0.0120298478881318,0.163398536991005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,37714,-0.00587633821962687,0.00421734770985529,-0.0141423397309432,0.0023896632916895,0.163530392338172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,-0.00295266374896915,0.00212057272801639,-0.00710898629588128,0.00120365879794298,0.163823908937207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,0.00666988670172626,0.00479174387689992,-0.00272193129699759,0.0160617047004501,0.163960001091876
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0030196703303235,0.00217131523855862,-0.00123610753725139,0.0072754481978984,0.164332552190721
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.00551874991694467,0.00398181874202102,-0.00228561481741652,0.0133231146513059,0.165773982935626
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00426166735360767,0.00307914771457458,-0.0102967968741738,0.0017734621669585,0.166365725734066
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00640619593620054,0.00463059173984023,-0.0154821557462874,0.00266976387388632,0.166546589925671
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.00700729634926339,0.00508170764253378,-0.0169674433286296,0.00295285063010282,0.167940974601459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,-0.00363631349067762,0.00263811069560197,-0.00880701045405748,0.00153438347270224,0.168105950883564
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,40228,-0.00461828208645751,0.00335645477911044,-0.011196933453514,0.00196036928059896,0.16885958549999
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.00579741112414495,0.00421665857798267,-0.00246723968870108,0.014062061936991,0.169191231495045
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00860637906518292,0.00627893869238923,-0.0209130989022658,0.00370034077189996,0.170499813202207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7,Complement component C7,37678,0.00411815339630591,0.00300471807923253,-0.00177109403898985,0.0100074008316017,0.170534693800563
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00876044579463536,0.00639566394420443,-0.00377505553600531,0.021295947125276,0.170789141381824
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.0109991580901421,0.00803451331298276,-0.0267468041835883,0.0047484880033041,0.171026254955174
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,37598,0.00560191749316097,0.00409685188917463,-0.00242791220962129,0.0136317471959432,0.171532346404157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,37572,-0.00755043037722239,0.00552422934660273,-0.0183779198965637,0.00327705914211896,0.171716320079893
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00546852830658684,0.00400657086293456,-0.00238435058476489,0.0133214071979386,0.172311000447296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.0115500500440636,0.00848446888099472,-0.0281796090508133,0.00507950896268604,0.173437135249824
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,37598,0.00753909431758526,0.00554320116700425,-0.00332557996974308,0.0184037686049136,0.173833795580808
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,37900,0.00593889847541866,0.00436766065270691,-0.00262171640388688,0.0144995133547242,0.173933882476655
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,37541,0.0118385774348381,0.00871014975007919,-0.00523331607531713,0.0289104709449933,0.174116026074785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,37857,-0.00923983218662758,0.00680463206587644,-0.0225769110357454,0.00409724666249024,0.174526560156905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,37541,-0.00836156070768475,0.00618726196541106,-0.0204885941598904,0.00376547274452093,0.176585779692743
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,-0.00575649295370098,0.00426421521801664,-0.0141143547810136,0.00260136887361164,0.177050120665981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,37671,-0.00554753978003286,0.00412033994706351,-0.0136234060762773,0.00252832651621162,0.178203358258293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,0.00559298480783216,0.00415956751478204,-0.00255976752114063,0.013745737136805,0.17877549316954
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,37714,0.00736943802847968,0.00548296318305649,-0.00337716981031104,0.0181160458672704,0.178951591919203
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,37714,-0.0218096736384132,0.0162915227850965,-0.0537410582972023,0.0101217110203758,0.180687063734204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,-0.00533043235671309,0.00400275278641139,-0.0131758278180794,0.00251496310465323,0.182984141990896
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,-0.0116237536093291,0.00873788043991939,-0.0287499992715711,0.0055024920529129,0.183451697535487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.0106813914603593,0.00803730263827955,-0.0264345046313872,0.00507172171066861,0.183874961735269
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00635585458619882,0.00482456713954652,-0.00310029700731236,0.01581200617971,0.187729735379888
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,-0.00837600051808114,0.00635880950764473,-0.0208392671530648,0.00408726611690252,0.187785289287682
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,-0.00427597489582085,0.00324641578050371,-0.0106389498256081,0.00208700003396643,0.187811964695419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,37541,0.00797742475028896,0.00605952210594314,-0.00389923857735959,0.0198540880779375,0.188025793053487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0106389736484095,0.00810718578901571,-0.0265290577948803,0.00525111049806125,0.189444918313007
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,37572,-0.00391001417125281,0.00297969079673074,-0.00975020813284506,0.00193017979033944,0.189468383929827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,37562,0.0065798056902662,0.00501451863007588,-0.00324865082468252,0.0164082622052149,0.189492160868503
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS2,Podocin,37598,0.013065032255619,0.00999074747400444,-0.00651683279342966,0.0326468973046677,0.190993475811222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,0.00654633589511874,0.0050241400563729,-0.00330097861537213,0.0163936504056096,0.192605705418555
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,39961,-0.00541218837785911,0.00417212795691524,-0.013589559173413,0.00276518241769476,0.194573103336316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,37714,-0.00648718384483619,0.00500501206399392,-0.0162970074902643,0.0033226398005919,0.194950670984943
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00526144443398731,0.0040596324018401,-0.00269543507361928,0.0132183239415939,0.194984077491925
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.00402080934225483,0.00310487010474643,-0.0101063547475578,0.00206473606304817,0.195342687957922
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00555578542897162,0.00429793984047084,-0.00286817665835122,0.0139797475162945,0.196150351535195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,-0.00656939000681268,0.00511264507554874,-0.0165901743548882,0.00345139434126286,0.198838787182602
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.00408539697037011,0.00319054036504914,-0.0021680621451262,0.0103388560858664,0.200401909526678
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESPL1,Separin,37482,0.00695252763148926,0.00546917367427384,-0.00376705277008747,0.017672108033066,0.20367278162161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,37942,-0.00465418036584673,0.00368039245931959,-0.0118677495861131,0.00255938885441967,0.206040881651642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,37998,0.00369607025811891,0.002930634841227,-0.00204797403068602,0.00944011454692383,0.207264221357996
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,-0.00354280728867716,0.00281297178874376,-0.00905623199461493,0.0019706174172606,0.207888964725661
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,0.0044106947580027,0.0035114363594277,-0.0024717205064756,0.011293110022481,0.209103553237727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,37572,-0.00825418814257671,0.00657311394386109,-0.0211374914725444,0.00462911518739102,0.209228970277973
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.0062724237374371,0.00499550276083202,-0.00351876167379366,0.0160636091486678,0.209278292119068
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.00312738594519037,0.00249446541515617,-0.00801653815889645,0.00176176626851572,0.209958673990229
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.00525483540650802,0.00420652997535908,-0.0134996341582118,0.00298996334519578,0.211607367781295
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,-0.00389222891748674,0.00312199193299424,-0.0100113331061555,0.00222687527118198,0.212524796511654
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,37541,0.00601542015230932,0.00483960999960929,-0.0034702154469249,0.0155010557515435,0.213906475196649
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00668484673105065,0.00538607045226811,-0.00387185135539484,0.0172415448174961,0.214577801706064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,0.0084624296093444,0.00681862433502493,-0.00490207408730446,0.0218269333059933,0.214599957305103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,-0.00511045252220541,0.00411794170421479,-0.0131816182624664,0.00296071321805558,0.214619663730078
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,-0.00388573457490495,0.00314771559355571,-0.0100552571382742,0.00228378798846424,0.217052385503695
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.00661123157282637,0.00537057370435636,-0.0171375560333648,0.0039150928877121,0.218340471889055
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.00291288261226551,0.00237397515924656,-0.00174010869985774,0.00756587392438876,0.219841526322456
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,39980,-0.00474900968890912,0.00387495065831185,-0.0123439129792003,0.00284589360138212,0.220380441156239
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,37942,0.00269824405638506,0.00220895828038089,-0.00163131417316148,0.00702780228593161,0.221917851685377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.00726127743294649,0.00595174041405315,-0.00440413377859768,0.0189266886444907,0.222476943920251
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,0.00669364157812866,0.00550458717881077,-0.00409534929234045,0.0174826324485978,0.224002452487235
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.00617847087107477,0.00509917560320516,-0.0161728550533569,0.00381591331120735,0.225663932563691
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.00808686982328185,0.00671747250515983,-0.00507937628683142,0.0212531159333951,0.228666962473542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,37562,0.00516983496484289,0.00429534684095299,-0.00324904484342498,0.0135887147731108,0.228769957289544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.00324681826368487,0.00270022449080577,-0.00204562173829444,0.00853925826566418,0.229216687179663
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,37628,0.00777451862127069,0.00649429703787702,-0.00495430357296827,0.0205033408155096,0.231277377411281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,0.00750062166318401,0.00627859625729596,-0.00480542700111607,0.0198066703274841,0.232248249834555
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,37541,0.00413972961161896,0.00348127309522461,-0.00268356565502127,0.0109630248782592,0.23440518887283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.00525353151440646,0.00442082191387009,-0.0139183424655918,0.00341127943677892,0.234709463585688
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,0.0045928994965321,0.00388620067619032,-0.00302405382880092,0.0122098528218651,0.237287352348043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,-0.00554213455780141,0.00469810546761144,-0.0147504212743198,0.00366615215871701,0.238156319295208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,0.0108814929173577,0.00925077347149227,-0.00725002308676716,0.0290130089214826,0.239504661460331
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.0106707458786795,0.00910346906484464,-0.00717205348841598,0.028513545245775,0.241153215428334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,-0.00310255420275154,0.00265316703570473,-0.00830276159273281,0.00209765318722972,0.242269037102713
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,-0.00347908397079049,0.00297867854453343,-0.009317293918076,0.00235912597649503,0.242829227521975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.00614047526175128,0.00526111078160805,-0.0041713018702005,0.0164522523937031,0.243173377690407
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.00385204830660745,0.00330048022764476,-0.00261689293957628,0.0103209895527912,0.243184174206853
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.00393601725126213,0.00339093774957168,-0.00271022073789836,0.0105822552404226,0.245765770392319
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.00388665012279902,0.00335496521472474,-0.00268908169806147,0.0104623819436595,0.246690466426785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,0.00707601952523147,0.00612233336741719,-0.00492375387490623,0.0190757929253692,0.247795751341086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,0.0190655581476777,0.0165054234446635,-0.0132850718038627,0.0514161880992181,0.248066439827621
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.00854989556035663,0.00741031840004681,-0.0230741196244484,0.00597432850373512,0.248610149816806
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,37572,-0.00761574539165247,0.00664989848459778,-0.0206495464214641,0.00541805563815919,0.252129668125313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00331306464758293,0.00291608999397317,-0.00902860103577035,0.00240247174060449,0.255918665823759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.00848081409408575,0.0074647644930526,-0.0231117525004688,0.00615012431229734,0.255930181700285
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,37987,0.00703779839276021,0.00619677935383727,-0.00510788914076084,0.0191834859262813,0.256094407794978
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,-0.00362244325128552,0.00319551803775388,-0.00988565860528313,0.00264077210271208,0.256979024346183
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.00850084689725147,0.007507736315312,-0.00621431628076004,0.023216010075263,0.257538192989193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.00520836069933556,0.00461154854159372,-0.0142469958408593,0.00383027444218813,0.258739083616618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.0039659816257126,0.00351378806182389,-0.0108530062268874,0.00292104297546223,0.259048173733035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.00526272750416921,0.00468313363500696,-0.00391621442044443,0.0144416694287828,0.261134593339551
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,-0.00191175276451737,0.00170157476150569,-0.00524683929706851,0.00142333376803378,0.261236727588754
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,-0.00734076632572174,0.00657506838120445,-0.0202279003528825,0.00554636770143898,0.264247389406646
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.00280701177605984,0.00252719006901147,-0.00776030431132232,0.00214628075920264,0.266707474373938
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,37429,-0.00368713407804695,0.00333114837324888,-0.0102161848896148,0.00284191673352086,0.268372488218027
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,40042,0.00536080764873403,0.00484879610763199,-0.00414283272222466,0.0148644480196927,0.268918655559775
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,40044,0.0152386968007327,0.0138317183956408,-0.0118714712547233,0.0423488648561886,0.270599922128876
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,40044,-0.00829798542865763,0.00754294055946384,-0.0230821489252068,0.0064861780678915,0.271305738991759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,0.0054673797087798,0.00497195070572633,-0.00427764367444381,0.0152124030920034,0.271507233059939
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00378097593129882,0.00343960269471616,-0.00296064535034485,0.0105225972129425,0.271680134599327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.00348785929451031,0.0031750372976686,-0.00273521380892015,0.00971093239794077,0.271995266819597
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,0.00229042689550404,0.0020904952473336,-0.0018069437892698,0.00638779758027789,0.27325711587907
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00399643337028336,0.00364818447714693,-0.0111468749454913,0.00315400820492462,0.273336100008282
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,40359,-0.00467654823256322,0.00428660042704721,-0.0130782850695757,0.0037251886044493,0.275303042858508
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,0.00473317734982989,0.00433853433851628,-0.00377034995366202,0.0132367046533218,0.2753059558498
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,40406,-0.00415362986906921,0.00381654237948086,-0.0116340529328517,0.00332679319471326,0.276469094080576
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.0042170485169353,0.00387837460984095,-0.0118186627522236,0.00338456571835296,0.276913780930122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.00504653515969066,0.00464607967617206,-0.00405978100560658,0.0141528513249879,0.277414127993784
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,37482,0.00740076482678455,0.00683569761118564,-0.0059972024911393,0.0207987321447084,0.278977551294261
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,0.00570805780847274,0.00528982487617537,-0.00465999894883098,0.0160761145657765,0.280575728391829
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.00411299563234574,0.00384848141233556,-0.0116560192005234,0.00343002793583196,0.28520991693856
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,0.00345758528970022,0.00323983896129556,-0.00289249907443908,0.00980766965383952,0.285897122192744
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00275754924344938,0.00258765175304653,-0.00231424819252183,0.00782934667942058,0.286594776835893
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSPN,Claspin,39925,-0.0034457310663756,0.00323898445998562,-0.00979414060794742,0.00290267847519622,0.287422008264146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIM,Vimentin,40042,-0.0119402048094838,0.0112351291088739,-0.0339610578628767,0.010080648243909,0.287908920487587
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.00455624485687649,0.00428797708085962,-0.0129606799353613,0.00384819022160836,0.287999620428092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,37572,-0.00616852953530607,0.00581152750003383,-0.0175591234353724,0.00522206436476023,0.288514074784547
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.00673424091177893,0.00636619024280474,-0.0192119737876762,0.00574349196411835,0.290160075245385
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00416902546090604,0.00394202637260743,-0.00355734622940453,0.0118953971512166,0.290264444959974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.002604585881049,0.00247015749746209,-0.00223692281397669,0.00744609457607468,0.291709556984417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,0.00544593255977599,0.00518416894104015,-0.00471503856466269,0.0156069036842147,0.293510957391036
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,0.0048993439911811,0.00466480123501274,-0.00424366642944386,0.0140423544118061,0.293609097300844
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,40489,0.0058952690520407,0.00565854567628909,-0.00519548047348592,0.0169860185775673,0.297504043681344
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,-0.00882131279953691,0.00847684924092069,-0.0254359373117415,0.00779331171266765,0.298063917356786
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNLY,Granulysin,40332,-0.0050014858726297,0.00481019039023361,-0.0144294590374876,0.00442648729222818,0.298463159858061
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.00543914580729771,0.00524057926575052,-0.0048323895535733,0.0157106811681687,0.299336797635628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.00700692195040123,0.00675655898559685,-0.0202497775621711,0.0062359336613686,0.299729225099746
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,37572,0.00588989701684034,0.00569224980078745,-0.00526691259270306,0.0170467066263837,0.300817754643742
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.00619359977416512,0.00599226856999878,-0.00555124662303249,0.0179384461713627,0.301342873705428
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,37598,-0.00291514013448038,0.00283860327284473,-0.00847880254925606,0.0026485222802953,0.304456848406375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00347277481680259,0.00338472874333733,-0.00316129352013857,0.0101068431537437,0.304901560803806
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,-0.0116958090662229,0.0114158836968514,-0.0340709411120517,0.010679322979606,0.305608336217977
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,-0.00271532952244025,0.00265047851043846,-0.00791026740289964,0.00247960835801913,0.305629945162741
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,-0.00983630124921435,0.00960790853550196,-0.0286678019787982,0.00899519948036948,0.305961994961881
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00286940874278421,0.00280319694774027,-0.00836367476035514,0.00262485727478672,0.306033079260854
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,-0.00445169837012938,0.00435808698373301,-0.0129935488582461,0.00409015211798731,0.307045432679136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00555911070331707,0.00544228804352671,-0.0162259952686294,0.00510777386199529,0.307052673841033
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00377142584300349,0.00370128575948567,-0.00348309424558843,0.0110259459315954,0.30824540099709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,40332,-0.00466308024619592,0.00457836636716383,-0.013636678325837,0.0043105178334452,0.308454454348953
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,39871,0.00673847211425699,0.00663089070976028,-0.00625807367687315,0.0197350179053871,0.309538543709376
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,37572,0.00377319778914344,0.00374778495456702,-0.00357246072180791,0.0111188563000948,0.31405870907549
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,-0.008929814893711,0.00892036576445347,-0.0264137317920398,0.00855410200461779,0.316816577364314
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,-0.00423828252084561,0.00427509568491224,-0.0126174700632736,0.00414090502158239,0.321513728826549
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,-0.00634743147944113,0.00642631982205685,-0.0189430183306726,0.00624815537179029,0.323303157838981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,39980,0.0158088791058215,0.0160263827129897,-0.0156028310116384,0.0472205892232814,0.323938302686677
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.00385288662483288,0.00390798766522304,-0.01151254244867,0.00380676919900428,0.324200132519592
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,40384,-0.00530076948679318,0.00538001800747255,-0.0158456047814394,0.00524406580785303,0.324506504826456
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.00196809423796053,0.00200465405915403,-0.00589721619390242,0.00196102771798137,0.326231834839481
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,37671,0.00841171614116043,0.00858703418513934,-0.00841887086171267,0.0252423031440335,0.327309729407989
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,-0.00272163035514945,0.00278330811005984,-0.00817691425086674,0.00273365354056785,0.328171555397685
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.0110954116763964,0.0113735527299946,-0.0333875750271858,0.0111967516743931,0.329308027106556
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,37900,-0.00328499035043994,0.00336823816945532,-0.00988673716257236,0.00331675646169248,0.329436718524871
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.00447183659835665,0.0046014433892688,-0.0134906656413235,0.00454699244461019,0.33115134224871
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00530393786388946,0.00546017783754622,-0.00539801069770113,0.01600588642548,0.33137427036602
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,-0.00619849686138874,0.00638965019867783,-0.0187222112507973,0.0063252175280198,0.332022514948131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,-0.00490584030342416,0.00505805644052286,-0.014819630926849,0.00500795032000063,0.332110937270878
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,0.00359450563609448,0.00370634060005026,-0.00366992194000403,0.010858933212193,0.332151101151401
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,0.00744007145064281,0.00771769556774522,-0.00768661186213782,0.0225667547634234,0.335049984652475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,40227,-0.00481404903605521,0.00499975284286938,-0.0146135646080792,0.00498546653596877,0.335633847976266
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,0.00573618946629592,0.00596583736342058,-0.00595685176600842,0.0174292306986003,0.336315564020385
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.00639256218140227,0.00665803880765509,-0.00665719388160171,0.0194423182444063,0.337005782699671
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,39961,-0.00343209726020407,0.00357740479434671,-0.0104438106571236,0.00357961613671547,0.337381366688824
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,37959,-0.002337475622379,0.00243725858680022,-0.00711450245250742,0.00243955120774942,0.337546016543754
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00717796182212624,0.0075277797225319,-0.0219324100782888,0.00757648643403628,0.340339424708672
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,40017,-0.00504939970369831,0.00529893672584237,-0.0154353156863493,0.00533651627895273,0.34065143532324
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.00548859768236752,0.00578199169350459,-0.0168213014016365,0.00584410603690147,0.342504491959467
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.00376651361347752,0.00396788802249397,-0.00401054691061066,0.0115435741375657,0.342511606533323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,-0.00364694830097501,0.00384475459603229,-0.0111826673091983,0.00388877070724827,0.342863147362604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,37598,-0.0057253611394802,0.00603984264212345,-0.0175634527180422,0.00611273043908177,0.3431814111744
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00293625606730203,0.00310485852501027,-0.00314926664171811,0.00902177877632216,0.344320578358494
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,37541,0.00445248292638272,0.00473227076129256,-0.00482276776575069,0.0137277336185161,0.346785452910984
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-0.00571730359169864,0.00607678497367408,-0.0176278021400998,0.00619319495670257,0.346802391344591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,37934,-0.00282121868722533,0.00300101359398511,-0.00870320533143614,0.00306076795698548,0.347188955091949
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00699563365579809,0.00744898309157462,-0.0215956405152843,0.00760437320368816,0.347676456416335
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.00251620731696848,0.00268450925915364,-0.00274543083097265,0.00777784546490961,0.348615395482709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,40458,0.00265731517891251,0.00283930544565439,-0.00290772349457009,0.00822235385239511,0.349337126435613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.00630220269373803,0.00678048224824369,-0.00698754251281961,0.0195919479002957,0.352666689652529
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.00259012104101438,0.00280203560549487,-0.00808211082778433,0.00290186874575557,0.355310046015184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.00604502905830328,0.00654001260845674,-0.0188634537708785,0.00677339565427194,0.35533908284605
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,-0.00641111778079295,0.00693792592538028,-0.0200094525945383,0.00718721703295239,0.355467723619747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00488094768527852,0.00531336438161249,-0.015295141873239,0.00553324650268196,0.358312588643625
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,37541,-0.00394024786481045,0.00428952726801336,-0.0123477213101166,0.00446722558049574,0.358335406341804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00297253677568217,0.00323719178067759,-0.00337235911444591,0.00931743266581026,0.35850727420857
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.00561610081923,0.0061168348871385,-0.0176050971980215,0.00637289555956146,0.358563422914668
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0119366026173829,0.0130910386891143,-0.0375950384480468,0.013721833213281,0.361882452506506
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0227510676623489,0.0250444089222358,-0.0718381091499311,0.0263359738252332,0.363668218282115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,-0.00530462120920953,0.00588526931636653,-0.0168397490692879,0.00623050665086887,0.367424756308278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,40536,0.00226057429728526,0.00251202306433494,-0.00266299090881122,0.00718413950338174,0.368185938397279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,-0.00428352200867214,0.0047835943253733,-0.0136593668864038,0.00509232286905953,0.370554383786122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,37598,0.0041093454507847,0.00459122622692816,-0.00488945795399449,0.0131081488555639,0.370780424728097
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,-0.00213574155747942,0.00239516315909527,-0.00683026134930615,0.0025587782343473,0.372572785416595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,37998,0.007668821312862,0.00861691154204615,-0.00922032530954846,0.0245579679352725,0.373496021063447
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.00286203744266275,0.00322066563412691,-0.00917454208555149,0.00345046720022599,0.374208216100311
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,37410,-0.00371645565735907,0.00418819990521846,-0.0119253274715873,0.00449241615686911,0.374899706251801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,-0.00573391374359304,0.00650148472460118,-0.0184768238038113,0.00700899631662526,0.377825853404019
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00633804283604841,0.00722055385500486,-0.00781424271976111,0.0204903283918579,0.380080353629752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,-0.00226616328003266,0.00259593738182902,-0.00735420054841754,0.00282187398835222,0.382695120765197
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.00611046150762542,0.00704294945615059,-0.0199146424416806,0.00769371942642973,0.385626567692963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,-0.00731839719107047,0.00844130188954135,-0.0238633488945715,0.00922655451243058,0.385971608482435
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,37671,-0.00424514444747488,0.00491045941154996,-0.0138696448941128,0.00537935599916303,0.387323120580111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,37937,0.00191442669687201,0.0022197995395195,-0.0024363804005862,0.00626523379433022,0.388465040329927
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.00770175026530135,0.00893247152963471,-0.0252093944633854,0.00980589393278268,0.38858252243526
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,0.00294115906968054,0.00341842334634981,-0.00375895068916509,0.00964126882852616,0.389590104001462
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.00514601307582838,0.00598159247683665,-0.0168699343304282,0.00657790817877144,0.389634666797328
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,39980,-0.00877470081362091,0.010200759384835,-0.0287681892078975,0.0112187875806557,0.389691675127772
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRN1,Neuritin,37959,-0.00298904126727612,0.00348746300827363,-0.00982446876349245,0.0038463862289402,0.3914148540644
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,-0.00315679683336048,0.00370020459338142,-0.0104091978363881,0.0040956041696671,0.39359660383604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,37482,0.00761700629550366,0.0089881637782145,-0.00999979470979676,0.0252338073008041,0.396760722515407
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,37714,-0.00590486891621869,0.00698898528832544,-0.0196032800813365,0.00779354224889916,0.398191882908565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,37541,0.006369374957273,0.00755862204127435,-0.00844552424362472,0.0211842741581707,0.399432059581168
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00446272745247986,0.00531058869414366,-0.00594602638804172,0.0148714812930014,0.400727847981888
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,-0.00700671102577286,0.00840148762391636,-0.0234736267686489,0.00946020471710321,0.404302240409246
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,0.0055704503766748,0.00668782278449298,-0.00753768228093143,0.018678583034281,0.404902563279553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00621753005869567,0.00746688006803028,-0.020852614992035,0.00841755487464367,0.405039317642306
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,40419,0.00263444772568224,0.00317026887259677,-0.00357927926460744,0.00884817471597192,0.405994199850132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,37598,0.00466119387091765,0.00563082101769534,-0.00637521532376521,0.0156976030656005,0.407798778207376
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,-0.0085506969059854,0.0103358329149683,-0.0288089294193233,0.0117075356073525,0.408089672959789
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,40044,0.00232667114140463,0.00281438890344454,-0.00318953110934668,0.00784287339215593,0.408416582231067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.00636436788427865,0.00773091935872969,-0.00878823405883154,0.0215169698273888,0.410389037499334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.00474800758897367,0.00579853040435461,-0.0161131271815087,0.00661711200356136,0.412896229605626
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,-0.00287073363183972,0.00351554002435872,-0.0097611920795828,0.00401972481590337,0.414181015434667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.00384721496450044,0.00473642523905763,-0.00543617850405252,0.0131306084330534,0.416653864927287
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.00303666340306424,0.00373942265509178,-0.0103659318070441,0.00429260500091565,0.416767676378559
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00391681621001374,0.00482640379348005,-0.00554293522520717,0.0133765676452346,0.417070874915746
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,0.00392646657165859,0.0048566032395865,-0.00559247577793095,0.0134454089212481,0.418828987182596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,0.00215283568967976,0.00267430963686907,-0.00308881119858363,0.00739448257794314,0.420830692912372
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,-0.00642630064004491,0.0080694327429371,-0.0222423888162016,0.0093897875361118,0.425827964130064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.00335051077575323,0.00422796206170573,-0.0116373164166965,0.00493629486518999,0.428103733699767
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,40044,-0.00402611804999798,0.00510785423742143,-0.014037512355344,0.00598527625534802,0.430579422161187
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0134343452478023,0.0170553152844323,-0.0199940727096851,0.0468627632052896,0.430888339475294
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00176972025346387,0.00224962599546974,-0.00617898720458456,0.00263954669765681,0.431487057311118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,-0.00164936777437741,0.0021099715300297,-0.00578491197323563,0.00248617642448081,0.434403774729979
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,-0.00367510334752304,0.00471584962351138,-0.0129181686096054,0.00556796191455927,0.435809679201082
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,-0.00317778050084372,0.00409151421110469,-0.0111971483546089,0.00484158735292147,0.437361851339095
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,0.0047777457895452,0.00616984395298695,-0.00731514835830923,0.0168706399373996,0.438725649115786
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,0.00439390729498335,0.00569018541187233,-0.00675885611228642,0.0155466707022531,0.440015438692491
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,37562,0.0046000461030817,0.00597995259238345,-0.00712066097798986,0.0163207531841533,0.441761990303163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,-0.00279507104979313,0.00363647404313696,-0.00992256017434156,0.00433241807475531,0.442132058630614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.00163507858410886,0.00213879259434117,-0.00255695490079983,0.00582711206901754,0.444588561403002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.00344535423620785,0.00451208750362838,-0.00539833727090377,0.0122890457433195,0.445129364365919
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,0.00186190932495671,0.00246172257620223,-0.00296306692439967,0.00668688557431309,0.449456072325089
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,37598,-0.00636606755784488,0.00846611581359998,-0.0229596545525008,0.0102275194368111,0.452096595380465
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00367469403862919,0.00490352116885626,-0.00593620745232907,0.0132855955295875,0.453630286508218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,39802,-0.00185399554941982,0.00249458510243239,-0.00674338235018731,0.00303539125134766,0.457367148419695
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00530927481324029,0.00714504106380091,-0.0086950056718095,0.0193135552982901,0.457451862385375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,-0.00261430424232788,0.00353682221195484,-0.00954647577775936,0.0043178672931036,0.459818490804785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,39602,-0.00193867123578244,0.00265323959754032,-0.00713902084696148,0.0032616783753966,0.464985444101932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00395622071546652,0.0054177359277923,-0.00666254170300639,0.0145749831339394,0.46525958510288
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,-0.00503613475666595,0.00697574133281002,-0.0187085877689736,0.00863631825564169,0.470338265416645
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,0.00296883336845541,0.00412720839169526,-0.0051204950792673,0.0110581618161781,0.471947027703209
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,0.00271289692834884,0.00379484163702447,-0.00472499268021913,0.0101507865369168,0.474688965908187
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,39980,0.00210347932469322,0.00294557162069147,-0.00366984105186206,0.0078767997012485,0.475166291602053
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.00224211219328121,0.00314191609795146,-0.00391604335870365,0.00840026774526607,0.475477237632287
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,39934,-0.00243016120219708,0.0034066948255793,-0.00910728306033251,0.00424696065593834,0.475640783604316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_A,,37959,-0.00221946907973338,0.00311259050305905,-0.00832014646572912,0.00388120830626236,0.475819895983822
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.00592537534614474,0.00832104997304111,-0.0103838826010158,0.0222346332933053,0.476416563299367
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.0022866239628423,0.00322949878456478,-0.00404319365490467,0.00861644158058928,0.478930753214554
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,37900,0.00186217077478259,0.0026329571201915,-0.00329842518079275,0.00702276673035794,0.47942059008734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.0030693512579744,0.00434775478291458,-0.011590950632487,0.00545224811653818,0.48022408539018
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,-0.00502004602592925,0.00712350568472513,-0.0189821171679905,0.00894202511613201,0.480999577616662
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,0.00278753013287099,0.00398428994336632,-0.00502167815612699,0.010596738421869,0.484170592869955
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00572111416510052,0.00821261696421465,-0.0218178434149612,0.0103756150847602,0.486049942732471
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,-0.00152852827018774,0.00219562747575828,-0.00583195812267396,0.00277490158229848,0.486333087891585
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRELP,Prolargin,40357,0.0015322510367296,0.0022011821603379,-0.00278206599753268,0.00584656807099189,0.486374063915472
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,37572,-0.00432990884460583,0.00623030334679209,-0.0165413034043183,0.00788148571510667,0.487082896540793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,-0.00271383673276833,0.0039408465711385,-0.0104378960121998,0.00501022254666312,0.491057834530432
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00241294188466644,0.00351496815726091,-0.00447639570356495,0.00930227947289783,0.492425016941368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.00282798268312365,0.00413764098884351,-0.0109377590212569,0.00528179365500964,0.49431721777955
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,0.00260196560329559,0.00380941331845429,-0.00486448450087481,0.010068415707466,0.494594435528457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,37721,-0.00162506578197995,0.00239941169866171,-0.00632791271135691,0.00307778114739701,0.498242180667009
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,0.00215530233898131,0.00320206056006735,-0.00412073635875069,0.00843134103671332,0.50089456980902
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,37598,0.00170470634369372,0.00253443491044339,-0.00326278608077532,0.00667219876816276,0.501202218916892
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00405546538595769,0.00607696033324386,-0.00785537686720027,0.0159663076391156,0.504559793000874
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.00260063458332083,0.00389807935952797,-0.00503960096135399,0.0102408701279957,0.504682863433336
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,0.00225573085845732,0.0033814283334518,-0.00437186867510821,0.00888333039202285,0.504723775447951
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.0052177646903903,0.00783954335131404,-0.0205832696589658,0.0101477402781852,0.505697415845399
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,37998,-0.00328284590095534,0.00495794150134414,-0.0130004112435899,0.00643471944167917,0.507893475698013
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.00361522133678651,0.00546684874911808,-0.00709980221148493,0.014330244885058,0.508432254881604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,37482,-0.00362270169519002,0.00549541896376877,-0.0143937228641768,0.00714831947379677,0.50976479949494
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,40299,-0.00494376352311116,0.00750451792005112,-0.0196526186464114,0.00976509160018904,0.510051997197072
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,-0.0038464483503901,0.00585507342708724,-0.0153223922674811,0.00762949556670088,0.51122739062573
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,37482,0.00282388052286175,0.00430060353200878,-0.00560530239987546,0.011253063445599,0.511434155139249
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,-0.00527944988292569,0.00804697038702766,-0.0210515118414999,0.0104926120756485,0.511782900685212
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.00358889878001838,0.00548761818893177,-0.0143446304303246,0.00716683287028788,0.513121712022127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.00224401503920499,0.00343650309837216,-0.00449153103360444,0.00897956111201441,0.513771750826692
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,0.00282617563722566,0.00434286411998064,-0.00568583803793641,0.0113381893123877,0.515210709549981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,-0.00223521498163594,0.00344186960113161,-0.00898127939985389,0.00451084943658202,0.516078933239671
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,-0.00149608414728321,0.00231802609517422,-0.00603941529382467,0.00304724699925825,0.518668908758548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,37482,-0.00499035076272848,0.00773230290498887,-0.0201456644565067,0.0101649629310497,0.51868586362152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,37482,0.00257669627847904,0.00399452224856207,-0.00525256732870262,0.0104059598856607,0.518901322896207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,37572,0.00264594498501954,0.00410587042905564,-0.00540156105592952,0.0106934510259686,0.519308075336214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0031708590800038,0.00495395708514487,-0.00653889680688016,0.0128806149668877,0.522140932140457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00300804612765289,0.00471530129257549,-0.00623394440579507,0.0122500366611009,0.523528460654752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,37598,-0.00192243398713197,0.00303865800156181,-0.00787820367019311,0.00403333569592917,0.526967427511633
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.00232320944708089,0.00368163721385618,-0.00953921838623902,0.00489279949207723,0.528032659833171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,39961,-0.00360072294191593,0.00573459428311136,-0.0148405277368142,0.00763908185298234,0.53008198717693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,39980,-0.00504825995415261,0.00805550959520403,-0.0208370587607525,0.0107405388524473,0.530875527107647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.00199404098237671,0.00320546936354987,-0.00827676093493445,0.00428867897018103,0.533903644164198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,40203,0.00182023051588018,0.00296331862278314,-0.00398787398477477,0.00762833501653513,0.539056322219277
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,0.00160988864828939,0.0026240705712162,-0.00353328967129436,0.00675306696787315,0.539550711349459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.00223976346582023,0.00366259955461038,-0.00941845859285657,0.00493893166121611,0.54086398528995
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,37671,-0.00185354882579503,0.00304420334445085,-0.00782018738091869,0.00411308972932864,0.542615687390762
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,37562,0.00429413455776778,0.00706746615536632,-0.00955809910675021,0.0181463682222858,0.543468757559713
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.00282733151625518,0.00466280279609464,-0.00631176196409031,0.0119664249966007,0.544286753836985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.0019804458218014,0.0033027043606433,-0.00449285472505946,0.00845374636866227,0.548753783462096
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,37598,0.0031032354736417,0.00518553636840794,-0.00706041580843787,0.0132668867557213,0.54955629555827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,37572,-0.00276142604083092,0.00461699884548984,-0.011810743777991,0.00628789169632916,0.549783674223155
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.00383241773253173,0.00641014948006389,-0.0087314752483935,0.016396310713457,0.549938796398256
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,37697,0.00561055488826259,0.00939077859423795,-0.0127953711564438,0.024016480932969,0.550214761451081
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00287965488747609,0.00482531410172816,-0.0065779607519111,0.0123372705268633,0.550663935530207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,40417,-0.00634919898563401,0.01068326680434,-0.0272884019221405,0.0145900039508724,0.552311542186672
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,-0.0030972342650988,0.00524099101838943,-0.0133695766611421,0.00717510813094449,0.554555098285274
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTTG1,Securin,37714,-0.00232065290116678,0.00394166443326649,-0.0100463151903691,0.00540500938803554,0.556039364659346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,37959,-0.00897121005601702,0.0153133276001325,-0.0389853321522766,0.0210429120402426,0.557990625343686
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,37572,-0.00238229872831258,0.00409812319867451,-0.0104146201977146,0.00565002274108945,0.561038448399678
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,-0.00218120126414749,0.0037593208182329,-0.00954947006788398,0.00518706753958899,0.561780412029537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,39980,-0.00514366586650871,0.00889544630063674,-0.0225787406157567,0.0122914088827393,0.563113290132439
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00272775034641618,0.00472608418901108,-0.00653537466404554,0.0119908753568779,0.563835071346232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,0.003337841190421,0.00578743304068334,-0.00800552756931834,0.0146812099501603,0.564125352402647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,-0.00692714417088143,0.012015802962705,-0.0304781179777832,0.0166238296360203,0.564283727408716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.00480090813374405,0.00834011851107379,-0.0115457241479606,0.0211475404154487,0.564866521389621
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.00225591756626052,0.0039279997323128,-0.00544296190907258,0.00995479704159361,0.565762954408383
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,40042,-0.00294639273501398,0.00517174321153391,-0.0130830094296204,0.00719022395959248,0.568882758200146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,0.0036990931799137,0.00650903672446964,-0.00905861880004679,0.0164568051598742,0.569840278583255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTG,Protogenin,40489,0.00135398280033691,0.0023830095571901,-0.00331671593175569,0.00602468153242952,0.569919443256853
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,0.00463270612850347,0.00817643582288158,-0.0113931080843444,0.0206585203413514,0.57100087685175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,37959,-0.00163153927593856,0.00289966925144324,-0.00731489100876731,0.00405181245689018,0.573673093494253
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.00376068553452394,0.00668489612986836,-0.0168630819490659,0.00934171088001804,0.573741053899218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,0.00145005441455906,0.00257781765575502,-0.00360246819072078,0.00650257701983891,0.573776346577357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,-0.00293140107004698,0.00522981631065892,-0.0131818410389385,0.0073190388988445,0.575136168579487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,37541,0.002500905152139,0.00447121118227628,-0.0062626687651225,0.0112644790694005,0.575942645776755
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00154809196020316,0.0027710528251679,-0.00388317157712592,0.00697935549753224,0.576397965819409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.00335158846610482,0.006058446003173,-0.00852296570011426,0.0152261426323239,0.580129613993758
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,-0.00299511433502461,0.00552914218585143,-0.0138322330192934,0.00784200434924419,0.588035495674415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFP,Properdin,38013,-0.00112427639011831,0.00207921230106608,-0.00519953250020782,0.0029509797199712,0.588707908828324
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,0.00311754656973406,0.00579529048478904,-0.00824122278045245,0.0144763159199206,0.590624281998595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,-0.00296152186789254,0.00552687954774261,-0.013794205781468,0.00787116204568297,0.592078338144454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,37900,-0.00205241027474128,0.00383059817770124,-0.00956038270303571,0.00545556215355314,0.592110015044103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00285686664700699,0.00535707638304652,-0.0133567363577782,0.0076430030637642,0.593843057921756
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00204105814087573,0.00383729239338196,-0.00548003495015291,0.00956215123190437,0.594802218106981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,37541,0.0029448142263329,0.00556790820529156,-0.00796828585603857,0.0138579143087044,0.596890322038146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-0.0028349595901984,0.00538652254864378,-0.0133925437855402,0.00772262460514341,0.598684514340787
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,40044,-0.00317665362830155,0.00605484685914843,-0.0150441534722325,0.00869084621562937,0.599836480970431
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00252003329311194,0.0048222642832552,-0.00693160470206825,0.0119716712882921,0.601273208776088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,39878,-0.00347680307576202,0.00666355746973546,-0.0165373757164435,0.00958376956491948,0.601842287364426
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,-0.00205575396839942,0.00396223109521748,-0.00982172691502567,0.00571021897822684,0.603882895059756
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.00317782822944753,0.00620439566247978,-0.00898278726901285,0.0153384437279079,0.608525468181646
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,37901,-0.00519428156551219,0.0101611524498727,-0.0251101403672627,0.0147215772362383,0.609226271015369
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,-0.00179315358187236,0.00358405661066593,-0.00881790453877759,0.00523159737503287,0.61686237680846
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,40044,-0.00162062224346252,0.00324613162494782,-0.00798304022836025,0.00474179574143521,0.617612264859067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,0.00219864591753209,0.00443738200722383,-0.00649862281662662,0.0108959146516908,0.620267542986974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,37942,-0.00445221867515527,0.00902655643651731,-0.0221442692907292,0.0132398319404187,0.621854179071489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,-0.00274337456644966,0.00561203905990069,-0.013742971123855,0.0082562219909557,0.62496364479899
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,40044,-0.00228072422151525,0.00467753183090039,-0.01144868661008,0.00688723816704952,0.625846154719923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,37482,-0.00250234128119585,0.00514575729783668,-0.0125880255849558,0.00758334302256405,0.626768236038148
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,-0.00194982489306233,0.00407073326439458,-0.00992846209127571,0.00602881230515105,0.631956423564372
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,-0.00298087271126069,0.00625339355701525,-0.0152375240830106,0.0092757786604892,0.633597374035874
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.00184751094197727,0.00387884982321625,-0.00575503471152658,0.00945005659548112,0.633865850625071
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEB,Nebulin,37562,-0.00164959274602702,0.00346630794873196,-0.00844355632554167,0.00514437083348763,0.634158321882379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,0.00236064301955019,0.00500732378944028,-0.00745371160775275,0.0121749976468531,0.637335711614467
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.00149323942045659,0.00317358188361495,-0.00472698107142871,0.00771345991234189,0.637989852116757
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPS,Colipase,40311,0.00304991663637173,0.00649506261896451,-0.00968040609679871,0.0157802393695422,0.638665408655038
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,40042,-0.00147353117498432,0.00314323214235298,-0.00763426617399617,0.00468720382402753,0.639222805839872
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,40044,-0.00213014530731995,0.0045486994843404,-0.0110455962966271,0.00678530568198724,0.639578290452954
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,0.000604854360686383,0.00129199465204345,-0.00192745515731878,0.00313716387869154,0.639681085329448
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.00573710371947698,0.0122548396525423,-0.0297565894384599,0.018282381999506,0.639684880523394
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,0.00110730825532139,0.00238732658497792,-0.00357185185123533,0.00578646836187811,0.642778623666386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,37900,0.00149217834720072,0.00322265894639292,-0.00482423318772939,0.00780858988213084,0.64335245239327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,0.001895445411526,0.0040950199568244,-0.00613079370384982,0.00992168452690182,0.643468113178256
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,40355,0.00802840019612855,0.0174692535324966,-0.0262113367275648,0.0422681371198219,0.645828904110714
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.00128081749289693,0.00279919213485178,-0.00676723407720642,0.00420559909141257,0.647269853870055
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,0.0040114879309933,0.00882149726103234,-0.0132786467006301,0.0213016225626167,0.649303787331628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00195238673539639,0.004302330548802,-0.00648018114025553,0.0103849546110483,0.64998192479904
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,37942,0.00254973488841233,0.0056776395322603,-0.00857843859481786,0.0136779083716425,0.653378553553695
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,0.00180734238163276,0.0040382473406121,-0.00610762240596694,0.00972230716923247,0.654480959475316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,-0.00192552100180532,0.00430485288730061,-0.0103630326609145,0.00651199065730388,0.654671274473254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,37900,-0.00157134398267862,0.0035310704748798,-0.00849224211344302,0.00534955414808578,0.656323309973963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,37562,0.00358731135061669,0.0080880052852375,-0.0122651790084488,0.0194398017096822,0.657386313940371
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,37541,-0.00486192351302036,0.0109884332590948,-0.0263992527008462,0.0166754056748055,0.658164909453043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,37572,-0.00276363090138074,0.00630974613828348,-0.0151307333324164,0.00960347152965488,0.661397849039537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,37987,0.00106600526004475,0.00243492831360057,-0.00370645423461236,0.00583846475470186,0.661540149230061
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,-0.00275794758792197,0.00630687784744705,-0.0151194281689182,0.00960353299307425,0.661905611379312
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,37598,0.0018031051746951,0.00413849934555088,-0.00630835354258461,0.00991456389197482,0.663068395773046
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00266548147140583,0.0061497555976729,-0.00938803950003305,0.0147190024428447,0.66471029759816
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC1,Hamartin,37598,-0.00312466282621763,0.00726024917756007,-0.0173547512142354,0.0111054255618001,0.66692661875699
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,40536,0.00130867908911632,0.00306332489519308,-0.00469543770546212,0.00731279588369475,0.669233033584265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00351301896323043,0.00823143659537152,-0.0196466346901586,0.0126205967636978,0.669546023268308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPGN,Epigen,37900,-0.00200361194785844,0.0047058452830181,-0.0112270687025739,0.00721984480685704,0.670281612164573
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00108488281753542,0.00255842120224412,-0.00392962273886305,0.00609938837393389,0.671540575352515
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00268422506837756,0.00640664082987505,-0.00987279095817755,0.0152412410949327,0.675240951017842
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,-0.00110208659864812,0.00264923417079945,-0.00629458557341505,0.00409041237611881,0.677415362194658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.00284298246077275,0.00683467790596797,-0.0105529862349245,0.01623895115647,0.677441650912423
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,-0.00140222223779183,0.00338763527580217,-0.00804198737836408,0.00523754290278042,0.678936650151123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,37541,0.00253265148557737,0.0062122844878357,-0.0096434261105806,0.0147087290817353,0.683512058210894
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.0018872603234645,0.00465999119018627,-0.0110208430562296,0.0072463224093006,0.685489796459613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,37880,0.00194976988138501,0.00487148316383248,-0.00759833711972666,0.0114978768824967,0.688984994759067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00321947370560321,0.00806354497920088,-0.0190240218648369,0.0125850744536305,0.689705988788703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.0019450506145943,0.00487337357946932,-0.00760676160116556,0.0114968628303542,0.689811831052197
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,0.00155196302678599,0.00390843201719453,-0.0061085637269153,0.00921248978048728,0.691314435407474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00176877532706568,0.00448996211779307,-0.00703155042380874,0.0105691010779401,0.693630638601477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.0018188797633646,0.00462946688223839,-0.00725487532582264,0.0108926348525518,0.694405756467804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00183867061598024,0.00472926412463693,-0.0111080283002686,0.00743068706830813,0.697439955492753
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,-0.00210519063668716,0.00543744717720727,-0.0127625871040134,0.00855220583063908,0.698639152995379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,-0.000927166134765851,0.00240979152972033,-0.0056503575330177,0.003796025263486,0.700429292364688
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,40403,-0.00169098015287887,0.00441540863722128,-0.0103451810818326,0.00696322077607483,0.701745246013866
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,-0.000816876257059713,0.00213755766577443,-0.0050064892819776,0.00337273676785818,0.702352246718834
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,-0.00171537082200111,0.00455556300460427,-0.0106442743110255,0.00721353266702326,0.706518456878932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTN,Titin,37562,-0.00234029494065248,0.00624780398492501,-0.0145859907511055,0.00990540086980053,0.70797979815523
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,-0.00126798953706994,0.00339516343470506,-0.00792250986909186,0.00538653079495198,0.708804985089881
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,-0.000980275772030512,0.00264345914990349,-0.00616145570584135,0.00420090416178032,0.710768590146223
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,-0.00306634229883244,0.00840777834395387,-0.019545587852982,0.0134129032553171,0.715337928051963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00173550851237525,0.00476054864295678,-0.00759516682782005,0.0110661838525705,0.715445312852198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,37998,0.00195368478731895,0.00543717711007324,-0.00870318234842461,0.0126105519230625,0.719361547698648
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,37562,0.00146895353154162,0.00409853556556741,-0.0065641761769705,0.00950208324005374,0.720042754811445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,37598,0.00132235145902202,0.00369747395389341,-0.00592469749060907,0.00856940040865312,0.720621138337073
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,-0.00387370469410975,0.010841648173528,-0.0251233351142246,0.0173759257260051,0.720873930575417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,37562,-0.00184346631873758,0.0051999103318387,-0.0120352905691414,0.00834835793166626,0.722955769397179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,-0.00195369704124105,0.00552659669759898,-0.012785826568535,0.00887843248605296,0.723713229996666
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,40228,0.000408236503516776,0.00115612610710436,-0.00185777066640776,0.00267424367344131,0.724012760078941
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,40341,0.00129716497060016,0.00368276764950759,-0.00592105962243471,0.00851538956363503,0.724673766159483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,37572,-0.00310401055075634,0.00882741267448948,-0.0204057393927557,0.014197718291243,0.725119079597373
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00117902456837939,0.00337334430303023,-0.00543273026555987,0.00779077940231865,0.726710516495356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,-0.0020934054861957,0.00599084713627529,-0.0138354658732953,0.00964865490090387,0.726769148336858
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,-0.000888127739901267,0.00256805768315,-0.00592152079887526,0.00414526531907272,0.729471057257842
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,-0.00143377456370721,0.00415102632634812,-0.00956978616334952,0.00670223703593511,0.729797404104142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,40341,-0.00196057699334871,0.0056843537001533,-0.0131019102456492,0.00918075625895177,0.730168375510912
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,40489,-0.00197207259019604,0.00575888321424388,-0.013259483690114,0.00931533850972196,0.732024196842122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,37642,0.0010367185736693,0.00303989599324659,-0.00492147757309402,0.00699491472043262,0.733080772393092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,37598,0.00158941094694931,0.0046765424003101,-0.00757661215765849,0.0107554340515571,0.733960748276926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,37482,0.00378452897671748,0.0111438038733095,-0.0180573266149692,0.0256263845684041,0.73415695385251
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.0012167595491342,0.00359384918732102,-0.00582718485801501,0.0082607039562834,0.734941135727233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,0.0010812670876447,0.00320505740958857,-0.00520064543514891,0.0073631796104383,0.735848870707399
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,0.00145704130370788,0.00432182654394158,-0.00701373872241762,0.00992782132983339,0.736019183902784
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00103976217742938,0.00309202614882957,-0.00502060907427659,0.00710013342913534,0.736671056531312
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,-0.00119532322344482,0.00355807521995424,-0.00816915065455513,0.00577850420766549,0.736915666257482
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,37482,-0.00194578769793055,0.00582071416157724,-0.0133543874546219,0.00946281205876083,0.73816855786163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,0.00133008419122274,0.00399368049382756,-0.00649752957667928,0.00915769795912475,0.739103996808696
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NENF,Neudesin,37900,-0.00337638131046971,0.0102951705332115,-0.0235549155555643,0.0168021529346249,0.742948688157514
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,37598,-0.00159679351130305,0.00491024459026326,-0.011220872908219,0.00802728588561295,0.745037662603091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,37562,0.00202218453581659,0.00622921600902904,-0.0101870788418803,0.0142314479135135,0.745467010446614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,37572,0.00185180597459291,0.00572333411196584,-0.00936592888486014,0.0130695408340459,0.746281096662645
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,-0.00210865860212822,0.00663938110332607,-0.0151218455646473,0.0109045283603909,0.750794428014252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00127897811392815,0.00403211692938358,-0.00918192729551996,0.00662397106766366,0.751098661545717
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,37562,-0.0021623663737866,0.00690061236913274,-0.0156875666172868,0.0113628338697136,0.754013203183869
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,37572,-0.00101141899591232,0.00332404774900622,-0.00752655258396451,0.00550371459213987,0.760924506437152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,-0.00172678219947092,0.00572009343217445,-0.0129381653265328,0.009484600927591,0.762747457252392
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00157384145283594,0.00522984546096147,-0.0118243385563204,0.00867665565064855,0.763469124665928
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,40042,0.0030375182629859,0.0102009018205627,-0.0169562493053169,0.0230312858312887,0.765883000457081
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,40355,0.00127436441431289,0.00428618049457106,-0.00712654935504638,0.00967527818367216,0.766226590684535
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,0.000914983159374354,0.00310981229899522,-0.00518024894665627,0.00701021526540498,0.768590816852201
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.00111831448798723,0.00383945485186616,-0.00864364599764491,0.00640701702167044,0.770850147569894
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,-0.00150732626111358,0.0051943987354362,-0.0116883477825685,0.00867369526034138,0.771680819267519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,-0.00109966018135354,0.00379428097719971,-0.00853645089666498,0.0063371305339579,0.771958064316459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,39980,-0.00379429284921454,0.013595556976509,-0.0304415845231722,0.0228529988247431,0.780184618737887
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,37562,-0.00124664996167441,0.00446908191902771,-0.0100060505229687,0.0075127505996199,0.780287671809918
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,40042,-0.000725786769522675,0.00262607683934998,-0.00587289737464863,0.00442132383560328,0.782262321173564
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,0.00130895836464634,0.00476556773250533,-0.00803155439106411,0.0106494711203568,0.783574126277665
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,37572,-0.00225284077537281,0.00828840830385522,-0.018498121050929,0.0139924395001834,0.78577531353032
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,-0.00244087466765839,0.00902218979239676,-0.020124366660756,0.0152426173254393,0.786748024572318
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,40044,-0.00130366520681012,0.00483750462135152,-0.0107851742646591,0.00817784385103887,0.78755523456966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,40379,0.000752920040454166,0.00281367037996907,-0.00476187390428522,0.00626771398519355,0.789015662706638
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.0010862593458884,0.00409206168823273,-0.00910670025482455,0.00693418156304776,0.790662933077771
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,37572,0.00122469530212095,0.00465451144230322,-0.00789814712479336,0.0103475377290353,0.792462179273401
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRL,Prolactin,40471,-0.00189345255925367,0.00726117320424669,-0.0161253520395772,0.0123384469210698,0.794277860993966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,-0.00240918437101628,0.00928826955276161,-0.020614192694429,0.0157958239523965,0.795346718898716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.000893049915818734,0.00345602958146062,-0.00588076806384409,0.00766686789548156,0.79609961105988
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,37901,0.00276892164230186,0.0107822714810332,-0.0183643304605233,0.023902173745127,0.797334640626418
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.00141871349411505,0.00570897922050146,-0.0126083127662979,0.00977088577806782,0.803747104820665
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,37572,-0.00110480217965952,0.00444736625635691,-0.00982164004211907,0.00761203568280002,0.80381553114854
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,0.000952294532804611,0.00383376311942985,-0.00656188118127791,0.00846647024688713,0.803830672104833
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,37562,0.00117457399263862,0.00477342649634485,-0.00818134194019729,0.0105304899254745,0.805635638303697
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,0.00118080794391688,0.00481142211668212,-0.00824957940478007,0.0106111952926138,0.806136923560872
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,0.00134662061443966,0.00552029146511239,-0.00947315065718062,0.0121663918860599,0.80728100615468
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00146116672799976,0.00601771881113664,-0.0103335621418281,0.0132558955978276,0.808155774024814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,40042,0.00166498403611364,0.00688198766366918,-0.011823711784678,0.0151536798569052,0.808834798106581
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,-0.00134327855096649,0.00566814366120809,-0.0124528401269343,0.00976628302500136,0.812670301458363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.000439182453237566,0.00186389983340772,-0.00409242612671669,0.00321406122024156,0.813726791237228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.00202279372500683,0.00864439896342536,-0.0149202282433069,0.0189658156933205,0.814988262713186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,-0.000603909441671936,0.00258106846926129,-0.00566280364142406,0.00445498475808019,0.815006202828056
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,37766,0.000733527552658715,0.00315069484467168,-0.00544183434289778,0.00690888944821521,0.81590900510775
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00128000210941222,0.00557837169584558,-0.00965360641444512,0.0122136106332696,0.818516517186185
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,0.00102368200901873,0.0044757522146863,-0.00774879233176641,0.00979615634980387,0.819091707799415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,40357,-0.000771719945003248,0.00341324438832636,-0.00746167894612291,0.00591823905611642,0.821129879199676
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.0011332927107117,0.00504401755649986,-0.0110195671214514,0.00875298170002802,0.822230745486557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.000564453702638937,0.002517540204252,-0.00436992509769498,0.00549883250297285,0.822598518203779
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,37572,0.000490364604148477,0.00222770192858959,-0.00387593117588712,0.00485666038418407,0.825780125502131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,-0.00120540729176395,0.00548466245483093,-0.0119553457032326,0.00954453111970468,0.826046972631157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00149733711483722,0.00697809900117953,-0.0121797369274747,0.0151744111571491,0.83010074236064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,-0.00207555412741413,0.00968670543155876,-0.0210614967732693,0.016910388518441,0.830341148880235
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,37562,-0.00096605023328737,0.0045410438639818,-0.0098664962066917,0.00793439574011696,0.831535037760961
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,38013,0.000398272250716099,0.00189515142297066,-0.00331622453830639,0.00411276903973859,0.833551214792364
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,37598,-0.00124939112083188,0.00595754633801127,-0.012926181943334,0.0104273997016702,0.833892805220315
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,-0.000685550287291829,0.00330476551055896,-0.00716289068798739,0.00579179011340373,0.835666576843245
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,40044,-0.000610582827671033,0.00297083317628757,-0.00643341585319467,0.0052122501978526,0.837164035809342
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00051887574735928,0.00260439951375454,-0.00458574729959961,0.00562349879431817,0.842084981490719
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,37541,0.00104252431311329,0.00523686252747077,-0.00922172624072942,0.011306774866956,0.842207780655223
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,-0.00091131212535998,0.00462197467815965,-0.0099703824945529,0.00814775824383294,0.843697998405165
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,37959,-0.000676965938788395,0.00345283783671931,-0.00744452809875824,0.00609059622118145,0.844565574815788
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,37714,0.00157590863904718,0.00812842471730537,-0.0143558038068713,0.0175076210849657,0.846275736755155
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00116375932348104,0.00608521106655441,-0.0130907730139277,0.0107632543669656,0.848337460969017
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,37981,-0.000405305827647846,0.00212595002690144,-0.00457216788037467,0.00376155622507898,0.84880508696526
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,-0.000648992973948358,0.00342397232767799,-0.00735997873619722,0.0060619927883005,0.849669040292032
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.000981159663293521,0.00518783604644295,-0.0111493183143217,0.00918699898773465,0.849996205443342
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,39311,0.000852628336355727,0.0045753633181954,-0.00811508376730726,0.00982034044001871,0.852171235758977
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,-0.00120717975528548,0.00657888987243616,-0.0141018039052603,0.0116874443946894,0.854413667188341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,39992,-0.000821715365103703,0.00453931343725574,-0.00971876970212496,0.00807533897191755,0.856352708604243
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.000664623048941705,0.00368103318738264,-0.00787944809621167,0.00655020199832826,0.856720838830297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,37959,0.000637179535112252,0.0035653789641917,-0.00635096323470348,0.00762532230492799,0.858165749214261
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,40305,-0.000319153978477031,0.00181268547903837,-0.00387201751739223,0.00323370956043817,0.86024360514366
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,37598,-0.00080412207777851,0.00459457174467229,-0.00980948269733619,0.00820123854177917,0.861070011700442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,-0.000431169340113809,0.00251185477190209,-0.0053544046930419,0.00449206601281428,0.863712315371267
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,37598,0.0016644570150436,0.00986215135495257,-0.0176653596406634,0.0209942736707506,0.865978419618485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,37942,-0.000481066483517424,0.00290533766718223,-0.00617552831119459,0.00521339534415975,0.868489786723034
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.0011942498120162,0.00739816792319236,-0.0156946589414732,0.0133061593174408,0.871761043591484
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.000860094489905166,0.00535749426213991,-0.00964059426388906,0.0113607832436994,0.87245781280897
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,-0.00104319312285283,0.00662383529633793,-0.0140259103036752,0.0119395240579695,0.87486045520052
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,37598,0.000454933422393117,0.00290219743916863,-0.0052333735583774,0.00614324040316363,0.875440492170488
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.00107400615081302,0.00691368986074596,-0.0124768259762491,0.0146248382778751,0.876551845164175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.000353742899981469,0.00229377237301787,-0.00414205095113355,0.00484953675109649,0.877439142822841
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,40341,0.000863189250890694,0.00559799700385496,-0.010108884876665,0.0118352633784464,0.877457083273357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.000989082934976612,0.00648244074334771,-0.0117165009219849,0.0136946667919381,0.878732777029512
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,39980,0.000813952225077107,0.00534729058017634,-0.00966673731206852,0.0112946417622227,0.879017218794211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00119302523286421,0.00786396309538666,-0.0166063928998221,0.0142203424340936,0.879419643025036
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,-0.000462114000105561,0.00310884379146761,-0.00655544783138207,0.00563121983117095,0.881836074095325
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,0.00180521648244015,0.0121728181080068,-0.0220535070092531,0.0256639399741334,0.882108688633905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.000892589433372706,0.00602801976445556,-0.0127075081717056,0.0109223293049602,0.882286749964853
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,-0.000821646064436488,0.00556800241089796,-0.0117349307897965,0.0100916386609235,0.882687457459903
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,37628,0.000245684762600397,0.00170377385710968,-0.00309371199733457,0.00358508152253536,0.885344481027406
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,37998,0.000592095934124975,0.00423800160064251,-0.00771438720313434,0.00889857907138429,0.888890320166869
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,0.000354198201756163,0.0025423740221657,-0.0046288548816886,0.00533725128520093,0.889201077440935
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,37900,0.00105444257941912,0.00768332074210456,-0.0140048660751058,0.0161137512339441,0.890844832012259
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,37990,0.000378807544232461,0.00277624426523638,-0.00506263121563084,0.00582024630409576,0.891470705854314
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.000640416871910523,0.00485302879872296,-0.0101523533174075,0.00887151957358647,0.895016129838685
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,-0.0010456983329238,0.00797725326705303,-0.0166811147363477,0.0145897180705001,0.895710068112969
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.00144698091201441,0.0113885672149964,-0.0208746108293785,0.0237685726534074,0.898898053876065
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,37482,0.000360403526987278,0.00295687692040167,-0.00543507523699999,0.00615588229097455,0.902990747244994
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,0.00100664562838394,0.00835680901492146,-0.0153727000408621,0.01738599129763,0.904122091845255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,-0.000837634718827495,0.00723709502819106,-0.015022340974082,0.013347071536427,0.907858895289078
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.000986409340811022,0.00868976786128783,-0.0160455356673131,0.0180183543489352,0.909624586892779
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.00061074807833927,0.00541339985833766,-0.00999951564400255,0.0112210118006811,0.910173473882399
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,0.000528278652456776,0.00474440794646067,-0.00877076092260613,0.00982731822751968,0.911342325588089
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.000452546475209236,0.00418686212087222,-0.00775370328170032,0.0086587962321188,0.913928082597754
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.000284228232171011,0.00268327285448447,-0.00497498656261856,0.00554344302696058,0.915642719206138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,37482,0.000407148040331541,0.00402058020375446,-0.00747318915902719,0.00828748523969028,0.919340870424875
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,37598,-0.000539664472774328,0.00554461605288193,-0.0114071119364229,0.0103277829908743,0.922464814866899
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,37714,0.000391378680921277,0.0040876759937914,-0.00762046626690987,0.00840322362875242,0.923723741887913
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,37959,-0.00039638388765371,0.00417043889554443,-0.00857044412292079,0.00777767634761337,0.924279632367814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.000435157857120271,0.00465970292576144,-0.00869785987737215,0.0095681755916127,0.92559721564021
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,0.000577567116497627,0.00622826554642618,-0.0116298333544977,0.0127849675874929,0.926116703092527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,-0.000418136675235349,0.00454173111403847,-0.00931992965875075,0.00848365630828006,0.9266471753205
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,0.000773461724523979,0.00848442358979671,-0.0158560085114776,0.0174029319605255,0.927364604407233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.000327657294223646,0.00391789022538268,-0.0080067221359737,0.00735140754752641,0.933351051713815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,-0.000167513028170028,0.00213050031929957,-0.00434329365399719,0.00400826759765713,0.937331187477119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.000306060110709587,0.00405776517954035,-0.0076471596411895,0.00825927986260868,0.939877063815987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.000339330885502622,0.00451717900686757,-0.00919300173896306,0.00851433996795782,0.940120311059946
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.000243708146919002,0.00328575046998748,-0.00619636277425647,0.00668377906809447,0.940875276572523
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,37671,-0.00022851308901239,0.0032238706826358,-0.00654729962697855,0.00609027344895377,0.943493065579206
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,-0.000385124535151547,0.00547006634722505,-0.0111064545757126,0.0103362055054096,0.943871701788854
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,-0.000314967195796894,0.00473502474585206,-0.00959561569766693,0.00896568130607315,0.946965966962781
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,37562,0.000255788556206011,0.00386329829970524,-0.00731627611121625,0.00782785322362827,0.947211732406332
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,0.000285166374177489,0.00438634725320902,-0.0083120742421122,0.00888240699046718,0.948165226938966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,40387,-0.000186615996398749,0.00288205796217506,-0.00583544960226186,0.00546221760946437,0.948373106407684
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,0.000507944903362777,0.00809671014870431,-0.0153616069880977,0.0163774967948232,0.949978688867947
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.000288454384826067,0.00470615142470897,-0.00893560240760351,0.00951251117725564,0.951126764020005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,37714,-0.000320301338600838,0.00579713883180022,-0.0116826934489293,0.0110420907717276,0.955938833502421
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.000230294959731824,0.00418405059789578,-0.0079704442121439,0.00843103413160755,0.956106371145936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,40044,-0.000213701810789746,0.00390285090328244,-0.00786328958122333,0.00743588595964384,0.956334106006658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,40489,-0.000149171499538162,0.00277893381980411,-0.00559588178635421,0.00529753878727789,0.957191264338978
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,0.000172701542093239,0.0032386154293581,-0.00617498469944864,0.00652038778363511,0.957473060550454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,37482,0.000314988289022272,0.00594255562208981,-0.0113324207302737,0.0119623973083183,0.957728317030573
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,37572,0.000132601354443695,0.0025889993613032,-0.00494183739371058,0.00520704010259797,0.959153208566441
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.000683178011625047,0.013503411847029,-0.0257835092085517,0.0271498652318018,0.959650622498869
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,37714,0.00027525788812934,0.0058807468251941,-0.0112510058892511,0.0118015216655098,0.962668056758088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,37562,0.000470409511846158,0.0105313277765975,-0.020170992930285,0.0211118119539773,0.964372911259448
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLC,Galectin-10,40333,-0.000250083149587556,0.00623892824215424,-0.0124783825042099,0.0119782162050348,0.968026412401368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,37482,-0.000282007340351914,0.00703900566133066,-0.01407845843656,0.0135144437558562,0.968043099486565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,-0.00029832337961411,0.00826647142342634,-0.0165006073695297,0.0159039606103015,0.971212454326215
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00018559287370085,0.00532571234874527,-0.0102528033298399,0.0106239890772416,0.972201112393486
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,37714,0.00017745251426417,0.00526836074665105,-0.0101485345491719,0.0105034395777002,0.973130696616889
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.000135530962817271,0.00472221329542933,-0.00912000709622421,0.00939106902185875,0.977103644449832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00012036147082817,0.00472491178439331,-0.00938118856823905,0.00914046562658271,0.97967743416936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,37482,0.000124862513534951,0.00518568969730337,-0.0100390892931797,0.0102888143202496,0.980790533209899
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,37577,-0.000145409124306134,0.00656627641681154,-0.0130153109012567,0.0127244926526445,0.982332756704004
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,-7.14860635739941e-05,0.00460629434637714,-0.0090998229824732,0.00895685085532521,0.987618192653258
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,-6.67114672666444e-05,0.00439003348645168,-0.00867117710071193,0.00853775416617864,0.987875942416814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,40044,-6.46633580133109e-05,0.00445824597244612,-0.0088028254640077,0.00867349874798108,0.988427902124002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,-3.21501277063584e-05,0.00276360836159419,-0.00544882251643097,0.00538452226101826,0.990718285403042
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,4.14267849282572e-05,0.00578487389303422,-0.0112969260454188,0.0113797796152753,0.994286327412196
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-3.26793864311314e-05,0.00478990215108685,-0.00942088760256136,0.0093555288296991,0.994556537029974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,-4.14390074291176e-06,0.00341218912721389,-0.00669203459008213,0.00668374678859631,0.999031032150782
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,1.41552113230439e-06,0.00472944061949302,-0.00926828809307401,0.00927111913533862,0.999761197636899
